ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:2001028,positive regulation of endothelial cell chemotaxis,3/173,15/18888,0.000316861347883663,0.208771593989789,0.194924607326593,PRKD2/SEMA5A/SMOC2,3
GO:0050854,regulation of antigen receptor-mediated signaling pathway,5/173,68/18888,0.000397878160092879,0.208771593989789,0.194924607326593,CD226/LPXN/NECTIN2/PRKD2/SH2D1A,5
GO:0050862,positive regulation of T cell receptor signaling pathway,3/173,18/18888,0.000556890445761465,0.208771593989789,0.194924607326593,CD226/NECTIN2/PRKD2,3
GO:0002714,positive regulation of B cell mediated immunity,4/173,42/18888,0.000579908077005988,0.208771593989789,0.194924607326593,CD226/CLCF1/NECTIN2/XCL1,4
GO:0002891,positive regulation of immunoglobulin mediated immune response,4/173,42/18888,0.000579908077005988,0.208771593989789,0.194924607326593,CD226/CLCF1/NECTIN2/XCL1,4
GO:0016064,immunoglobulin mediated immune response,8/173,208/18888,0.000677187906656377,0.208771593989789,0.194924607326593,CD226/CLCF1/FCGR3A/IGHG4/IGHV3-64D/NECTIN2/SANBR/XCL1,8
GO:0019724,B cell mediated immunity,8/173,212/18888,0.000766748967274666,0.208771593989789,0.194924607326593,CD226/CLCF1/FCGR3A/IGHG4/IGHV3-64D/NECTIN2/SANBR/XCL1,8
GO:0030517,negative regulation of axon extension,4/173,46/18888,0.000821755845563071,0.208771593989789,0.194924607326593,NTN1/SEMA3C/SEMA4C/SEMA5A,4
GO:0050856,regulation of T cell receptor signaling pathway,4/173,46/18888,0.000821755845563071,0.208771593989789,0.194924607326593,CD226/NECTIN2/PRKD2/SH2D1A,4
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,11/173,385/18888,0.000867309695514329,0.208771593989789,0.194924607326593,CD226/CLCF1/FCGR3A/IGHG4/IGHV3-64D/IL6R/LY9/NECTIN2/SANBR/SLC11A1/XCL1,11
GO:0050919,negative chemotaxis,4/173,47/18888,0.000891839818985509,0.208771593989789,0.194924607326593,NTN1/SEMA3C/SEMA4C/SEMA5A,4
GO:0050920,regulation of chemotaxis,8/173,229/18888,0.0012596581784441,0.244014969540437,0.227830430426309,IL6R/PRKD2/SEMA3C/SEMA4C/SEMA5A/SMOC2/TNFAIP6/XCL1,8
GO:0099072,regulation of postsynaptic membrane neurotransmitter receptor levels,5/173,88/18888,0.00129105428046361,0.244014969540437,0.227830430426309,ARC/FLOT2/NPTX1/SNAP25/VAC14,5
GO:2001026,regulation of endothelial cell chemotaxis,3/173,24/18888,0.00132668332954024,0.244014969540437,0.227830430426309,PRKD2/SEMA5A/SMOC2,3
GO:0002762,negative regulation of myeloid leukocyte differentiation,4/173,54/18888,0.00150465272951724,0.258298718567126,0.241166795383675,CDK6/CUL4A/NME2/TNFAIP6,4
GO:0048511,rhythmic process,9/173,297/18888,0.00170593751823945,0.261742444630981,0.244382112840944,ATF5/CUL4A/NR1H3/OXTR/PER3/PSPC1/RBM4B/SRRD/TNFAIP6,9
GO:0045638,negative regulation of myeloid cell differentiation,5/173,97/18888,0.00198840477823405,0.261742444630981,0.244382112840944,CDK6/CUL4A/NME2/TNFAIP6/ZFP36L1,5
GO:0048843,negative regulation of axon extension involved in axon guidance,3/173,28/18888,0.00209046983530891,0.261742444630981,0.244382112840944,SEMA3C/SEMA4C/SEMA5A,3
GO:0050857,positive regulation of antigen receptor-mediated signaling pathway,3/173,28/18888,0.00209046983530891,0.261742444630981,0.244382112840944,CD226/NECTIN2/PRKD2,3
GO:0010977,negative regulation of neuron projection development,6/173,146/18888,0.00228246630492917,0.261742444630981,0.244382112840944,GFI1/NTN1/SEMA3C/SEMA4C/SEMA5A/ZNF365,6
GO:0045954,positive regulation of natural killer cell mediated cytotoxicity,3/173,29/18888,0.00231610119883256,0.261742444630981,0.244382112840944,CD226/NECTIN2/SH2D1A,3
GO:0002712,regulation of B cell mediated immunity,4/173,62/18888,0.00250793588782181,0.261742444630981,0.244382112840944,CD226/CLCF1/NECTIN2/XCL1,4
GO:0002889,regulation of immunoglobulin mediated immune response,4/173,62/18888,0.00250793588782181,0.261742444630981,0.244382112840944,CD226/CLCF1/NECTIN2/XCL1,4
GO:0002699,positive regulation of immune effector process,8/173,257/18888,0.00259210560068722,0.261742444630981,0.244382112840944,CD226/CLCF1/COLEC11/NECTIN2/PANX1/SH2D1A/SPON2/XCL1,8
GO:0035767,endothelial cell chemotaxis,3/173,31/18888,0.00281125635327495,0.261742444630981,0.244382112840944,PRKD2/SEMA5A/SMOC2,3
GO:0099590,neurotransmitter receptor internalization,3/173,31/18888,0.00281125635327495,0.261742444630981,0.244382112840944,ARC/SNAP25/VAC14,3
GO:0050771,negative regulation of axonogenesis,4/173,66/18888,0.00314985283208729,0.261742444630981,0.244382112840944,NTN1/SEMA3C/SEMA4C/SEMA5A,4
GO:0002420,natural killer cell mediated cytotoxicity directed against tumor cell target,2/173,10/18888,0.00357648065755917,0.261742444630981,0.244382112840944,CD226/NECTIN2,2
GO:0002855,regulation of natural killer cell mediated immune response to tumor cell,2/173,10/18888,0.00357648065755917,0.261742444630981,0.244382112840944,CD226/NECTIN2,2
GO:0043653,mitochondrial fragmentation involved in apoptotic process,2/173,10/18888,0.00357648065755917,0.261742444630981,0.244382112840944,MFF/NPTX1,2
GO:0002717,positive regulation of natural killer cell mediated immunity,3/173,34/18888,0.00366812860961888,0.261742444630981,0.244382112840944,CD226/NECTIN2/SH2D1A,3
GO:0048841,regulation of axon extension involved in axon guidance,3/173,34/18888,0.00366812860961888,0.261742444630981,0.244382112840944,SEMA3C/SEMA4C/SEMA5A,3
GO:0001912,positive regulation of leukocyte mediated cytotoxicity,4/173,69/18888,0.00369904241037946,0.261742444630981,0.244382112840944,CD226/NECTIN2/SH2D1A/XCL1,4
GO:0050922,negative regulation of chemotaxis,4/173,70/18888,0.00389563816032678,0.261742444630981,0.244382112840944,SEMA3C/SEMA4C/SEMA5A/TNFAIP6,4
GO:0042752,regulation of circadian rhythm,5/173,114/18888,0.0040006811361946,0.261742444630981,0.244382112840944,NR1H3/PER3/PSPC1/RBM4B/SRRD,5
GO:0002423,natural killer cell mediated immune response to tumor cell,2/173,11/18888,0.00434502095522104,0.261742444630981,0.244382112840944,CD226/NECTIN2,2
GO:0060272,embryonic skeletal joint morphogenesis,2/173,11/18888,0.00434502095522104,0.261742444630981,0.244382112840944,COL2A1/SHOX2,2
GO:0071313,cellular response to caffeine,2/173,11/18888,0.00434502095522104,0.261742444630981,0.244382112840944,RYR3/TMEM38A,2
GO:0014015,positive regulation of gliogenesis,4/173,74/18888,0.00475272990943075,0.261742444630981,0.244382112840944,CLCF1/GJC2/NTN1/ZNF365,4
GO:0001906,cell killing,7/173,226/18888,0.00488098227971413,0.261742444630981,0.244382112840944,APOL1/CD226/FCGR3A/GSDMB/NECTIN2/SH2D1A/XCL1,7
GO:0048846,axon extension involved in axon guidance,3/173,38/18888,0.0050348180841153,0.261742444630981,0.244382112840944,SEMA3C/SEMA4C/SEMA5A,3
GO:1902284,neuron projection extension involved in neuron projection guidance,3/173,38/18888,0.0050348180841153,0.261742444630981,0.244382112840944,SEMA3C/SEMA4C/SEMA5A,3
GO:0010721,negative regulation of cell development,8/173,288/18888,0.00514664348410366,0.261742444630981,0.244382112840944,CDK6/CUL4A/NME2/NTN1/SEMA3C/SEMA4C/SEMA5A/TNFAIP6,8
GO:0006216,cytidine catabolic process,2/173,12/18888,0.00518275715741786,0.261742444630981,0.244382112840944,APOBEC3D/APOBEC3H,2
GO:0009972,cytidine deamination,2/173,12/18888,0.00518275715741786,0.261742444630981,0.244382112840944,APOBEC3D/APOBEC3H,2
GO:0016554,cytidine to uridine editing,2/173,12/18888,0.00518275715741786,0.261742444630981,0.244382112840944,APOBEC3D/APOBEC3H,2
GO:0021670,lateral ventricle development,2/173,12/18888,0.00518275715741786,0.261742444630981,0.244382112840944,CDK6/DNAH5,2
GO:0030157,pancreatic juice secretion,2/173,12/18888,0.00518275715741786,0.261742444630981,0.244382112840944,CEL/NR1H3,2
GO:0046087,cytidine metabolic process,2/173,12/18888,0.00518275715741786,0.261742444630981,0.244382112840944,APOBEC3D/APOBEC3H,2
GO:0031343,positive regulation of cell killing,4/173,76/18888,0.00522525678462595,0.261742444630981,0.244382112840944,CD226/NECTIN2/SH2D1A/XCL1,4
GO:0042267,natural killer cell mediated cytotoxicity,4/173,76/18888,0.00522525678462595,0.261742444630981,0.244382112840944,CD226/FCGR3A/NECTIN2/SH2D1A,4
GO:0007616,long-term memory,3/173,39/18888,0.00541810818126044,0.261742444630981,0.244382112840944,ARC/SLC2A4/SNAP25,3
GO:0051962,positive regulation of nervous system development,8/173,294/18888,0.00580955375325488,0.261742444630981,0.244382112840944,CLCF1/GJC2/NTN1/OXTR/SEMA5A/SHOX2/SLITRK6/ZNF365,8
GO:0050808,synapse organization,11/173,493/18888,0.0058445316531269,0.261742444630981,0.244382112840944,ACTN1/ARC/DNER/NPTX1/NTN1/OXTR/RHOB/SLITRK6/SNAP25/ZMYND8/ZNF365,11
GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,5/173,125/18888,0.00589957208729075,0.261742444630981,0.244382112840944,CD226/CLCF1/NECTIN2/SLC11A1/XCL1,5
GO:0002228,natural killer cell mediated immunity,4/173,79/18888,0.0059914493608871,0.261742444630981,0.244382112840944,CD226/FCGR3A/NECTIN2/SH2D1A,4
GO:0002768,immune response-regulating cell surface receptor signaling pathway,9/173,360/18888,0.00605477397893277,0.261742444630981,0.244382112840944,CD226/COLEC11/FCGR3A/IGHG4/LPXN/NECTIN2/NR1H3/PRKD2/SH2D1A,9
GO:0015838,amino-acid betaine transport,2/173,13/18888,0.00608837211795023,0.261742444630981,0.244382112840944,SLC22A1/SLC6A12,2
GO:0045006,DNA deamination,2/173,13/18888,0.00608837211795023,0.261742444630981,0.244382112840944,APOBEC3D/APOBEC3H,2
GO:0007613,memory,5/173,126/18888,0.00609885307878013,0.261742444630981,0.244382112840944,ARC/OXTR/SLC2A4/SNAP25/TAFA2,5
GO:0002708,positive regulation of lymphocyte mediated immunity,5/173,128/18888,0.00651154414189762,0.26738006997655,0.24964581699599,CD226/CLCF1/NECTIN2/SH2D1A/XCL1,5
GO:0002761,regulation of myeloid leukocyte differentiation,5/173,128/18888,0.00651154414189762,0.26738006997655,0.24964581699599,CDK6/CUL4A/NME2/TNFAIP6/ZFP36L1,5
GO:0002720,positive regulation of cytokine production involved in immune response,4/173,81/18888,0.0065417259838923,0.26738006997655,0.24964581699599,CD226/PANX1/SPON2/XCL1,4
GO:0046131,pyrimidine ribonucleoside metabolic process,2/173,14/18888,0.00706056677085693,0.267968678721471,0.250195385671881,APOBEC3D/APOBEC3H,2
GO:0046133,pyrimidine ribonucleoside catabolic process,2/173,14/18888,0.00706056677085693,0.267968678721471,0.250195385671881,APOBEC3D/APOBEC3H,2
GO:0071415,cellular response to purine-containing compound,2/173,14/18888,0.00706056677085693,0.267968678721471,0.250195385671881,RYR3/TMEM38A,2
GO:0014904,myotube cell development,3/173,43/18888,0.00712392655192686,0.267968678721471,0.250195385671881,DNER/SHOX2/TMEM182,3
GO:0002821,positive regulation of adaptive immune response,5/173,131/18888,0.00716674545452995,0.267968678721471,0.250195385671881,CD226/CLCF1/NECTIN2/SLC11A1/XCL1,5
GO:0050807,regulation of synapse organization,7/173,243/18888,0.00718051993467242,0.267968678721471,0.250195385671881,ARC/NTN1/OXTR/RHOB/SLITRK6/SNAP25/ZMYND8,7
GO:0002449,lymphocyte mediated immunity,9/173,372/18888,0.00744024034298655,0.272823145644784,0.254727875177389,CD226/CLCF1/FCGR3A/IGHG4/IGHV3-64D/NECTIN2/SANBR/SH2D1A/XCL1,9
GO:0071526,semaphorin-plexin signaling pathway,3/173,44/18888,0.00759445346062899,0.272823145644784,0.254727875177389,SEMA3C/SEMA4C/SEMA5A,3
GO:0002702,positive regulation of production of molecular mediator of immune response,5/173,134/18888,0.00786667457311488,0.272823145644784,0.254727875177389,CD226/CLCF1/PANX1/SPON2/XCL1,5
GO:0001504,neurotransmitter uptake,3/173,45/18888,0.00808293944795419,0.272823145644784,0.254727875177389,SLC22A1/SLC6A12/SNAP25,3
GO:0031000,response to caffeine,2/173,15/18888,0.00809805991285281,0.272823145644784,0.254727875177389,RYR3/TMEM38A,2
GO:0072498,embryonic skeletal joint development,2/173,15/18888,0.00809805991285281,0.272823145644784,0.254727875177389,COL2A1/SHOX2,2
GO:1903826,L-arginine transmembrane transport,2/173,15/18888,0.00809805991285281,0.272823145644784,0.254727875177389,SLC11A1/SLC38A4,2
GO:0050803,regulation of synapse structure or activity,7/173,249/18888,0.00815820668530035,0.272823145644784,0.254727875177389,ARC/NTN1/OXTR/RHOB/SLITRK6/SNAP25/ZMYND8,7
GO:0010232,vascular transport,4/173,87/18888,0.00839079927130822,0.273497571185046,0.255357568763064,ABCC2/SLC16A2/SLC22A1/SLC2A4,4
GO:0150104,transport across blood-brain barrier,4/173,87/18888,0.00839079927130822,0.273497571185046,0.255357568763064,ABCC2/SLC16A2/SLC22A1/SLC2A4,4
GO:0002836,positive regulation of response to tumor cell,2/173,16/18888,0.00919958798819895,0.278693400818968,0.260208779752897,CD226/NECTIN2,2
GO:0002839,positive regulation of immune response to tumor cell,2/173,16/18888,0.00919958798819895,0.278693400818968,0.260208779752897,CD226/NECTIN2,2
GO:0015697,quaternary ammonium group transport,2/173,16/18888,0.00919958798819895,0.278693400818968,0.260208779752897,SLC22A1/SLC6A12,2
GO:0045869,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,2/173,16/18888,0.00919958798819895,0.278693400818968,0.260208779752897,APOBEC3D/APOBEC3H,2
GO:0046135,pyrimidine nucleoside catabolic process,2/173,16/18888,0.00919958798819895,0.278693400818968,0.260208779752897,APOBEC3D/APOBEC3H,2
GO:0099149,regulation of postsynaptic neurotransmitter receptor internalization,2/173,16/18888,0.00919958798819895,0.278693400818968,0.260208779752897,ARC/VAC14,2
GO:0050921,positive regulation of chemotaxis,5/173,142/18888,0.00996291029080488,0.28206144478868,0.263353434807295,IL6R/PRKD2/SEMA5A/SMOC2/XCL1,5
GO:0010975,regulation of neuron projection development,10/173,460/18888,0.0100194790146248,0.28206144478868,0.263353434807295,ARC/GFI1/NME2/NTN1/SEMA3C/SEMA4C/SEMA5A/SHOX2/SNAP25/ZNF365,10
GO:0030516,regulation of axon extension,4/173,92/18888,0.0101699366223029,0.28206144478868,0.263353434807295,NTN1/SEMA3C/SEMA4C/SEMA5A,4
GO:0042269,regulation of natural killer cell mediated cytotoxicity,3/173,49/18888,0.0102193260854713,0.28206144478868,0.263353434807295,CD226/NECTIN2/SH2D1A,3
GO:0003159,morphogenesis of an endothelium,2/173,17/18888,0.010363904875979,0.28206144478868,0.263353434807295,PRKD2/RHOB,2
GO:0008228,opsonization,2/173,17/18888,0.010363904875979,0.28206144478868,0.263353434807295,COLEC11/SPON2,2
GO:0043031,negative regulation of macrophage activation,2/173,17/18888,0.010363904875979,0.28206144478868,0.263353434807295,CD200/NR1H3,2
GO:0061154,endothelial tube morphogenesis,2/173,17/18888,0.010363904875979,0.28206144478868,0.263353434807295,PRKD2/RHOB,2
GO:0072540,T-helper 17 cell lineage commitment,2/173,17/18888,0.010363904875979,0.28206144478868,0.263353434807295,IL6R/LY9,2
GO:0001909,leukocyte mediated cytotoxicity,5/173,144/18888,0.0105414589997456,0.28206144478868,0.263353434807295,CD226/FCGR3A/NECTIN2/SH2D1A/XCL1,5
GO:0007589,body fluid secretion,4/173,93/18888,0.0105528037162121,0.28206144478868,0.263353434807295,CEL/MTCO2P12/NR1H3/OXTR,4
GO:0031345,negative regulation of cell projection organization,6/173,201/18888,0.0106252272405833,0.28206144478868,0.263353434807295,GFI1/NTN1/SEMA3C/SEMA4C/SEMA5A/ZNF365,6
GO:0006935,chemotaxis,10/173,466/18888,0.0109028129777513,0.283382194768661,0.264586584711956,ACKR4/IL6R/NTN1/PRKD2/SEMA3C/SEMA4C/SEMA5A/SMOC2/TNFAIP6/XCL1,10
GO:0042330,taxis,10/173,468/18888,0.0112100517898848,0.283382194768661,0.264586584711956,ACKR4/IL6R/NTN1/PRKD2/SEMA3C/SEMA4C/SEMA5A/SMOC2/TNFAIP6/XCL1,10
GO:0051960,regulation of nervous system development,10/173,468/18888,0.0112100517898848,0.283382194768661,0.264586584711956,CLCF1/GJC2/NTN1/OXTR/SEMA3C/SEMA4C/SEMA5A/SHOX2/SLITRK6/ZNF365,10
GO:0002443,leukocyte mediated immunity,10/173,469/18888,0.0113661179240162,0.283382194768661,0.264586584711956,CD226/CLCF1/FCGR3A/IGHG4/IGHV3-64D/NECTIN2/SANBR/SH2D1A/SPON2/XCL1,10
GO:0002827,positive regulation of T-helper 1 type immune response,2/173,18/18888,0.0115897816797562,0.283382194768661,0.264586584711956,SLC11A1/XCL1,2
GO:0007623,circadian rhythm,6/173,205/18888,0.0116272531342585,0.283382194768661,0.264586584711956,ATF5/NR1H3/PER3/PSPC1/RBM4B/SRRD,6
GO:0002429,immune response-activating cell surface receptor signaling pathway,8/173,332/18888,0.0116295354774289,0.283382194768661,0.264586584711956,CD226/COLEC11/IGHG4/LPXN/NECTIN2/NR1H3/PRKD2/SH2D1A,8
GO:0001910,regulation of leukocyte mediated cytotoxicity,4/173,96/18888,0.0117569474526542,0.283382194768661,0.264586584711956,CD226/NECTIN2/SH2D1A/XCL1,4
GO:0060996,dendritic spine development,4/173,96/18888,0.0117569474526542,0.283382194768661,0.264586584711956,ARC/PAK4/ZMYND8/ZNF365,4
GO:0002705,positive regulation of leukocyte mediated immunity,5/173,150/18888,0.0124143264663104,0.283382194768661,0.264586584711956,CD226/CLCF1/NECTIN2/SH2D1A/XCL1,5
GO:0007416,synapse assembly,6/173,208/18888,0.0124213168283905,0.283382194768661,0.264586584711956,DNER/NPTX1/NTN1/OXTR/SLITRK6/SNAP25,6
GO:0050851,antigen receptor-mediated signaling pathway,6/173,208/18888,0.0124213168283905,0.283382194768661,0.264586584711956,CD226/IGHG4/LPXN/NECTIN2/PRKD2/SH2D1A,6
GO:0045786,negative regulation of cell cycle,9/173,405/18888,0.0125089368211687,0.283382194768661,0.264586584711956,ATF5/CDK6/CHFR/CUL4A/FBXO43/GJC2/RHOB/SUSD2/ZFP36L1,9
GO:0002715,regulation of natural killer cell mediated immunity,3/173,53/18888,0.012653449483716,0.283382194768661,0.264586584711956,CD226/NECTIN2/SH2D1A,3
GO:0010885,regulation of cholesterol storage,2/173,19/18888,0.0128760065195858,0.283382194768661,0.264586584711956,MSR1/NR1H3,2
GO:0016553,base conversion or substitution editing,2/173,19/18888,0.0128760065195858,0.283382194768661,0.264586584711956,APOBEC3D/APOBEC3H,2
GO:0033003,regulation of mast cell activation,2/173,19/18888,0.0128760065195858,0.283382194768661,0.264586584711956,CD226/NECTIN2,2
GO:0045091,regulation of single stranded viral RNA replication via double stranded DNA intermediate,2/173,19/18888,0.0128760065195858,0.283382194768661,0.264586584711956,APOBEC3D/APOBEC3H,2
GO:0051447,negative regulation of meiotic cell cycle,2/173,19/18888,0.0128760065195858,0.283382194768661,0.264586584711956,CHFR/FBXO43,2
GO:1990822,basic amino acid transmembrane transport,2/173,19/18888,0.0128760065195858,0.283382194768661,0.264586584711956,SLC11A1/SLC38A4,2
GO:0002285,lymphocyte activation involved in immune response,6/173,212/18888,0.0135384320484657,0.295436123091519,0.275841024074003,CLCF1/FCGR3A/IL6R/LY9/SANBR/SLC11A1,6
GO:0030150,protein import into mitochondrial matrix,2/173,20/18888,0.0142213843263574,0.300164464265331,0.28025575324763,TIMM21/TOMM40,2
GO:0039692,single stranded viral RNA replication via double stranded DNA intermediate,2/173,20/18888,0.0142213843263574,0.300164464265331,0.28025575324763,APOBEC3D/APOBEC3H,2
GO:0042454,ribonucleoside catabolic process,2/173,20/18888,0.0142213843263574,0.300164464265331,0.28025575324763,APOBEC3D/APOBEC3H,2
GO:0045655,regulation of monocyte differentiation,2/173,20/18888,0.0142213843263574,0.300164464265331,0.28025575324763,CDK6/ZFP36L1,2
GO:0045667,regulation of osteoblast differentiation,5/173,156/18888,0.0145010415096159,0.300307700239378,0.280389488951146,CDK6/GDPD2/IL6R/TNFAIP6/ZHX3,5
GO:0050770,regulation of axonogenesis,5/173,156/18888,0.0145010415096159,0.300307700239378,0.280389488951146,NTN1/SEMA3C/SEMA4C/SEMA5A/SHOX2,5
GO:0042063,gliogenesis,8/173,346/18888,0.0146011732841688,0.300307700239378,0.280389488951146,CDK6/CERS5/CLCF1/DNER/GJC2/MMP24/NTN1/ZNF365,8
GO:0006865,amino acid transport,5/173,158/18888,0.0152458384716205,0.300307700239378,0.280389488951146,SERINC3/SLC11A1/SLC16A2/SLC38A4/SLC6A12,5
GO:1905039,carboxylic acid transmembrane transport,5/173,158/18888,0.0152458384716205,0.300307700239378,0.280389488951146,ACSL5/SLC11A1/SLC16A2/SLC38A4/SLC6A12,5
GO:0002027,regulation of heart rate,4/173,104/18888,0.0153883523748983,0.300307700239378,0.280389488951146,ADM5/KCNJ2/SCN4B/SHOX2,4
GO:0003333,amino acid transmembrane transport,4/173,104/18888,0.0153883523748983,0.300307700239378,0.280389488951146,SLC11A1/SLC16A2/SLC38A4/SLC6A12,4
GO:0001755,neural crest cell migration,3/173,57/18888,0.0153914236677575,0.300307700239378,0.280389488951146,SEMA3C/SEMA4C/SEMA5A,3
GO:0002295,T-helper cell lineage commitment,2/173,21/18888,0.015624736638443,0.300307700239378,0.280389488951146,IL6R/LY9,2
GO:0090141,positive regulation of mitochondrial fission,2/173,21/18888,0.015624736638443,0.300307700239378,0.280389488951146,MFF/MIEF2,2
GO:0097501,stress response to metal ion,2/173,21/18888,0.015624736638443,0.300307700239378,0.280389488951146,MT1X/SLC11A1,2
GO:1903825,organic acid transmembrane transport,5/173,159/18888,0.0156276628474084,0.300307700239378,0.280389488951146,ACSL5/SLC11A1/SLC16A2/SLC38A4/SLC6A12,5
GO:0002381,immunoglobulin production involved in immunoglobulin-mediated immune response,3/173,58/18888,0.0161239278771493,0.307548994693774,0.287150497242956,CLCF1/SANBR/XCL1,3
GO:0006936,muscle contraction,8/173,355/18888,0.0167826464376239,0.309814233145139,0.28926549146796,CRYAB/KCNJ2/MYLK2/MYOM2/OXTR/RYR3/SCN4B/TMEM38A,8
GO:0090497,mesenchymal cell migration,3/173,59/18888,0.0168757436116731,0.309814233145139,0.28926549146796,SEMA3C/SEMA4C/SEMA5A,3
GO:0001819,positive regulation of cytokine production,10/173,500/18888,0.0170728768105752,0.309814233145139,0.28926549146796,CD200/CD226/FCGR3A/IL6R/LY9/PANX1/PRKD2/SLC11A1/SPON2/XCL1,10
GO:0002837,regulation of immune response to tumor cell,2/173,22/18888,0.0170849014006252,0.309814233145139,0.28926549146796,CD226/NECTIN2,2
GO:0015802,basic amino acid transport,2/173,22/18888,0.0170849014006252,0.309814233145139,0.28926549146796,SLC11A1/SLC38A4,2
GO:0061687,detoxification of inorganic compound,2/173,22/18888,0.0170849014006252,0.309814233145139,0.28926549146796,MT1X/SLC11A1,2
GO:0086012,membrane depolarization during cardiac muscle cell action potential,2/173,22/18888,0.0170849014006252,0.309814233145139,0.28926549146796,KCNJ2/SCN4B,2
GO:0007292,female gamete generation,5/173,163/18888,0.0172187735526737,0.310058334951992,0.289493402976127,BCL2L10/MARF1/PANX1/SEPTIN1/TNFAIP6,5
GO:0046942,carboxylic acid transport,8/173,358/18888,0.0175595316985258,0.312895089196957,0.292142006632948,ABCC2/ACSL5/SERINC3/SLC11A1/SLC16A2/SLC22A1/SLC38A4/SLC6A12,8
GO:0051289,protein homotetramerization,3/173,60/18888,0.017646912811888,0.312895089196957,0.292142006632948,KCNJ2/MAT1A/RYR3,3
GO:0015849,organic acid transport,8/173,359/18888,0.0178241585998211,0.312895089196957,0.292142006632948,ABCC2/ACSL5/SERINC3/SLC11A1/SLC16A2/SLC22A1/SLC38A4/SLC6A12,8
GO:0061387,regulation of extent of cell growth,4/173,109/18888,0.0179800528240627,0.312895089196957,0.292142006632948,NTN1/SEMA3C/SEMA4C/SEMA5A,4
GO:0031341,regulation of cell killing,4/173,110/18888,0.0185289555397213,0.312895089196957,0.292142006632948,CD226/NECTIN2/SH2D1A/XCL1,4
GO:0042116,macrophage activation,4/173,110/18888,0.0185289555397213,0.312895089196957,0.292142006632948,CD200/FCGR3A/NR1H3/SLC11A1,4
GO:0002834,regulation of response to tumor cell,2/173,23/18888,0.0186007327652819,0.312895089196957,0.292142006632948,CD226/NECTIN2,2
GO:0015874,norepinephrine transport,2/173,23/18888,0.0186007327652819,0.312895089196957,0.292142006632948,OXTR/SLC22A1,2
GO:0071636,positive regulation of transforming growth factor beta production,2/173,23/18888,0.0186007327652819,0.312895089196957,0.292142006632948,CD200/XCL1,2
GO:0033013,tetrapyrrole metabolic process,3/173,62/18888,0.0192474473437778,0.312895089196957,0.292142006632948,ABCC2/MMAA/SRRD,3
GO:0014013,regulation of gliogenesis,4/173,112/18888,0.0196577441948945,0.312895089196957,0.292142006632948,CLCF1/GJC2/NTN1/ZNF365,4
GO:1902106,negative regulation of leukocyte differentiation,4/173,112/18888,0.0196577441948945,0.312895089196957,0.292142006632948,CDK6/CUL4A/NME2/TNFAIP6,4
GO:1905954,positive regulation of lipid localization,4/173,112/18888,0.0196577441948945,0.312895089196957,0.292142006632948,ACSL5/LRAT/MSR1/NR1H3,4
GO:0015695,organic cation transport,3/173,63/18888,0.0200768649729138,0.312895089196957,0.292142006632948,OXTR/SLC22A1/SLC6A12,3
GO:0006213,pyrimidine nucleoside metabolic process,2/173,24/18888,0.0201711008958038,0.312895089196957,0.292142006632948,APOBEC3D/APOBEC3H,2
GO:0006706,steroid catabolic process,2/173,24/18888,0.0201711008958038,0.312895089196957,0.292142006632948,HSD11B1/HSD17B11,2
GO:0043373,"CD4-positive, alpha-beta T cell lineage commitment",2/173,24/18888,0.0201711008958038,0.312895089196957,0.292142006632948,IL6R/LY9,2
GO:0046039,GTP metabolic process,2/173,24/18888,0.0201711008958038,0.312895089196957,0.292142006632948,EFL1/NME2,2
GO:0060907,positive regulation of macrophage cytokine production,2/173,24/18888,0.0201711008958038,0.312895089196957,0.292142006632948,PANX1/SPON2,2
GO:0071294,cellular response to zinc ion,2/173,24/18888,0.0201711008958038,0.312895089196957,0.292142006632948,MT1X/ZNF658,2
GO:0090200,positive regulation of release of cytochrome c from mitochondria,2/173,24/18888,0.0201711008958038,0.312895089196957,0.292142006632948,MFF/MLLT11,2
GO:0098884,postsynaptic neurotransmitter receptor internalization,2/173,24/18888,0.0201711008958038,0.312895089196957,0.292142006632948,ARC/VAC14,2
GO:0140239,postsynaptic endocytosis,2/173,24/18888,0.0201711008958038,0.312895089196957,0.292142006632948,ARC/VAC14,2
GO:0048640,negative regulation of developmental growth,4/173,114/18888,0.0208281655713542,0.321152852372676,0.299852065332322,NTN1/SEMA3C/SEMA4C/SEMA5A,4
GO:0051963,regulation of synapse assembly,4/173,115/18888,0.0214291027461438,0.328197931657695,0.306429872623883,NTN1/OXTR/SLITRK6/SNAP25,4
GO:0009164,nucleoside catabolic process,2/173,25/18888,0.0217948917722197,0.328197931657695,0.306429872623883,APOBEC3D/APOBEC3H,2
GO:0010878,cholesterol storage,2/173,25/18888,0.0217948917722197,0.328197931657695,0.306429872623883,MSR1/NR1H3,2
GO:0043153,entrainment of circadian clock by photoperiod,2/173,25/18888,0.0217948917722197,0.328197931657695,0.306429872623883,PER3/RBM4B,2
GO:0006909,phagocytosis,6/173,237/18888,0.02214767198821,0.331571252149075,0.309579454229325,COLEC11/MERTK/MSR1/NR1H3/SLC11A1/SPON2,6
GO:0015711,organic anion transport,9/173,451/18888,0.0233815183448612,0.344369149202205,0.321528517844798,ABCC2/ACSL5/SERINC3/SLC11A1/SLC16A2/SLC22A1/SLC2A4/SLC38A4/SLC6A12,9
GO:0002363,alpha-beta T cell lineage commitment,2/173,26/18888,0.0234710069990067,0.344369149202205,0.321528517844798,IL6R/LY9,2
GO:0070102,interleukin-6-mediated signaling pathway,2/173,26/18888,0.0234710069990067,0.344369149202205,0.321528517844798,GFI1/IL6R,2
GO:0010634,positive regulation of epithelial cell migration,5/173,177/18888,0.0236225027231319,0.344369149202205,0.321528517844798,MAP4K4/PRKD2/RHOB/SEMA5A/SMOC2,5
GO:0002274,myeloid leukocyte activation,6/173,241/18888,0.0238032801922022,0.344369149202205,0.321528517844798,CD200/CD226/FCGR3A/NECTIN2/NR1H3/SLC11A1,6
GO:0048675,axon extension,4/173,119/18888,0.0239386709542504,0.344369149202205,0.321528517844798,NTN1/SEMA3C/SEMA4C/SEMA5A,4
GO:1903707,negative regulation of hemopoiesis,4/173,119/18888,0.0239386709542504,0.344369149202205,0.321528517844798,CDK6/CUL4A/NME2/TNFAIP6,4
GO:0002440,production of molecular mediator of immune response,7/173,310/18888,0.024343832365631,0.348252046341665,0.325153877912872,CD226/CLCF1/IGLV2-8/PANX1/SANBR/SPON2/XCL1,7
GO:0002718,regulation of cytokine production involved in immune response,4/173,120/18888,0.0245927100891775,0.348715856081078,0.325586925003242,CD226/PANX1/SPON2/XCL1,4
GO:0015718,monocarboxylic acid transport,5/173,179/18888,0.0246471012841772,0.348715856081078,0.325586925003242,ABCC2/ACSL5/SLC16A2/SLC22A1/SLC6A12,5
GO:0006869,lipid transport,9/173,456/18888,0.0248761305992758,0.350032985208389,0.326816694211941,ABCC2/ACSL5/APOL1/APOL2/CEL/LRAT/MSR1/NR1H3/SLC22A1,9
GO:0060384,innervation,2/173,27/18888,0.0251983636150617,0.35264014298252,0.329250929615565,NPTX1/SLITRK6,2
GO:0051445,regulation of meiotic cell cycle,3/173,69/18888,0.0254621919295476,0.354406184965325,0.330899837081575,CDC16/CHFR/FBXO43,3
GO:0002697,regulation of immune effector process,8/173,385/18888,0.0257529987836494,0.355940791040336,0.33233265885994,CD226/CLCF1/COLEC11/NECTIN2/PANX1/SH2D1A/SPON2/XCL1,8
GO:0002367,cytokine production involved in immune response,4/173,122/18888,0.0259330103215481,0.355940791040336,0.33233265885994,CD226/PANX1/SPON2/XCL1,4
GO:0050769,positive regulation of neurogenesis,6/173,246/18888,0.0259871334817799,0.355940791040336,0.33233265885994,CLCF1/GJC2/NTN1/SEMA5A/SHOX2/ZNF365,6
GO:0045926,negative regulation of growth,6/173,247/18888,0.0264393770410385,0.358056323749822,0.334307876727479,CRYAB/MT1X/NTN1/SEMA3C/SEMA4C/SEMA5A,6
GO:0010948,negative regulation of cell cycle process,7/173,316/18888,0.0266556696031615,0.358056323749822,0.334307876727479,ATF5/CHFR/CUL4A/FBXO43/GJC2/SUSD2/ZFP36L1,7
GO:0009648,photoperiodism,2/173,28/18888,0.0269758939058119,0.358056323749822,0.334307876727479,PER3/RBM4B,2
GO:0043369,"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment",2/173,28/18888,0.0269758939058119,0.358056323749822,0.334307876727479,IL6R/LY9,2
GO:0086010,membrane depolarization during action potential,2/173,28/18888,0.0269758939058119,0.358056323749822,0.334307876727479,KCNJ2/SCN4B,2
GO:0090314,positive regulation of protein targeting to membrane,2/173,28/18888,0.0269758939058119,0.358056323749822,0.334307876727479,MFF/MIEF2,2
GO:0060047,heart contraction,6/173,249/18888,0.0273595112686683,0.361285853932415,0.337323205061476,ADM5/KCNJ2/MYLK2/SCN4B/SHOX2/TMEM38A,6
GO:0010822,positive regulation of mitochondrion organization,3/173,72/18888,0.0284174306229071,0.365691143136839,0.341436309013609,MFF/MIEF2/MLLT11,3
GO:0050766,positive regulation of phagocytosis,3/173,72/18888,0.0284174306229071,0.365691143136839,0.341436309013609,COLEC11/MERTK/SLC11A1,3
GO:0002706,regulation of lymphocyte mediated immunity,5/173,186/18888,0.0284568103195252,0.365691143136839,0.341436309013609,CD226/CLCF1/NECTIN2/SH2D1A/XCL1,5
GO:0050767,regulation of neurogenesis,8/173,393/18888,0.028622243702151,0.365691143136839,0.341436309013609,CLCF1/GJC2/NTN1/SEMA3C/SEMA4C/SEMA5A/SHOX2/ZNF365,8
GO:0002418,immune response to tumor cell,2/173,29/18888,0.02880254521744,0.365691143136839,0.341436309013609,CD226/NECTIN2,2
GO:0006910,"phagocytosis, recognition",2/173,29/18888,0.02880254521744,0.365691143136839,0.341436309013609,COLEC11/SPON2,2
GO:0034656,nucleobase-containing small molecule catabolic process,2/173,29/18888,0.02880254521744,0.365691143136839,0.341436309013609,APOBEC3D/APOBEC3H,2
GO:0002700,regulation of production of molecular mediator of immune response,5/173,187/18888,0.0290298103650287,0.365691143136839,0.341436309013609,CD226/CLCF1/PANX1/SPON2/XCL1,5
GO:0045766,positive regulation of angiogenesis,5/173,187/18888,0.0290298103650287,0.365691143136839,0.341436309013609,PAK4/PRKD2/RHOB/SEMA5A/SMOC2,5
GO:0060326,cell chemotaxis,7/173,322/18888,0.0291132754730299,0.365691143136839,0.341436309013609,ACKR4/IL6R/PRKD2/SEMA5A/SMOC2/TNFAIP6/XCL1,7
GO:0045661,regulation of myoblast differentiation,3/173,73/18888,0.0294412793718127,0.368015992147658,0.343606960067553,FLOT2/TMEM182/ZFP36L1,3
GO:0009649,entrainment of circadian clock,2/173,30/18888,0.0306772797732024,0.375785140241635,0.35086081157359,PER3/RBM4B,2
GO:0039694,viral RNA genome replication,2/173,30/18888,0.0306772797732024,0.375785140241635,0.35086081157359,APOBEC3D/APOBEC3H,2
GO:0090140,regulation of mitochondrial fission,2/173,30/18888,0.0306772797732024,0.375785140241635,0.35086081157359,MFF/MIEF2,2
GO:0030308,negative regulation of cell growth,5/173,190/18888,0.0307924911032952,0.375785140241635,0.35086081157359,CRYAB/NTN1/SEMA3C/SEMA4C/SEMA5A,5
GO:1904018,positive regulation of vasculature development,5/173,190/18888,0.0307924911032952,0.375785140241635,0.35086081157359,PAK4/PRKD2/RHOB/SEMA5A/SMOC2,5
GO:0051209,release of sequestered calcium ion into cytosol,4/173,129/18888,0.0309654613608942,0.376113504737276,0.351167396962673,PLCH1/RYR3/TMEM38A/XCL1,4
GO:0001649,osteoblast differentiation,6/173,257/18888,0.031251680956445,0.377763180670667,0.352707656474932,CDK6/GDPD2/IL6R/SHOX2/TNFAIP6/ZHX3,6
GO:0006941,striated muscle contraction,5/173,191/18888,0.0313946876363195,0.377763180670667,0.352707656474932,KCNJ2/MYLK2/RYR3/SCN4B/TMEM38A,5
GO:0051283,negative regulation of sequestering of calcium ion,4/173,130/18888,0.0317280649367859,0.379998917266157,0.354795105584426,PLCH1/RYR3/TMEM38A/XCL1,4
GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,5/173,192/18888,0.0320042386598438,0.381532011801378,0.356226516077403,CD226/CLCF1/NECTIN2/SLC11A1/XCL1,5
GO:0010595,positive regulation of endothelial cell migration,4/173,131/18888,0.0325016498023687,0.383908216272023,0.358445116388472,PRKD2/RHOB/SEMA5A/SMOC2,4
GO:0002825,regulation of T-helper 1 type immune response,2/173,31/18888,0.0325990744918181,0.383908216272023,0.358445116388472,SLC11A1/XCL1,2
GO:0003015,heart process,6/173,260/18888,0.0327999252737262,0.383908216272023,0.358445116388472,ADM5/KCNJ2/MYLK2/SCN4B/SHOX2/TMEM38A,6
GO:0010001,glial cell differentiation,6/173,260/18888,0.0327999252737262,0.383908216272023,0.358445116388472,CDK6/CERS5/CLCF1/DNER/MMP24/ZNF365,6
GO:0019730,antimicrobial humoral response,4/173,132/18888,0.0332862322282924,0.38609030625159,0.360482477047984,COLEC11/IGHG4/SLC11A1/SPON2,4
GO:0051282,regulation of sequestering of calcium ion,4/173,132/18888,0.0332862322282924,0.38609030625159,0.360482477047984,PLCH1/RYR3/TMEM38A/XCL1,4
GO:0045669,positive regulation of osteoblast differentiation,3/173,77/18888,0.0337295458881764,0.389231397434316,0.363415232188034,GDPD2/IL6R/ZHX3,3
GO:1903522,regulation of blood circulation,6/173,262/18888,0.0338593526311793,0.389231397434316,0.363415232188034,ADM5/KCNJ2/OXTR/SCN4B/SHOX2/TMEM38A,6
GO:0099173,postsynapse organization,5/173,196/18888,0.0345163932274346,0.392113749252669,0.366106409113172,ACTN1/ARC/NPTX1/ZMYND8/ZNF365,5
GO:0045777,positive regulation of blood pressure,2/173,32/18888,0.0345669208079052,0.392113749252669,0.366106409113172,OXTR/QRFP,2
GO:0080111,DNA demethylation,2/173,32/18888,0.0345669208079052,0.392113749252669,0.366106409113172,APOBEC3D/APOBEC3H,2
GO:0050772,positive regulation of axonogenesis,3/173,78/18888,0.0348495973998401,0.393586461862229,0.367481442572645,NTN1/SEMA5A/SHOX2,3
GO:0051208,sequestering of calcium ion,4/173,136/18888,0.0365348080752246,0.400821481162527,0.374236591916285,PLCH1/RYR3/TMEM38A/XCL1,4
GO:0010743,regulation of macrophage derived foam cell differentiation,2/173,33/18888,0.0365798244944442,0.400821481162527,0.374236591916285,MSR1/NR1H3,2
GO:0021591,ventricular system development,2/173,33/18888,0.0365798244944442,0.400821481162527,0.374236591916285,CDK6/DNAH5,2
GO:0033198,response to ATP,2/173,33/18888,0.0365798244944442,0.400821481162527,0.374236591916285,PANX1/RYR3,2
GO:0050858,negative regulation of antigen receptor-mediated signaling pathway,2/173,33/18888,0.0365798244944442,0.400821481162527,0.374236591916285,LPXN/SH2D1A,2
GO:0060351,cartilage development involved in endochondral bone morphogenesis,2/173,33/18888,0.0365798244944442,0.400821481162527,0.374236591916285,COL2A1/SHOX2,2
GO:0072539,T-helper 17 cell differentiation,2/173,33/18888,0.0365798244944442,0.400821481162527,0.374236591916285,IL6R/LY9,2
GO:0014032,neural crest cell development,3/173,80/18888,0.037146897025212,0.401913792077306,0.375256454207283,SEMA3C/SEMA4C/SEMA5A,3
GO:0042440,pigment metabolic process,3/173,80/18888,0.037146897025212,0.401913792077306,0.375256454207283,ABCC2/PMEL/SRRD,3
GO:0071248,cellular response to metal ion,5/173,200/18888,0.0371477601997665,0.401913792077306,0.375256454207283,MT1X/NPTX1/RYR3/SLC11A1/ZNF658,5
GO:1904064,positive regulation of cation transmembrane transport,4/173,138/18888,0.0382253897258884,0.407744975941222,0.380700878916607,GJC2/KCNJ2/KCNMB1/XCL1,4
GO:0097061,dendritic spine organization,3/173,81/18888,0.0383240189883396,0.407744975941222,0.380700878916607,ARC/ZMYND8/ZNF365,3
GO:0002360,T cell lineage commitment,2/173,34/18888,0.0386368054872459,0.407744975941222,0.380700878916607,IL6R/LY9,2
GO:0090022,regulation of neutrophil chemotaxis,2/173,34/18888,0.0386368054872459,0.407744975941222,0.380700878916607,TNFAIP6/XCL1,2
GO:0090313,regulation of protein targeting to membrane,2/173,34/18888,0.0386368054872459,0.407744975941222,0.380700878916607,MFF/MIEF2,2
GO:1901658,glycosyl compound catabolic process,2/173,34/18888,0.0386368054872459,0.407744975941222,0.380700878916607,APOBEC3D/APOBEC3H,2
GO:0055001,muscle cell development,5/173,204/18888,0.0398993867724116,0.41791837293569,0.390199515088448,ACTN1/DNER/MYOM2/SHOX2/TMEM182,5
GO:1901988,negative regulation of cell cycle phase transition,6/173,273/18888,0.0400821891625603,0.41791837293569,0.390199515088448,ATF5/CHFR/CUL4A/GJC2/SUSD2/ZFP36L1,6
GO:0001667,ameboidal-type cell migration,9/173,498/18888,0.040202969360685,0.41791837293569,0.390199515088448,LPXN/MAP4K4/PRKD2/PXN/RHOB/SEMA3C/SEMA4C/SEMA5A/SMOC2,9
GO:0009119,ribonucleoside metabolic process,2/173,35/18888,0.0407368977114012,0.41791837293569,0.390199515088448,APOBEC3D/APOBEC3H,2
GO:0030224,monocyte differentiation,2/173,35/18888,0.0407368977114012,0.41791837293569,0.390199515088448,CDK6/ZFP36L1,2
GO:0061081,positive regulation of myeloid leukocyte cytokine production involved in immune response,2/173,35/18888,0.0407368977114012,0.41791837293569,0.390199515088448,PANX1/SPON2,2
GO:0098810,neurotransmitter reuptake,2/173,35/18888,0.0407368977114012,0.41791837293569,0.390199515088448,SLC22A1/SLC6A12,2
GO:0002757,immune response-activating signaling pathway,9/173,500/18888,0.0410635334389982,0.419597613513573,0.391767378340318,CD226/COLEC11/GFI1/IGHG4/LPXN/NECTIN2/NR1H3/PRKD2/SH2D1A,9
GO:0003018,vascular process in circulatory system,6/173,275/18888,0.041286549293098,0.420208950315128,0.392338167611549,ABCC2/KCNMB1/OXTR/SLC16A2/SLC22A1/SLC2A4,6
GO:0001523,retinoid metabolic process,3/173,84/18888,0.0419684371103143,0.422889019485179,0.394840478489177,CEL/CYP4V2/LRAT,3
GO:0072527,pyrimidine-containing compound metabolic process,3/173,84/18888,0.0419684371103143,0.422889019485179,0.394840478489177,APOBEC3D/APOBEC3H/NME2,3
GO:0002819,regulation of adaptive immune response,5/173,207/18888,0.0420425588303712,0.422889019485179,0.394840478489177,CD226/CLCF1/NECTIN2/SLC11A1/XCL1,5
GO:0014074,response to purine-containing compound,4/173,143/18888,0.0426455778243415,0.424668494009475,0.396501927569807,PANX1/RYR3/TMEM38A/ZFP36L1,4
GO:0008016,regulation of heart contraction,5/173,208/18888,0.0427721460717992,0.424668494009475,0.396501927569807,ADM5/KCNJ2/SCN4B/SHOX2/TMEM38A,5
GO:0014808,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,2/173,36/18888,0.0428791489096946,0.424668494009475,0.396501927569807,RYR3/TMEM38A,2
GO:2000352,negative regulation of endothelial cell apoptotic process,2/173,36/18888,0.0428791489096946,0.424668494009475,0.396501927569807,PAK4/SEMA5A,2
GO:0007611,learning or memory,6/173,278/18888,0.0431356807478135,0.425572329216934,0.397345814994983,ARC/OXTR/SLC2A4/SNAP25/TAFA2/VDAC3,6
GO:0060048,cardiac muscle contraction,4/173,145/18888,0.0444911688980785,0.426603851903908,0.398308920898733,KCNJ2/MYLK2/SCN4B/TMEM38A,4
GO:0048864,stem cell development,3/173,86/18888,0.04449149043368,0.426603851903908,0.398308920898733,SEMA3C/SEMA4C/SEMA5A,3
GO:0043270,positive regulation of monoatomic ion transport,5/173,211/18888,0.0450066363716625,0.426603851903908,0.398308920898733,GJC2/KCNJ2/KCNMB1/SCN4B/XCL1,5
GO:0010934,macrophage cytokine production,2/173,37/18888,0.0450626204729564,0.426603851903908,0.398308920898733,PANX1/SPON2,2
GO:0010935,regulation of macrophage cytokine production,2/173,37/18888,0.0450626204729564,0.426603851903908,0.398308920898733,PANX1/SPON2,2
GO:0035510,DNA dealkylation,2/173,37/18888,0.0450626204729564,0.426603851903908,0.398308920898733,APOBEC3D/APOBEC3H,2
GO:0045773,positive regulation of axon extension,2/173,37/18888,0.0450626204729564,0.426603851903908,0.398308920898733,NTN1/SEMA5A,2
GO:0071276,cellular response to cadmium ion,2/173,37/18888,0.0450626204729564,0.426603851903908,0.398308920898733,MT1X/SLC11A1,2
GO:0072529,pyrimidine-containing compound catabolic process,2/173,37/18888,0.0450626204729564,0.426603851903908,0.398308920898733,APOBEC3D/APOBEC3H,2
GO:1901381,positive regulation of potassium ion transmembrane transport,2/173,37/18888,0.0450626204729564,0.426603851903908,0.398308920898733,KCNJ2/KCNMB1,2
GO:1903514,release of sequestered calcium ion into cytosol by endoplasmic reticulum,2/173,37/18888,0.0450626204729564,0.426603851903908,0.398308920898733,RYR3/TMEM38A,2
GO:0050852,T cell receptor signaling pathway,4/173,146/18888,0.0454305647323087,0.428511736943937,0.400090263538049,CD226/NECTIN2/PRKD2/SH2D1A,4
GO:0032370,positive regulation of lipid transport,3/173,87/18888,0.0457808008323361,0.43023927789513,0.401703223592223,ACSL5/LRAT/NR1H3,3
GO:0034764,positive regulation of transmembrane transport,5/173,213/18888,0.0465344878311058,0.435732022418536,0.406831656291849,ACSL5/GJC2/KCNJ2/KCNMB1/XCL1,5
GO:0044743,protein transmembrane import into intracellular organelle,2/173,38/18888,0.0472863872723365,0.438453811153608,0.409372919642245,TIMM21/TOMM40,2
GO:0051648,vesicle localization,5/173,215/18888,0.0480929583357324,0.438453811153608,0.409372919642245,CEP19/KIF13A/SLC2A4/SNAP25/TPGS1,5
GO:1901888,regulation of cell junction assembly,5/173,215/18888,0.0480929583357324,0.438453811153608,0.409372919642245,MAP4K4/NTN1/OXTR/SLITRK6/SNAP25,5
GO:0050768,negative regulation of neurogenesis,4/173,149/18888,0.0483150760690033,0.438453811153608,0.409372919642245,NTN1/SEMA3C/SEMA4C/SEMA5A,4
GO:0043542,endothelial cell migration,6/173,286/18888,0.0483186019122523,0.438453811153608,0.409372919642245,LPXN/PRKD2/PXN/RHOB/SEMA5A/SMOC2,6
GO:0016101,diterpenoid metabolic process,3/173,89/18888,0.0484145422602794,0.438453811153608,0.409372919642245,CEL/CYP4V2/LRAT,3
GO:0007143,female meiotic nuclear division,2/173,39/18888,0.0495495374934757,0.438453811153608,0.409372919642245,MARF1/SEPTIN1,2
GO:0016233,telomere capping,2/173,39/18888,0.0495495374934757,0.438453811153608,0.409372919642245,TFIP11/TINF2,2
GO:0032438,melanosome organization,2/173,39/18888,0.0495495374934757,0.438453811153608,0.409372919642245,KIF13A/PMEL,2
GO:0040036,regulation of fibroblast growth factor receptor signaling pathway,2/173,39/18888,0.0495495374934757,0.438453811153608,0.409372919642245,PRKD2/SMOC2,2
GO:0045616,regulation of keratinocyte differentiation,2/173,39/18888,0.0495495374934757,0.438453811153608,0.409372919642245,NME2/ZFP36L1,2
GO:0048741,skeletal muscle fiber development,2/173,39/18888,0.0495495374934757,0.438453811153608,0.409372919642245,DNER/SHOX2,2
GO:0060306,regulation of membrane repolarization,2/173,39/18888,0.0495495374934757,0.438453811153608,0.409372919642245,KCNJ2/SCN4B,2
GO:0060416,response to growth hormone,2/173,39/18888,0.0495495374934757,0.438453811153608,0.409372919642245,NME2/PXN,2
GO:0071312,cellular response to alkaloid,2/173,39/18888,0.0495495374934757,0.438453811153608,0.409372919642245,RYR3/TMEM38A,2
GO:0097106,postsynaptic density organization,2/173,39/18888,0.0495495374934757,0.438453811153608,0.409372919642245,NPTX1/ZMYND8,2
GO:0045637,regulation of myeloid cell differentiation,5/173,218/18888,0.0504881695772608,0.440649403025861,0.411422886667784,CDK6/CUL4A/NME2/TNFAIP6/ZFP36L1,5
GO:0045089,positive regulation of innate immune response,7/173,365/18888,0.0512707684727683,0.440649403025861,0.411422886667784,CD226/COLEC11/GFI1/NECTIN2/NR1H3/PSPC1/SH2D1A,7
GO:0007601,visual perception,5/173,219/18888,0.0513019245076881,0.440649403025861,0.411422886667784,COL2A1/CYP4V2/LRAT/RPGRIP1/SLITRK6,5
GO:0030100,regulation of endocytosis,6/173,291/18888,0.0517455606920817,0.440649403025861,0.411422886667784,ARC/COLEC11/MERTK/NR1H3/SLC11A1/VAC14,6
GO:0000266,mitochondrial fission,2/173,40/18888,0.0518511724725576,0.440649403025861,0.411422886667784,MFF/MIEF2,2
GO:0001916,positive regulation of T cell mediated cytotoxicity,2/173,40/18888,0.0518511724725576,0.440649403025861,0.411422886667784,NECTIN2/XCL1,2
GO:0010742,macrophage derived foam cell differentiation,2/173,40/18888,0.0518511724725576,0.440649403025861,0.411422886667784,MSR1/NR1H3,2
GO:0048753,pigment granule organization,2/173,40/18888,0.0518511724725576,0.440649403025861,0.411422886667784,KIF13A/PMEL,2
GO:0071354,cellular response to interleukin-6,2/173,40/18888,0.0518511724725576,0.440649403025861,0.411422886667784,GFI1/IL6R,2
GO:0086091,regulation of heart rate by cardiac conduction,2/173,40/18888,0.0518511724725576,0.440649403025861,0.411422886667784,KCNJ2/SCN4B,2
GO:0099622,cardiac muscle cell membrane repolarization,2/173,40/18888,0.0518511724725576,0.440649403025861,0.411422886667784,KCNJ2/SCN4B,2
GO:1903115,regulation of actin filament-based movement,2/173,40/18888,0.0518511724725576,0.440649403025861,0.411422886667784,KCNJ2/MYLK2,2
GO:0007612,learning,4/173,153/18888,0.052315478030915,0.441802042320066,0.41249907599756,ARC/SNAP25/TAFA2/VDAC3,4
GO:0051262,protein tetramerization,3/173,92/18888,0.052501524252404,0.441802042320066,0.41249907599756,KCNJ2/MAT1A/RYR3,3
GO:0106027,neuron projection organization,3/173,92/18888,0.052501524252404,0.441802042320066,0.41249907599756,ARC/ZMYND8/ZNF365,3
GO:0034767,positive regulation of monoatomic ion transmembrane transport,4/173,154/18888,0.0533430616213476,0.444548055150876,0.415062956756096,GJC2/KCNJ2/KCNMB1/XCL1,4
GO:0014033,neural crest cell differentiation,3/173,93/18888,0.0538998149369437,0.444548055150876,0.415062956756096,SEMA3C/SEMA4C/SEMA5A,3
GO:0015807,L-amino acid transport,3/173,93/18888,0.0538998149369437,0.444548055150876,0.415062956756096,SERINC3/SLC11A1/SLC38A4,3
GO:0051899,membrane depolarization,3/173,93/18888,0.0538998149369437,0.444548055150876,0.415062956756096,KCNJ2/MLLT11/SCN4B,3
GO:0032570,response to progesterone,2/173,41/18888,0.0541904065342175,0.444548055150876,0.415062956756096,NR1H3/OXTR,2
GO:0071634,regulation of transforming growth factor beta production,2/173,41/18888,0.0541904065342175,0.444548055150876,0.415062956756096,CD200/XCL1,2
GO:0090077,foam cell differentiation,2/173,41/18888,0.0541904065342175,0.444548055150876,0.415062956756096,MSR1/NR1H3,2
GO:0008037,cell recognition,4/173,155/18888,0.054381606746612,0.444548055150876,0.415062956756096,CD226/COLEC11/SEMA5A/SPON2,4
GO:0051961,negative regulation of nervous system development,4/173,155/18888,0.054381606746612,0.444548055150876,0.415062956756096,NTN1/SEMA3C/SEMA4C/SEMA5A,4
GO:0050953,sensory perception of light stimulus,5/173,223/18888,0.0546337657945988,0.445196034560417,0.41566795827736,COL2A1/CYP4V2/LRAT/RPGRIP1/SLITRK6,5
GO:0002251,organ or tissue specific immune response,2/173,42/18888,0.0565663668312913,0.458045266008098,0.427664951481858,IL6R/XCL1,2
GO:0072337,modified amino acid transport,2/173,42/18888,0.0565663668312913,0.458045266008098,0.427664951481858,SLC22A1/SLC6A12,2
GO:0043279,response to alkaloid,3/173,95/18888,0.0567497057707187,0.458089317741695,0.427706081439768,OXTR/RYR3/TMEM38A,3
GO:0034329,cell junction assembly,8/173,453/18888,0.0573679285601363,0.460821426171772,0.430256980020982,ACTN1/DNER/MAP4K4/NPTX1/NTN1/OXTR/SLITRK6/SNAP25,8
GO:0030902,hindbrain development,4/173,158/18888,0.0575628240249213,0.460821426171772,0.430256980020982,ATF5/EN2/SEMA4C/ZNF365,4
GO:0010631,epithelial cell migration,7/173,375/18888,0.0576250482436158,0.460821426171772,0.430256980020982,LPXN/MAP4K4/PRKD2/PXN/RHOB/SEMA5A/SMOC2,7
GO:0007409,axonogenesis,8/173,455/18888,0.0585591860733822,0.463471107833119,0.432730918872087,NPTX1/NTN1/SEMA3C/SEMA4C/SEMA5A/SHOX2/SLITRK6/SNAP25,8
GO:1901987,regulation of cell cycle phase transition,8/173,455/18888,0.0585591860733822,0.463471107833119,0.432730918872087,ATF5/CDC16/CDK6/CHFR/CUL4A/GJC2/SUSD2/ZFP36L1,8
GO:0007595,lactation,2/173,43/18888,0.0589781931863822,0.463471107833119,0.432730918872087,MTCO2P12/OXTR,2
GO:0043368,positive T cell selection,2/173,43/18888,0.0589781931863822,0.463471107833119,0.432730918872087,IL6R/LY9,2
GO:0070296,sarcoplasmic reticulum calcium ion transport,2/173,43/18888,0.0589781931863822,0.463471107833119,0.432730918872087,RYR3/TMEM38A,2
GO:0002366,leukocyte activation involved in immune response,6/173,301/18888,0.0590363197550536,0.463471107833119,0.432730918872087,CLCF1/FCGR3A/IL6R/LY9/SANBR/SLC11A1,6
GO:0090132,epithelium migration,7/173,378/18888,0.0596225946554184,0.46560631616797,0.434724507359281,LPXN/MAP4K4/PRKD2/PXN/RHOB/SEMA5A/SMOC2,7
GO:0035082,axoneme assembly,3/173,97/18888,0.0596699356642446,0.46560631616797,0.434724507359281,CPLANE2/DNAH5/TPGS1,3
GO:0071241,cellular response to inorganic substance,5/173,229/18888,0.0598620145463609,0.465693919809303,0.434806300600694,MT1X/NPTX1/RYR3/SLC11A1/ZNF658,5
GO:0097191,extrinsic apoptotic signaling pathway,5/173,230/18888,0.0607602575006292,0.466576615584693,0.435630450687967,BCL2L10/BCL2L14/COL2A1/IL6R/MLLT11,5
GO:0003012,muscle system process,8/173,459/18888,0.0609885893029622,0.466576615584693,0.435630450687967,CRYAB/KCNJ2/MYLK2/MYOM2/OXTR/RYR3/SCN4B/TMEM38A,8
GO:0031018,endocrine pancreas development,2/173,44/18888,0.0614250379352276,0.466576615584693,0.435630450687967,CDK6/IL6R,2
GO:0043268,positive regulation of potassium ion transport,2/173,44/18888,0.0614250379352276,0.466576615584693,0.435630450687967,KCNJ2/KCNMB1,2
GO:0070741,response to interleukin-6,2/173,44/18888,0.0614250379352276,0.466576615584693,0.435630450687967,GFI1/IL6R,2
GO:0071604,transforming growth factor beta production,2/173,44/18888,0.0614250379352276,0.466576615584693,0.435630450687967,CD200/XCL1,2
GO:0090199,regulation of release of cytochrome c from mitochondria,2/173,44/18888,0.0614250379352276,0.466576615584693,0.435630450687967,MFF/MLLT11,2
GO:1903539,protein localization to postsynaptic membrane,2/173,44/18888,0.0614250379352276,0.466576615584693,0.435630450687967,NPTX1/SNAP25,2
GO:0043524,negative regulation of neuron apoptotic process,4/173,162/18888,0.0619566679596676,0.469061254037482,0.437950292987883,CLCF1/EN2/FOXQ1/VSTM2L,4
GO:0002263,cell activation involved in immune response,6/173,305/18888,0.0621164612142841,0.469061254037482,0.437950292987883,CLCF1/FCGR3A/IL6R/LY9/SANBR/SLC11A1,6
GO:0090130,tissue migration,7/173,383/18888,0.0630459780730346,0.472182458647943,0.440864480552642,LPXN/MAP4K4/PRKD2/PXN/RHOB/SEMA5A/SMOC2,7
GO:0002347,response to tumor cell,2/173,45/18888,0.0639060657718449,0.472182458647943,0.440864480552642,CD226/NECTIN2,2
GO:0006739,NADP metabolic process,2/173,45/18888,0.0639060657718449,0.472182458647943,0.440864480552642,PC/PGD,2
GO:0032941,secretion by tissue,2/173,45/18888,0.0639060657718449,0.472182458647943,0.440864480552642,CEL/NR1H3,2
GO:0062237,protein localization to postsynapse,2/173,45/18888,0.0639060657718449,0.472182458647943,0.440864480552642,NPTX1/SNAP25,2
GO:0099084,postsynaptic specialization organization,2/173,45/18888,0.0639060657718449,0.472182458647943,0.440864480552642,NPTX1/ZMYND8,2
GO:0120316,sperm flagellum assembly,2/173,45/18888,0.0639060657718449,0.472182458647943,0.440864480552642,TPGS1/VDAC3,2
GO:0006721,terpenoid metabolic process,3/173,100/18888,0.0641801400104,0.472182458647943,0.440864480552642,CEL/CYP4V2/LRAT,3
GO:0050764,regulation of phagocytosis,3/173,100/18888,0.0641801400104,0.472182458647943,0.440864480552642,COLEC11/MERTK/SLC11A1,3
GO:1904062,regulation of monoatomic cation transmembrane transport,6/173,309/18888,0.0652904311211503,0.473798687855006,0.442373511726452,GJC2/KCNJ2/KCNMB1/SCN4B/TMEM38A/XCL1,6
GO:0034446,substrate adhesion-dependent cell spreading,3/173,101/18888,0.0657176896409037,0.473798687855006,0.442373511726452,LPXN/MERTK/PXN,3
GO:0042168,heme metabolic process,2/173,46/18888,0.0664204535954392,0.473798687855006,0.442373511726452,ABCC2/SRRD,2
GO:0045646,regulation of erythrocyte differentiation,2/173,46/18888,0.0664204535954392,0.473798687855006,0.442373511726452,CDK6/ZFP36L1,2
GO:0045687,positive regulation of glial cell differentiation,2/173,46/18888,0.0664204535954392,0.473798687855006,0.442373511726452,CLCF1/ZNF365,2
GO:0170036,import into the mitochondrion,2/173,46/18888,0.0664204535954392,0.473798687855006,0.442373511726452,TIMM21/TOMM40,2
GO:1902622,regulation of neutrophil migration,2/173,46/18888,0.0664204535954392,0.473798687855006,0.442373511726452,TNFAIP6/XCL1,2
GO:0015850,organic hydroxy compound transport,6/173,311/18888,0.0669126089840221,0.473798687855006,0.442373511726452,ABCC2/CEL/MSR1/NR1H3/OXTR/SLC22A1,6
GO:0006665,sphingolipid metabolic process,4/173,167/18888,0.0676913255242574,0.473798687855006,0.442373511726452,B4GALT4/CEL/CERS5/PRKD2,4
GO:0006937,regulation of muscle contraction,4/173,167/18888,0.0676913255242574,0.473798687855006,0.442373511726452,KCNJ2/MYLK2/OXTR/TMEM38A,4
GO:0061351,neural precursor cell proliferation,4/173,167/18888,0.0676913255242574,0.473798687855006,0.442373511726452,ATF5/GJC2/RPGRIP1/SLC16A2,4
GO:0002833,positive regulation of response to biotic stimulus,7/173,390/18888,0.0680370505412957,0.473798687855006,0.442373511726452,CD226/COLEC11/GFI1/NECTIN2/NR1H3/PSPC1/SH2D1A,7
GO:0006775,fat-soluble vitamin metabolic process,2/173,47/18888,0.0689673903590513,0.473798687855006,0.442373511726452,GFI1/LRAT,2
GO:0006953,acute-phase response,2/173,47/18888,0.0689673903590513,0.473798687855006,0.442373511726452,APOL2/IL6R,2
GO:0072538,T-helper 17 type immune response,2/173,47/18888,0.0689673903590513,0.473798687855006,0.442373511726452,IL6R/LY9,2
GO:0002573,myeloid leukocyte differentiation,5/173,239/18888,0.0691887314468746,0.473798687855006,0.442373511726452,CDK6/CUL4A/NME2/TNFAIP6/ZFP36L1,5
GO:0051656,establishment of organelle localization,8/173,472/18888,0.0693185878646055,0.473798687855006,0.442373511726452,CEP19/KIF13A/NECTIN2/NTN1/SEPTIN1/SLC2A4/SNAP25/TLE6,8
GO:0042445,hormone metabolic process,5/173,240/18888,0.0701633464767195,0.473798687855006,0.442373511726452,CEL/GFI1/HSD17B11/LRAT/SLC16A2,5
GO:0007519,skeletal muscle tissue development,4/173,170/18888,0.0712599470989265,0.473798687855006,0.442373511726452,DNER/MYLK2/MYOM2/SHOX2,4
GO:0042088,T-helper 1 type immune response,2/173,48/18888,0.0715460769199302,0.473798687855006,0.442373511726452,SLC11A1/XCL1,2
GO:0043277,apoptotic cell clearance,2/173,48/18888,0.0715460769199302,0.473798687855006,0.442373511726452,MERTK/NR1H3,2
GO:1905477,positive regulation of protein localization to membrane,3/173,105/18888,0.0720352852291043,0.473798687855006,0.442373511726452,MFF/MIEF2/TNFAIP6,3
GO:0042254,ribosome biogenesis,6/173,319/18888,0.0736357098777063,0.473798687855006,0.442373511726452,CUL4A/DDX49/EFL1/RRN3/ZCCHC4/ZNF658,6
GO:0006626,protein targeting to mitochondrion,3/173,106/18888,0.0736558850727901,0.473798687855006,0.442373511726452,MFF/TIMM21/TOMM40,3
GO:0030148,sphingolipid biosynthetic process,3/173,106/18888,0.0736558850727901,0.473798687855006,0.442373511726452,B4GALT4/CERS5/PRKD2,3
GO:0042472,inner ear morphogenesis,3/173,106/18888,0.0736558850727901,0.473798687855006,0.442373511726452,COL2A1/NTN1/SLITRK6,3
GO:0044788,modulation by host of viral process,2/173,49/18888,0.0741557258916094,0.473798687855006,0.442373511726452,APOBEC3H/PC,2
GO:0008637,apoptotic mitochondrial changes,3/173,107/18888,0.0752926998088776,0.473798687855006,0.442373511726452,MFF/MLLT11/NPTX1,3
GO:0002703,regulation of leukocyte mediated immunity,5/173,246/18888,0.0761700170038054,0.473798687855006,0.442373511726452,CD226/CLCF1/NECTIN2/SH2D1A/XCL1,5
GO:0050890,cognition,6/173,322/18888,0.0762533638588939,0.473798687855006,0.442373511726452,ARC/OXTR/SLC2A4/SNAP25/TAFA2/VDAC3,6
GO:0001914,regulation of T cell mediated cytotoxicity,2/173,50/18888,0.0767955614976682,0.473798687855006,0.442373511726452,NECTIN2/XCL1,2
GO:0051403,stress-activated MAPK cascade,2/173,50/18888,0.0767955614976682,0.473798687855006,0.442373511726452,CRYAB/SEMA4C,2
GO:0061082,myeloid leukocyte cytokine production,2/173,50/18888,0.0767955614976682,0.473798687855006,0.442373511726452,PANX1/SPON2,2
GO:2000404,regulation of T cell migration,2/173,50/18888,0.0767955614976682,0.473798687855006,0.442373511726452,CD200/XCL1,2
GO:1901890,positive regulation of cell junction assembly,3/173,108/18888,0.0769455938018977,0.473798687855006,0.442373511726452,MAP4K4/OXTR/SLITRK6,3
GO:0045444,fat cell differentiation,5/173,248/18888,0.0782325029875402,0.473798687855006,0.442373511726452,ATF5/DLK2/PRDM16/SLC2A4/ZFP36L1,5
GO:0002526,acute inflammatory response,3/173,109/18888,0.0786144298673081,0.473798687855006,0.442373511726452,APOL2/FCGR3A/IL6R,3
GO:0010043,response to zinc ion,2/173,51/18888,0.0794648194271626,0.473798687855006,0.442373511726452,MT1X/ZNF658,2
GO:0051180,vitamin transport,2/173,51/18888,0.0794648194271626,0.473798687855006,0.442373511726452,SLC22A1/SLC2A4,2
GO:0071622,regulation of granulocyte chemotaxis,2/173,51/18888,0.0794648194271626,0.473798687855006,0.442373511726452,TNFAIP6/XCL1,2
GO:0089718,amino acid import across plasma membrane,2/173,51/18888,0.0794648194271626,0.473798687855006,0.442373511726452,SLC16A2/SLC38A4,2
GO:0002262,myeloid cell homeostasis,4/173,177/18888,0.0799534515878644,0.473798687855006,0.442373511726452,CDIN1/CDK6/MERTK/ZFP36L1,4
GO:1990138,neuron projection extension,4/173,177/18888,0.0799534515878644,0.473798687855006,0.442373511726452,NTN1/SEMA3C/SEMA4C/SEMA5A,4
GO:0048477,oogenesis,3/173,110/18888,0.0802990693344367,0.473798687855006,0.442373511726452,MARF1/PANX1/TNFAIP6,3
GO:0036293,response to decreased oxygen levels,6/173,327/18888,0.0807326235411144,0.473798687855006,0.442373511726452,CRYAB/KCNMB1/MTCO2P12/OXTR/SLC2A4/ZFP36L1,6
GO:0006672,ceramide metabolic process,3/173,111/18888,0.0819993721082087,0.473798687855006,0.442373511726452,B4GALT4/CEL/CERS5,3
GO:0045445,myoblast differentiation,3/173,111/18888,0.0819993721082087,0.473798687855006,0.442373511726452,FLOT2/TMEM182/ZFP36L1,3
GO:0042572,retinol metabolic process,2/173,52/18888,0.0821627466917047,0.473798687855006,0.442373511726452,CEL/LRAT,2
GO:0051646,mitochondrion localization,2/173,52/18888,0.0821627466917047,0.473798687855006,0.442373511726452,NECTIN2/TLE6,2
GO:0070988,demethylation,2/173,52/18888,0.0821627466917047,0.473798687855006,0.442373511726452,APOBEC3D/APOBEC3H,2
GO:0071470,cellular response to osmotic stress,2/173,52/18888,0.0821627466917047,0.473798687855006,0.442373511726452,SLC2A4/ZFP36L1,2
GO:0008202,steroid metabolic process,6/173,329/18888,0.0825649680109978,0.473798687855006,0.442373511726452,APOL1/APOL2/CYP4V2/GFI1/HSD11B1/HSD17B11,6
GO:0009451,RNA modification,4/173,180/18888,0.0838338382929553,0.473798687855006,0.442373511726452,APOBEC3D/APOBEC3H/METTL2A/ZCCHC4,4
GO:1905475,regulation of protein localization to membrane,4/173,180/18888,0.0838338382929553,0.473798687855006,0.442373511726452,MFF/MIEF2/TNFAIP6/ZMYND8,4
GO:0002204,somatic recombination of immunoglobulin genes involved in immune response,2/173,53/18888,0.0848886014841749,0.473798687855006,0.442373511726452,CLCF1/SANBR,2
GO:0002208,somatic diversification of immunoglobulins involved in immune response,2/173,53/18888,0.0848886014841749,0.473798687855006,0.442373511726452,CLCF1/SANBR,2
GO:0002639,positive regulation of immunoglobulin production,2/173,53/18888,0.0848886014841749,0.473798687855006,0.442373511726452,CLCF1/XCL1,2
GO:0006778,porphyrin-containing compound metabolic process,2/173,53/18888,0.0848886014841749,0.473798687855006,0.442373511726452,ABCC2/SRRD,2
GO:0038084,vascular endothelial growth factor signaling pathway,2/173,53/18888,0.0848886014841749,0.473798687855006,0.442373511726452,PRKD2/SMOC2,2
GO:0045190,isotype switching,2/173,53/18888,0.0848886014841749,0.473798687855006,0.442373511726452,CLCF1/SANBR,2
GO:0044782,cilium organization,7/173,412/18888,0.0852332085860506,0.473798687855006,0.442373511726452,CEP19/CPLANE2/DNAH5/NECTIN2/RPGRIP1/TPGS1/VDAC3,7
GO:0006766,vitamin metabolic process,3/173,113/18888,0.0854464004353673,0.473798687855006,0.442373511726452,GFI1/LRAT/MMAA,3
GO:0070252,actin-mediated cell contraction,3/173,113/18888,0.0854464004353673,0.473798687855006,0.442373511726452,KCNJ2/MYLK2/SCN4B,3
GO:0060538,skeletal muscle organ development,4/173,182/18888,0.0864714339728984,0.473798687855006,0.442373511726452,DNER/MYLK2/MYOM2/SHOX2,4
GO:0070588,calcium ion transmembrane transport,6/173,334/18888,0.0872469365858414,0.473798687855006,0.442373511726452,GJC2/PANX1/PLCH1/RYR3/TMEM38A/XCL1,6
GO:0071214,cellular response to abiotic stimulus,6/173,334/18888,0.0872469365858414,0.473798687855006,0.442373511726452,CRYAB/CUL4A/KCNJ2/RHOB/SLC2A4/ZFP36L1,6
GO:0104004,cellular response to environmental stimulus,6/173,334/18888,0.0872469365858414,0.473798687855006,0.442373511726452,CRYAB/CUL4A/KCNJ2/RHOB/SLC2A4/ZFP36L1,6
GO:0010883,regulation of lipid storage,2/173,54/18888,0.0876416530390473,0.473798687855006,0.442373511726452,MSR1/NR1H3,2
GO:0050873,brown fat cell differentiation,2/173,54/18888,0.0876416530390473,0.473798687855006,0.442373511726452,PRDM16/SLC2A4,2
GO:0086009,membrane repolarization,2/173,54/18888,0.0876416530390473,0.473798687855006,0.442373511726452,KCNJ2/SCN4B,2
GO:0001188,RNA polymerase I preinitiation complex assembly,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,RRN3,1
GO:0001794,type IIa hypersensitivity,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,FCGR3A,1
GO:0002445,type II hypersensitivity,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,FCGR3A,1
GO:0003253,cardiac neural crest cell migration involved in outflow tract morphogenesis,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,SEMA3C,1
GO:0006228,UTP biosynthetic process,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,NME2,1
GO:0006655,phosphatidylglycerol biosynthetic process,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,TAMM41,1
GO:0010496,intercellular transport,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,ARC,1
GO:0016081,synaptic vesicle docking,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,SNAP25,1
GO:0016559,peroxisome fission,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,MFF,1
GO:0031440,regulation of mRNA 3'-end processing,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,ZFP36L1,1
GO:0032329,serine transport,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,SERINC3,1
GO:0032353,negative regulation of hormone biosynthetic process,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,GFI1,1
GO:0032819,positive regulation of natural killer cell proliferation,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,FCGR3A,1
GO:0032988,protein-RNA complex disassembly,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,TFIP11,1
GO:0033313,meiotic cell cycle checkpoint signaling,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,CHFR,1
GO:0033605,positive regulation of catecholamine secretion,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,OXTR,1
GO:0035747,natural killer cell chemotaxis,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,XCL1,1
GO:0042368,vitamin D biosynthetic process,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,GFI1,1
GO:0042711,maternal behavior,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,OXTR,1
GO:0044650,adhesion of symbiont to host cell,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,NECTIN2,1
GO:0045657,positive regulation of monocyte differentiation,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,ZFP36L1,1
GO:0046548,retinal rod cell development,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,RPGRIP1,1
GO:0048023,positive regulation of melanin biosynthetic process,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,PMEL,1
GO:0051307,meiotic chromosome separation,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,CHFR,1
GO:0051643,endoplasmic reticulum localization,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,TLE6,1
GO:0051933,amino acid neurotransmitter reuptake,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,SLC6A12,1
GO:0060068,vagina development,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,MERTK,1
GO:0060075,regulation of resting membrane potential,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,KCNJ2,1
GO:0060368,regulation of Fc receptor mediated stimulatory signaling pathway,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,CD226,1
GO:0071421,manganese ion transmembrane transport,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,SLC11A1,1
GO:0072014,proximal tubule development,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,SLC22A1,1
GO:0099159,regulation of modification of postsynaptic structure,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,RHOB,1
GO:0140059,dendrite arborization,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,ZNF365,1
GO:1900378,positive regulation of secondary metabolite biosynthetic process,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,PMEL,1
GO:1900748,positive regulation of vascular endothelial growth factor signaling pathway,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,SMOC2,1
GO:1901401,regulation of tetrapyrrole metabolic process,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,SRRD,1
GO:1903044,protein localization to membrane raft,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,FLOT2,1
GO:1903911,positive regulation of receptor clustering,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,TNFAIP6,1
GO:1990504,dense core granule exocytosis,1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,SNAP25,1
GO:2000563,"positive regulation of CD4-positive, alpha-beta T cell proliferation",1/173,10/18888,0.0879282465834947,0.473798687855006,0.442373511726452,XCL1,1
GO:1904035,regulation of epithelial cell apoptotic process,3/173,115/18888,0.0889543678709043,0.473798687855006,0.442373511726452,PAK4/SEMA5A/ZFP36L1,3
GO:2000278,regulation of DNA biosynthetic process,3/173,115/18888,0.0889543678709043,0.473798687855006,0.442373511726452,PRKD2/SMOC2/TINF2,3
GO:0006959,humoral immune response,5/173,258/18888,0.0889914286277741,0.473798687855006,0.442373511726452,COLEC11/IGHG4/SH2D1A/SLC11A1/SPON2,5
GO:0051235,maintenance of location,6/173,337/18888,0.0901251168873511,0.473798687855006,0.442373511726452,MSR1/NR1H3/PLCH1/RYR3/TMEM38A/XCL1,6
GO:0001558,regulation of cell growth,7/173,418/18888,0.0903194314569612,0.473798687855006,0.442373511726452,CRYAB/DDX49/NTN1/PAK4/SEMA3C/SEMA4C/SEMA5A,7
GO:0001836,release of cytochrome c from mitochondria,2/173,55/18888,0.0904211814943134,0.473798687855006,0.442373511726452,MFF/MLLT11,2
GO:0002686,negative regulation of leukocyte migration,2/173,55/18888,0.0904211814943134,0.473798687855006,0.442373511726452,CD200/TNFAIP6,2
GO:0045071,negative regulation of viral genome replication,2/173,55/18888,0.0904211814943134,0.473798687855006,0.442373511726452,APOBEC3D/APOBEC3H,2
GO:0044344,cellular response to fibroblast growth factor stimulus,3/173,116/18888,0.0907308400691837,0.473798687855006,0.442373511726452,PRKD2/SMOC2/ZFP36L1,3
GO:1902749,regulation of cell cycle G2/M phase transition,3/173,116/18888,0.0907308400691837,0.473798687855006,0.442373511726452,ATF5/CDK6/CHFR,3
GO:0048736,appendage development,4/173,186/18888,0.0918665550000424,0.473798687855006,0.442373511726452,COL2A1/CPLANE2/SEMA3C/SHOX2,4
GO:0060173,limb development,4/173,186/18888,0.0918665550000424,0.473798687855006,0.442373511726452,COL2A1/CPLANE2/SEMA3C/SHOX2,4
GO:1905952,regulation of lipid localization,4/173,186/18888,0.0918665550000424,0.473798687855006,0.442373511726452,ACSL5/LRAT/MSR1/NR1H3,4
GO:0001954,positive regulation of cell-matrix adhesion,2/173,56/18888,0.0932264777549843,0.473798687855006,0.442373511726452,CDK6/MAP4K4,2
GO:0009116,nucleoside metabolic process,2/173,56/18888,0.0932264777549843,0.473798687855006,0.442373511726452,APOBEC3D/APOBEC3H,2
GO:0045058,T cell selection,2/173,56/18888,0.0932264777549843,0.473798687855006,0.442373511726452,IL6R/LY9,2
GO:0097553,calcium ion transmembrane import into cytosol,4/173,187/18888,0.0932400357570919,0.473798687855006,0.442373511726452,PLCH1/RYR3/TMEM38A/XCL1,4
GO:0008361,regulation of cell size,4/173,188/18888,0.0946232957745354,0.473798687855006,0.442373511726452,NTN1/SEMA3C/SEMA4C/SEMA5A,4
GO:0046148,pigment biosynthetic process,2/173,57/18888,0.0960568433581562,0.473798687855006,0.442373511726452,PMEL/SRRD,2
GO:0060997,dendritic spine morphogenesis,2/173,57/18888,0.0960568433581562,0.473798687855006,0.442373511726452,ARC/ZNF365,2
GO:0032609,type II interferon production,3/173,119/18888,0.096148438739231,0.473798687855006,0.442373511726452,CD226/SLC11A1/XCL1,3
GO:0032649,regulation of type II interferon production,3/173,119/18888,0.096148438739231,0.473798687855006,0.442373511726452,CD226/SLC11A1/XCL1,3
GO:0051702,biological process involved in interaction with symbiont,3/173,119/18888,0.096148438739231,0.473798687855006,0.442373511726452,APOBEC3H/APOL1/PC,3
GO:0000098,sulfur amino acid catabolic process,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,MAT1A,1
GO:0001867,"complement activation, lectin pathway",1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,COLEC11,1
GO:0002604,regulation of dendritic cell antigen processing and presentation,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,SLC11A1,1
GO:0002725,negative regulation of T cell cytokine production,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,XCL1,1
GO:0006183,GTP biosynthetic process,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,NME2,1
GO:0006703,estrogen biosynthetic process,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,HSD17B11,1
GO:0006828,manganese ion transport,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,SLC11A1,1
GO:0007614,short-term memory,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,SLC2A4,1
GO:0010248,establishment or maintenance of transmembrane electrochemical gradient,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,SLC22A1,1
GO:0010887,negative regulation of cholesterol storage,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,NR1H3,1
GO:0015808,L-alanine transport,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,SLC38A4,1
GO:0016185,synaptic vesicle budding from presynaptic endocytic zone membrane,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,SLC2A4,1
GO:0021562,vestibulocochlear nerve development,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,SLITRK6,1
GO:0021889,olfactory bulb interneuron differentiation,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,ATF5,1
GO:0022605,mammalian oogenesis stage,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,TNFAIP6,1
GO:0032610,interleukin-1 alpha production,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,PANX1,1
GO:0032650,regulation of interleukin-1 alpha production,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,PANX1,1
GO:0042167,heme catabolic process,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,ABCC2,1
GO:0042447,hormone catabolic process,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,HSD17B11,1
GO:0043320,natural killer cell degranulation,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,FCGR3A,1
GO:0045835,negative regulation of meiotic nuclear division,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,FBXO43,1
GO:0046149,pigment catabolic process,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,ABCC2,1
GO:0048241,epinephrine transport,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,SLC22A1,1
GO:0048742,regulation of skeletal muscle fiber development,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,SHOX2,1
GO:0060746,parental behavior,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,OXTR,1
GO:0060920,cardiac pacemaker cell differentiation,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,SHOX2,1
GO:0072124,regulation of glomerular mesangial cell proliferation,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,IL6R,1
GO:0086016,AV node cell action potential,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,SCN4B,1
GO:0086027,AV node cell to bundle of His cell signaling,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,SCN4B,1
GO:1901998,toxin transport,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,SLC22A1,1
GO:1903027,regulation of opsonization,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,COLEC11,1
GO:1904181,positive regulation of membrane depolarization,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,MLLT11,1
GO:1904464,regulation of matrix metallopeptidase secretion,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,CD200,1
GO:1990773,matrix metallopeptidase secretion,1/173,11/18888,0.0962865691463221,0.473798687855006,0.442373511726452,CD200,1
GO:0035710,"CD4-positive, alpha-beta T cell activation",3/173,120/18888,0.0979832010123092,0.473798687855006,0.442373511726452,IL6R/LY9/XCL1,3
GO:0072655,establishment of protein localization to mitochondrion,3/173,120/18888,0.0979832010123092,0.473798687855006,0.442373511726452,MFF/TIMM21/TOMM40,3
GO:0031503,protein-containing complex localization,4/173,191/18888,0.0988312289785298,0.473798687855006,0.442373511726452,ARC/NPTX1/SNAP25/VAC14,4
GO:0015804,neutral amino acid transport,2/173,58/18888,0.0989115903396207,0.473798687855006,0.442373511726452,SERINC3/SLC38A4,2
GO:0002695,negative regulation of leukocyte activation,4/173,192/18888,0.100253079836374,0.473798687855006,0.442373511726452,CD200/MERTK/NR1H3/XCL1,4
GO:0003007,heart morphogenesis,5/173,269/18888,0.101668890005585,0.473798687855006,0.442373511726452,COL2A1/CPLANE2/MYLK2/SEMA3C/SHOX2,5
GO:0031098,stress-activated protein kinase signaling cascade,2/173,59/18888,0.101790041102005,0.473798687855006,0.442373511726452,CRYAB/SEMA4C,2
GO:0045604,regulation of epidermal cell differentiation,2/173,59/18888,0.101790041102005,0.473798687855006,0.442373511726452,NME2/ZFP36L1,2
GO:0040013,negative regulation of locomotion,7/173,431/18888,0.101915749587095,0.473798687855006,0.442373511726452,CD200/RHOB/SEMA3C/SEMA4C/SEMA5A/TNFAIP6/ZMYND8,7
GO:0034765,regulation of monoatomic ion transmembrane transport,6/173,349/18888,0.102149302038117,0.473798687855006,0.442373511726452,GJC2/KCNJ2/KCNMB1/SCN4B/TMEM38A/XCL1,6
GO:0002377,immunoglobulin production,4/173,194/18888,0.103125263250138,0.473798687855006,0.442373511726452,CLCF1/IGLV2-8/SANBR/XCL1,4
GO:0002688,regulation of leukocyte chemotaxis,3/173,123/18888,0.103572059544619,0.473798687855006,0.442373511726452,IL6R/TNFAIP6/XCL1,3
GO:0001547,antral ovarian follicle growth,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,TNFAIP6,1
GO:0001967,suckling behavior,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,OXTR,1
GO:0003163,sinoatrial node development,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,SHOX2,1
GO:0006863,purine nucleobase transport,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,VDAC3,1
GO:0007320,insemination,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,OXTR,1
GO:0018095,protein polyglutamylation,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,TPGS1,1
GO:0030656,regulation of vitamin metabolic process,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,GFI1,1
GO:0031223,auditory behavior,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,SLITRK6,1
GO:0032351,negative regulation of hormone metabolic process,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,GFI1,1
GO:0032817,regulation of natural killer cell proliferation,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,FCGR3A,1
GO:0034454,microtubule anchoring at centrosome,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,CEP19,1
GO:0042797,tRNA transcription by RNA polymerase III,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,GTF3C1,1
GO:0043696,dedifferentiation,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,CDK6,1
GO:0043697,cell dedifferentiation,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,CDK6,1
GO:0044828,negative regulation by host of viral genome replication,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,APOBEC3H,1
GO:0046051,UTP metabolic process,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,NME2,1
GO:0048548,regulation of pinocytosis,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,NR1H3,1
GO:0048755,branching morphogenesis of a nerve,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,SHOX2,1
GO:0051549,positive regulation of keratinocyte migration,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,MAP4K4,1
GO:0061309,cardiac neural crest cell development involved in outflow tract morphogenesis,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,SEMA3C,1
GO:0070103,regulation of interleukin-6-mediated signaling pathway,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,GFI1,1
GO:0070142,synaptic vesicle budding,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,SLC2A4,1
GO:0070327,thyroid hormone transport,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,SLC16A2,1
GO:0072110,glomerular mesangial cell proliferation,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,IL6R,1
GO:0086067,AV node cell to bundle of His cell communication,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,SCN4B,1
GO:0090306,meiotic spindle assembly,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,SEPTIN1,1
GO:0097475,motor neuron migration,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,NTN1,1
GO:0098935,dendritic transport,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,FLOT2,1
GO:0140627,ubiquitin-dependent protein catabolic process via the C-end degron rule pathway,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,CUL4A,1
GO:1901993,regulation of meiotic cell cycle phase transition,1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,CHFR,1
GO:2000562,"negative regulation of CD4-positive, alpha-beta T cell proliferation",1/173,12/18888,0.104568733872586,0.473798687855006,0.442373511726452,XCL1,1
GO:0051260,protein homooligomerization,4/173,195/18888,0.10457548398502,0.473798687855006,0.442373511726452,ARC/KCNJ2/MAT1A/RYR3,4
GO:0001913,T cell mediated cytotoxicity,2/173,60/18888,0.104691528284423,0.473798687855006,0.442373511726452,NECTIN2/XCL1,2
GO:0043030,regulation of macrophage activation,2/173,60/18888,0.104691528284423,0.473798687855006,0.442373511726452,CD200/NR1H3,2
GO:0046686,response to cadmium ion,2/173,60/18888,0.104691528284423,0.473798687855006,0.442373511726452,MT1X/SLC11A1,2
GO:0060350,endochondral bone morphogenesis,2/173,60/18888,0.104691528284423,0.473798687855006,0.442373511726452,COL2A1/SHOX2,2
GO:0002286,T cell activation involved in immune response,3/173,124/18888,0.105462693702684,0.473798687855006,0.442373511726452,IL6R/LY9/SLC11A1,3
GO:0071774,response to fibroblast growth factor,3/173,124/18888,0.105462693702684,0.473798687855006,0.442373511726452,PRKD2/SMOC2/ZFP36L1,3
GO:0051650,establishment of vesicle localization,4/173,196/18888,0.106035048375803,0.473798687855006,0.442373511726452,CEP19/KIF13A/SLC2A4/SNAP25,4
GO:0070482,response to oxygen levels,6/173,354/18888,0.107397507135965,0.473798687855006,0.442373511726452,CRYAB/KCNMB1/MTCO2P12/OXTR/SLC2A4/ZFP36L1,6
GO:0140013,meiotic nuclear division,4/173,197/18888,0.107503898810073,0.473798687855006,0.442373511726452,CHFR/FBXO43/MARF1/SEPTIN1,4
GO:0016447,somatic recombination of immunoglobulin gene segments,2/173,61/18888,0.107615394633623,0.473798687855006,0.442373511726452,CLCF1/SANBR,2
GO:0042908,xenobiotic transport,2/173,61/18888,0.107615394633623,0.473798687855006,0.442373511726452,ABCC2/SLC22A1,2
GO:0086002,cardiac muscle cell action potential involved in contraction,2/173,61/18888,0.107615394633623,0.473798687855006,0.442373511726452,KCNJ2/SCN4B,2
GO:0001578,microtubule bundle formation,3/173,126/18888,0.109284559912152,0.473798687855006,0.442373511726452,CPLANE2/DNAH5/TPGS1,3
GO:0030099,myeloid cell differentiation,7/173,439/18888,0.109438914944521,0.473798687855006,0.442373511726452,ACTN1/CDIN1/CDK6/CUL4A/NME2/TNFAIP6/ZFP36L1,7
GO:1901990,regulation of mitotic cell cycle phase transition,6/173,356/18888,0.109535405608401,0.473798687855006,0.442373511726452,CDC16/CDK6/CHFR/CUL4A/GJC2/ZFP36L1,6
GO:0045088,regulation of innate immune response,7/173,440/18888,0.110399778951595,0.473798687855006,0.442373511726452,CD226/COLEC11/GFI1/NECTIN2/NR1H3/PSPC1/SH2D1A,7
GO:0002090,regulation of receptor internalization,2/173,62/18888,0.110560992876618,0.473798687855006,0.442373511726452,ARC/VAC14,2
GO:0071715,icosanoid transport,2/173,62/18888,0.110560992876618,0.473798687855006,0.442373511726452,ABCC2/SLC22A1,2
GO:0097120,receptor localization to synapse,2/173,62/18888,0.110560992876618,0.473798687855006,0.442373511726452,NPTX1/SNAP25,2
GO:2000351,regulation of endothelial cell apoptotic process,2/173,62/18888,0.110560992876618,0.473798687855006,0.442373511726452,PAK4/SEMA5A,2
GO:0031623,receptor internalization,3/173,127/18888,0.111215481723081,0.473798687855006,0.442373511726452,ARC/SNAP25/VAC14,3
GO:0042471,ear morphogenesis,3/173,127/18888,0.111215481723081,0.473798687855006,0.442373511726452,COL2A1/NTN1/SLITRK6,3
GO:0070585,protein localization to mitochondrion,3/173,127/18888,0.111215481723081,0.473798687855006,0.442373511726452,MFF/TIMM21/TOMM40,3
GO:0090150,establishment of protein localization to membrane,5/173,277/18888,0.111426520173372,0.473798687855006,0.442373511726452,KIF13A/MFF/MIEF2/SNAP25/TOMM40,5
GO:0005513,detection of calcium ion,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,KCNMB1,1
GO:0006563,L-serine metabolic process,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,SERINC3,1
GO:0006787,porphyrin-containing compound catabolic process,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,ABCC2,1
GO:0009068,aspartate family amino acid catabolic process,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,MAT1A,1
GO:0009304,tRNA transcription,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,GTF3C1,1
GO:0014061,regulation of norepinephrine secretion,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,OXTR,1
GO:0015851,nucleobase transport,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,VDAC3,1
GO:0016024,CDP-diacylglycerol biosynthetic process,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,TAMM41,1
GO:0019321,pentose metabolic process,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,PGD,1
GO:0030836,positive regulation of actin filament depolymerization,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,SEMA5A,1
GO:0032769,negative regulation of monooxygenase activity,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,GFI1,1
GO:0033015,tetrapyrrole catabolic process,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,ABCC2,1
GO:0034145,positive regulation of toll-like receptor 4 signaling pathway,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,NR1H3,1
GO:0035745,T-helper 2 cell cytokine production,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,XCL1,1
GO:0035865,cellular response to potassium ion,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,NPTX1,1
GO:0042362,fat-soluble vitamin biosynthetic process,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,GFI1,1
GO:0042976,activation of Janus kinase activity,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,IL6R,1
GO:0044406,adhesion of symbiont to host,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,NECTIN2,1
GO:0046341,CDP-diacylglycerol metabolic process,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,TAMM41,1
GO:0048711,positive regulation of astrocyte differentiation,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,CLCF1,1
GO:0051610,serotonin uptake,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,SLC22A1,1
GO:1902950,regulation of dendritic spine maintenance,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,ZMYND8,1
GO:1905907,negative regulation of amyloid fibril formation,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,CRYAB,1
GO:2000551,regulation of T-helper 2 cell cytokine production,1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,XCL1,1
GO:2000622,"regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",1/173,13/18888,0.112775430685473,0.473798687855006,0.442373511726452,UPF3A,1
GO:0007517,muscle organ development,6/173,359/18888,0.112783247214232,0.473798687855006,0.442373511726452,CRYAB/DNER/MYLK2/MYOM2/SHOX2/TMEM182,6
GO:0031589,cell-substrate adhesion,6/173,359/18888,0.112783247214232,0.473798687855006,0.442373511726452,ACTN1/CDK6/LPXN/MAP4K4/MERTK/PXN,6
GO:0046683,response to organophosphorus,3/173,128/18888,0.113159521575177,0.473798687855006,0.442373511726452,PANX1/RYR3/ZFP36L1,3
GO:0032623,interleukin-2 production,2/173,63/18888,0.113527685594772,0.473798687855006,0.442373511726452,PRKD2/XCL1,2
GO:0032663,regulation of interleukin-2 production,2/173,63/18888,0.113527685594772,0.473798687855006,0.442373511726452,PRKD2/XCL1,2
GO:0033059,cellular pigmentation,2/173,63/18888,0.113527685594772,0.473798687855006,0.442373511726452,KIF13A/PMEL,2
GO:0051965,positive regulation of synapse assembly,2/173,63/18888,0.113527685594772,0.473798687855006,0.442373511726452,OXTR/SLITRK6,2
GO:0010038,response to metal ion,6/173,360/18888,0.113876728765754,0.474486369857309,0.443015582525945,KCNMB1/MT1X/NPTX1/RYR3/SLC11A1/ZNF658,6
GO:0002696,positive regulation of leukocyte activation,6/173,362/18888,0.116079894058244,0.477192170503813,0.445541918213882,CD226/CLCF1/FCGR3A/FLOT2/NECTIN2/XCL1,6
GO:0001503,ossification,7/173,446/18888,0.11625950100568,0.477192170503813,0.445541918213882,CDK6/COL2A1/GDPD2/IL6R/SHOX2/TNFAIP6/ZHX3,7
GO:0098739,import across plasma membrane,4/173,203/18888,0.116508701207853,0.477192170503813,0.445541918213882,ACSL5/KCNJ2/SLC16A2/SLC38A4,4
GO:0045931,positive regulation of mitotic cell cycle,3/173,130/18888,0.117086329105041,0.477192170503813,0.445541918213882,CDC16/CUL4A/SMOC2,3
GO:0051028,mRNA transport,3/173,131/18888,0.119068782526197,0.477192170503813,0.445541918213882,ARC/UPF3A/ZFP36L1,3
GO:0045682,regulation of epidermis development,2/173,65/18888,0.119521853308453,0.477192170503813,0.445541918213882,NME2/ZFP36L1,2
GO:1904036,negative regulation of epithelial cell apoptotic process,2/173,65/18888,0.119521853308453,0.477192170503813,0.445541918213882,PAK4/SEMA5A,2
GO:0006241,CTP biosynthetic process,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,NME2,1
GO:0006361,transcription initiation at RNA polymerase I promoter,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,RRN3,1
GO:0007638,mechanosensory behavior,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,SLITRK6,1
GO:0008298,intracellular mRNA localization,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,ZFP36L1,1
GO:0010745,negative regulation of macrophage derived foam cell differentiation,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,NR1H3,1
GO:0010867,positive regulation of triglyceride biosynthetic process,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,NR1H3,1
GO:0021534,cell proliferation in hindbrain,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,ATF5,1
GO:0021924,cell proliferation in external granule layer,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,ATF5,1
GO:0021930,cerebellar granule cell precursor proliferation,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,ATF5,1
GO:0030049,muscle filament sliding,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,MYLK2,1
GO:0036151,phosphatidylcholine acyl-chain remodeling,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,NR1H3,1
GO:0045117,azole transmembrane transport,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,SLC22A1,1
GO:0045842,positive regulation of mitotic metaphase/anaphase transition,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,CDC16,1
GO:0046500,S-adenosylmethionine metabolic process,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,MAT1A,1
GO:0048243,norepinephrine secretion,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,OXTR,1
GO:0051004,regulation of lipoprotein lipase activity,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,NR1H3,1
GO:0051547,regulation of keratinocyte migration,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,MAP4K4,1
GO:0060330,regulation of response to type II interferon,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,NR1H3,1
GO:0060334,regulation of type II interferon-mediated signaling pathway,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,NR1H3,1
GO:0071361,cellular response to ethanol,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,KCNMB1,1
GO:0071472,cellular response to salt stress,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,ZFP36L1,1
GO:0072393,microtubule anchoring at microtubule organizing center,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,CEP19,1
GO:1900452,regulation of long-term synaptic depression,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,ARC,1
GO:1902047,polyamine transmembrane transport,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,SLC22A1,1
GO:1905244,regulation of modification of synaptic structure,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,RHOB,1
GO:1905522,negative regulation of macrophage migration,1/173,14/18888,0.120907343294289,0.477192170503813,0.445541918213882,CD200,1
GO:0030301,cholesterol transport,3/173,132/18888,0.121063725556381,0.477192170503813,0.445541918213882,CEL/MSR1/NR1H3,3
GO:0016445,somatic diversification of immunoglobulins,2/173,66/18888,0.122548101625472,0.477192170503813,0.445541918213882,CLCF1/SANBR,2
GO:0042446,hormone biosynthetic process,2/173,66/18888,0.122548101625472,0.477192170503813,0.445541918213882,GFI1/HSD17B11,2
GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein,2/173,66/18888,0.122548101625472,0.477192170503813,0.445541918213882,CLCF1/IL6R,2
GO:0071806,protein transmembrane transport,2/173,66/18888,0.122548101625472,0.477192170503813,0.445541918213882,TIMM21/TOMM40,2
GO:0014902,myotube differentiation,3/173,133/18888,0.123071000140509,0.477192170503813,0.445541918213882,DNER/SHOX2/TMEM182,3
GO:0010720,positive regulation of cell development,7/173,454/18888,0.124321639303008,0.477192170503813,0.445541918213882,CLCF1/GJC2/NTN1/SEMA5A/SHOX2/ZFP36L1/ZNF365,7
GO:0050878,regulation of body fluid levels,6/173,370/18888,0.125106018650165,0.477192170503813,0.445541918213882,CEL/MERTK/MTCO2P12/NR1H3/OXTR/TFPI2,6
GO:0006956,complement activation,2/173,67/18888,0.125592990818811,0.477192170503813,0.445541918213882,COLEC11/IGHG4,2
GO:0097192,extrinsic apoptotic signaling pathway in absence of ligand,2/173,67/18888,0.125592990818811,0.477192170503813,0.445541918213882,BCL2L10/COL2A1,2
GO:0007281,germ cell development,6/173,371/18888,0.12625799727428,0.477192170503813,0.445541918213882,MARF1/NECTIN2/PANX1/TNFAIP6/TPGS1/VDAC3,6
GO:0016050,vesicle organization,6/173,371/18888,0.12625799727428,0.477192170503813,0.445541918213882,CPLANE2/KIF13A/NECTIN2/PMEL/SLC2A4/SNAP25,6
GO:0006720,isoprenoid metabolic process,3/173,135/18888,0.127121910284072,0.477192170503813,0.445541918213882,CEL/CYP4V2/LRAT,3
GO:0030218,erythrocyte differentiation,3/173,135/18888,0.127121910284072,0.477192170503813,0.445541918213882,CDIN1/CDK6/ZFP36L1,3
GO:0030879,mammary gland development,3/173,135/18888,0.127121910284072,0.477192170503813,0.445541918213882,MTCO2P12/NTN1/OXTR,3
GO:0045576,mast cell activation,2/173,68/18888,0.128655930903096,0.477192170503813,0.445541918213882,CD226/NECTIN2,2
GO:0045668,negative regulation of osteoblast differentiation,2/173,68/18888,0.128655930903096,0.477192170503813,0.445541918213882,CDK6/TNFAIP6,2
GO:0046513,ceramide biosynthetic process,2/173,68/18888,0.128655930903096,0.477192170503813,0.445541918213882,B4GALT4/CERS5,2
GO:0072577,endothelial cell apoptotic process,2/173,68/18888,0.128655930903096,0.477192170503813,0.445541918213882,PAK4/SEMA5A,2
GO:0001768,establishment of T cell polarity,1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,FLOT2,1
GO:0001787,natural killer cell proliferation,1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,FCGR3A,1
GO:0007008,outer mitochondrial membrane organization,1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,TOMM40,1
GO:0007028,cytoplasm organization,1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,RRN3,1
GO:0007567,parturition,1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,OXTR,1
GO:0009048,dosage compensation by inactivation of X chromosome,1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,LRIF1,1
GO:0009209,pyrimidine ribonucleoside triphosphate biosynthetic process,1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,NME2,1
GO:0010820,positive regulation of T cell chemotaxis,1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,XCL1,1
GO:0030007,intracellular potassium ion homeostasis,1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,KCNJ2,1
GO:0032230,"positive regulation of synaptic transmission, GABAergic",1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,OXTR,1
GO:0033189,response to vitamin A,1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,LRAT,1
GO:0044771,meiotic cell cycle phase transition,1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,CHFR,1
GO:0044849,estrous cycle,1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,OXTR,1
GO:0045040,protein insertion into mitochondrial outer membrane,1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,TOMM40,1
GO:0045187,"regulation of circadian sleep/wake cycle, sleep",1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,PER3,1
GO:0060457,negative regulation of digestive system process,1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,NR1H3,1
GO:0061043,regulation of vascular wound healing,1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,SMOC2,1
GO:0061307,cardiac neural crest cell differentiation involved in heart development,1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,SEMA3C,1
GO:0061308,cardiac neural crest cell development involved in heart development,1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,SEMA3C,1
GO:0070341,fat cell proliferation,1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,SLC2A4,1
GO:0071599,otic vesicle development,1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,COL2A1,1
GO:1900153,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,ZFP36L1,1
GO:1901722,regulation of cell proliferation involved in kidney development,1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,IL6R,1
GO:1902101,positive regulation of metaphase/anaphase transition of cell cycle,1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,CDC16,1
GO:2000402,negative regulation of lymphocyte migration,1/173,15/18888,0.128965149250106,0.477192170503813,0.445541918213882,CD200,1
GO:0051321,meiotic cell cycle,5/173,291/18888,0.129544862630057,0.477192170503813,0.445541918213882,CDC16/CHFR/FBXO43/MARF1/SEPTIN1,5
GO:0002711,positive regulation of T cell mediated immunity,2/173,69/18888,0.13173634102171,0.477192170503813,0.445541918213882,NECTIN2/XCL1,2
GO:0019731,antibacterial humoral response,2/173,69/18888,0.13173634102171,0.477192170503813,0.445541918213882,IGHG4/SPON2,2
GO:0038034,signal transduction in absence of ligand,2/173,69/18888,0.13173634102171,0.477192170503813,0.445541918213882,BCL2L10/COL2A1,2
GO:0044458,motile cilium assembly,2/173,69/18888,0.13173634102171,0.477192170503813,0.445541918213882,TPGS1/VDAC3,2
GO:0030048,actin filament-based movement,3/173,138/18888,0.133286795470355,0.477192170503813,0.445541918213882,KCNJ2/MYLK2/SCN4B,3
GO:2000241,regulation of reproductive process,4/173,214/18888,0.133836332612921,0.477192170503813,0.445541918213882,CDC16/CHFR/FBXO43/OXTR,4
GO:0002548,monocyte chemotaxis,2/173,70/18888,0.134833649330694,0.477192170503813,0.445541918213882,IL6R/XCL1,2
GO:0002562,somatic diversification of immune receptors via germline recombination within a single locus,2/173,70/18888,0.134833649330694,0.477192170503813,0.445541918213882,CLCF1/SANBR,2
GO:0016444,somatic cell DNA recombination,2/173,70/18888,0.134833649330694,0.477192170503813,0.445541918213882,CLCF1/SANBR,2
GO:0032922,circadian regulation of gene expression,2/173,70/18888,0.134833649330694,0.477192170503813,0.445541918213882,PER3/RBM4B,2
GO:0071479,cellular response to ionizing radiation,2/173,70/18888,0.134833649330694,0.477192170503813,0.445541918213882,CRYAB/RHOB,2
GO:1902750,negative regulation of cell cycle G2/M phase transition,2/173,70/18888,0.134833649330694,0.477192170503813,0.445541918213882,ATF5/CHFR,2
GO:2000401,regulation of lymphocyte migration,2/173,70/18888,0.134833649330694,0.477192170503813,0.445541918213882,CD200/XCL1,2
GO:2000573,positive regulation of DNA biosynthetic process,2/173,70/18888,0.134833649330694,0.477192170503813,0.445541918213882,PRKD2/SMOC2,2
GO:0050866,negative regulation of cell activation,4/173,215/18888,0.135461799423863,0.477192170503813,0.445541918213882,CD200/MERTK/NR1H3/XCL1,4
GO:0050867,positive regulation of cell activation,6/173,380/18888,0.136857660510545,0.477192170503813,0.445541918213882,CD226/CLCF1/FCGR3A/FLOT2/NECTIN2/XCL1,6
GO:0001767,establishment of lymphocyte polarity,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,FLOT2,1
GO:0002468,dendritic cell antigen processing and presentation,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,SLC11A1,1
GO:0006266,DNA ligation,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,TFIP11,1
GO:0006555,methionine metabolic process,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,MAT1A,1
GO:0006855,xenobiotic transmembrane transport,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,ABCC2,1
GO:0010273,detoxification of copper ion,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,MT1X,1
GO:0010819,regulation of T cell chemotaxis,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,XCL1,1
GO:0015846,polyamine transport,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,SLC22A1,1
GO:0018146,keratan sulfate biosynthetic process,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,B4GALT4,1
GO:0030299,intestinal cholesterol absorption,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,CEL,1
GO:0030852,regulation of granulocyte differentiation,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,CUL4A,1
GO:0032048,cardiolipin metabolic process,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,TAMM41,1
GO:0032793,positive regulation of CREB transcription factor activity,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,CD200,1
GO:0033275,actin-myosin filament sliding,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,MYLK2,1
GO:0035435,phosphate ion transmembrane transport,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,SLC37A1,1
GO:0043455,regulation of secondary metabolic process,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,PMEL,1
GO:0046036,CTP metabolic process,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,NME2,1
GO:0046642,negative regulation of alpha-beta T cell proliferation,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,XCL1,1
GO:0048021,regulation of melanin biosynthetic process,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,PMEL,1
GO:0050802,"circadian sleep/wake cycle, sleep",1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,PER3,1
GO:0060841,venous blood vessel development,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,SEMA3C,1
GO:0072531,pyrimidine-containing compound transmembrane transport,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,SLC22A1,1
GO:0098969,neurotransmitter receptor transport to postsynaptic membrane,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,SNAP25,1
GO:1900376,regulation of secondary metabolite biosynthetic process,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,PMEL,1
GO:1903909,regulation of receptor clustering,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,TNFAIP6,1
GO:1905874,regulation of postsynaptic density organization,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,ZMYND8,1
GO:1990169,stress response to copper ion,1/173,16/18888,0.1369495200009,0.477192170503813,0.445541918213882,MT1X,1
GO:0006643,membrane lipid metabolic process,4/173,217/18888,0.138736912151779,0.482115450459959,0.450138656658374,B4GALT4/CEL/CERS5/PRKD2,4
GO:0071805,potassium ion transmembrane transport,4/173,217/18888,0.138736912151779,0.482115450459959,0.450138656658374,KCNJ2/KCNMB1/SNAP25/TMEM38A,4
GO:0010632,regulation of epithelial cell migration,5/173,298/18888,0.13907903271873,0.48265297742686,0.450640531606724,MAP4K4/PRKD2/RHOB/SEMA5A/SMOC2,5
GO:0030317,flagellated sperm motility,3/173,141/18888,0.139554083875721,0.482999685456965,0.450964243876835,DNAH5/TPGS1/VDAC3,3
GO:0097722,sperm motility,3/173,141/18888,0.139554083875721,0.482999685456965,0.450964243876835,DNAH5/TPGS1/VDAC3,3
GO:1903046,meiotic cell cycle process,4/173,218/18888,0.140386421358779,0.483809839736036,0.451720663855741,CHFR/FBXO43/MARF1/SEPTIN1,4
GO:0042698,ovulation cycle,2/173,72/18888,0.141076717520026,0.483809839736036,0.451720663855741,OXTR/TNFAIP6,2
GO:0034341,response to type II interferon,3/173,142/18888,0.141665192364375,0.483809839736036,0.451720663855741,NR1H3/SLC11A1/XCL1,3
GO:0060271,cilium assembly,6/173,385/18888,0.142923033943876,0.483809839736036,0.451720663855741,CEP19/CPLANE2/DNAH5/RPGRIP1/TPGS1/VDAC3,6
GO:0006997,nucleus organization,3/173,143/18888,0.143787041247375,0.483809839736036,0.451720663855741,NECTIN2/RRN3/TMEM43,3
GO:0050671,positive regulation of lymphocyte proliferation,3/173,143/18888,0.143787041247375,0.483809839736036,0.451720663855741,CLCF1/FCGR3A/XCL1,3
GO:1903900,regulation of viral life cycle,3/173,143/18888,0.143787041247375,0.483809839736036,0.451720663855741,APOBEC3D/APOBEC3H/NECTIN2,3
GO:0008333,endosome to lysosome transport,2/173,73/18888,0.144221377749553,0.483809839736036,0.451720663855741,KIF13A/RHOB,2
GO:0071560,cellular response to transforming growth factor beta stimulus,5/173,302/18888,0.144662948065616,0.483809839736036,0.451720663855741,LPXN/PRDM16/PXN/XCL1/ZFP36L1,5
GO:0007000,nucleolus organization,1/173,17/18888,0.144861120946207,0.483809839736036,0.451720663855741,RRN3,1
GO:0007549,sex-chromosome dosage compensation,1/173,17/18888,0.144861120946207,0.483809839736036,0.451720663855741,LRIF1,1
GO:0021535,cell migration in hindbrain,1/173,17/18888,0.144861120946207,0.483809839736036,0.451720663855741,SEMA4C,1
GO:0032488,Cdc42 protein signal transduction,1/173,17/18888,0.144861120946207,0.483809839736036,0.451720663855741,NTN1,1
GO:0038083,peptidyl-tyrosine autophosphorylation,1/173,17/18888,0.144861120946207,0.483809839736036,0.451720663855741,SRMS,1
GO:0044793,negative regulation by host of viral process,1/173,17/18888,0.144861120946207,0.483809839736036,0.451720663855741,APOBEC3H,1
GO:0048557,embryonic digestive tract morphogenesis,1/173,17/18888,0.144861120946207,0.483809839736036,0.451720663855741,SHOX2,1
GO:0051782,negative regulation of cell division,1/173,17/18888,0.144861120946207,0.483809839736036,0.451720663855741,SUSD2,1
GO:0055119,relaxation of cardiac muscle,1/173,17/18888,0.144861120946207,0.483809839736036,0.451720663855741,KCNJ2,1
GO:0060221,retinal rod cell differentiation,1/173,17/18888,0.144861120946207,0.483809839736036,0.451720663855741,RPGRIP1,1
GO:0072109,glomerular mesangium development,1/173,17/18888,0.144861120946207,0.483809839736036,0.451720663855741,IL6R,1
GO:0090494,dopamine uptake,1/173,17/18888,0.144861120946207,0.483809839736036,0.451720663855741,SLC22A1,1
GO:0098877,neurotransmitter receptor transport to plasma membrane,1/173,17/18888,0.144861120946207,0.483809839736036,0.451720663855741,SNAP25,1
GO:0150079,negative regulation of neuroinflammatory response,1/173,17/18888,0.144861120946207,0.483809839736036,0.451720663855741,CD200,1
GO:1902036,regulation of hematopoietic stem cell differentiation,1/173,17/18888,0.144861120946207,0.483809839736036,0.451720663855741,CDK6,1
GO:1903540,establishment of protein localization to postsynaptic membrane,1/173,17/18888,0.144861120946207,0.483809839736036,0.451720663855741,SNAP25,1
GO:1905906,regulation of amyloid fibril formation,1/173,17/18888,0.144861120946207,0.483809839736036,0.451720663855741,CRYAB,1
GO:1990403,embryonic brain development,1/173,17/18888,0.144861120946207,0.483809839736036,0.451720663855741,EN2,1
GO:0099003,vesicle-mediated transport in synapse,4/173,221/18888,0.145381932115746,0.484298873005537,0.452177261500111,ARC/SLC2A4/SNAP25/VAC14,4
GO:0008544,epidermis development,6/173,387/18888,0.145383700517779,0.484298873005537,0.452177261500111,FLOT2/FOXQ1/KRT86/NME2/SLITRK6/ZFP36L1,6
GO:0034101,erythrocyte homeostasis,3/173,144/18888,0.145919471095996,0.485301019003251,0.453112939153163,CDIN1/CDK6/ZFP36L1,3
GO:0042093,T-helper cell differentiation,2/173,74/18888,0.147380736644871,0.485301019003251,0.453112939153163,IL6R/LY9,2
GO:0050709,negative regulation of protein secretion,2/173,74/18888,0.147380736644871,0.485301019003251,0.453112939153163,CD200/NR1H3,2
GO:0050795,regulation of behavior,2/173,74/18888,0.147380736644871,0.485301019003251,0.453112939153163,PER3/QRFP,2
GO:0051937,catecholamine transport,2/173,74/18888,0.147380736644871,0.485301019003251,0.453112939153163,OXTR/SLC22A1,2
GO:0060415,muscle tissue morphogenesis,2/173,74/18888,0.147380736644871,0.485301019003251,0.453112939153163,MYLK2/SHOX2,2
GO:0072678,T cell migration,2/173,74/18888,0.147380736644871,0.485301019003251,0.453112939153163,CD200/XCL1,2
GO:1902475,L-alpha-amino acid transmembrane transport,2/173,74/18888,0.147380736644871,0.485301019003251,0.453112939153163,SLC11A1/SLC38A4,2
GO:1905818,regulation of chromosome separation,2/173,74/18888,0.147380736644871,0.485301019003251,0.453112939153163,CDC16/CHFR,2
GO:0015918,sterol transport,3/173,145/18888,0.148062322550882,0.486922708261201,0.454627068234475,CEL/MSR1/NR1H3,3
GO:0032946,positive regulation of mononuclear cell proliferation,3/173,146/18888,0.150215436351272,0.487383596490854,0.455057387587168,CLCF1/FCGR3A/XCL1,3
GO:0046467,membrane lipid biosynthetic process,3/173,146/18888,0.150215436351272,0.487383596490854,0.455057387587168,B4GALT4/CERS5/PRKD2,3
GO:0098656,monoatomic anion transmembrane transport,3/173,146/18888,0.150215436351272,0.487383596490854,0.455057387587168,ABCC2/APOL1/VDAC3,3
GO:0002637,regulation of immunoglobulin production,2/173,75/18888,0.150554265730265,0.487383596490854,0.455057387587168,CLCF1/XCL1,2
GO:0006650,glycerophospholipid metabolic process,5/173,307/18888,0.15177729961251,0.487383596490854,0.455057387587168,EFR3B/NR1H3/PLCH1/TAMM41/VAC14,5
GO:0035264,multicellular organism growth,3/173,147/18888,0.152378653363538,0.487383596490854,0.455057387587168,ATF5/SLITRK6/ZFP36L1,3
GO:1904019,epithelial cell apoptotic process,3/173,147/18888,0.152378653363538,0.487383596490854,0.455057387587168,PAK4/SEMA5A/ZFP36L1,3
GO:0002524,hypersensitivity,1/173,18/18888,0.152700611491293,0.487383596490854,0.455057387587168,FCGR3A,1
GO:0002830,positive regulation of type 2 immune response,1/173,18/18888,0.152700611491293,0.487383596490854,0.455057387587168,XCL1,1
GO:0007625,grooming behavior,1/173,18/18888,0.152700611491293,0.487383596490854,0.455057387587168,QRFP,1
GO:0009208,pyrimidine ribonucleoside triphosphate metabolic process,1/173,18/18888,0.152700611491293,0.487383596490854,0.455057387587168,NME2,1
GO:0014819,regulation of skeletal muscle contraction,1/173,18/18888,0.152700611491293,0.487383596490854,0.455057387587168,KCNJ2,1
GO:0015693,magnesium ion transport,1/173,18/18888,0.152700611491293,0.487383596490854,0.455057387587168,KCNJ2,1
GO:0016082,synaptic vesicle priming,1/173,18/18888,0.152700611491293,0.487383596490854,0.455057387587168,SNAP25,1
GO:0030949,positive regulation of vascular endothelial growth factor receptor signaling pathway,1/173,18/18888,0.152700611491293,0.487383596490854,0.455057387587168,PRKD2,1
GO:0032328,alanine transport,1/173,18/18888,0.152700611491293,0.487383596490854,0.455057387587168,SLC38A4,1
GO:0032874,positive regulation of stress-activated MAPK cascade,1/173,18/18888,0.152700611491293,0.487383596490854,0.455057387587168,SEMA4C,1
GO:0035864,response to potassium ion,1/173,18/18888,0.152700611491293,0.487383596490854,0.455057387587168,NPTX1,1
GO:0042339,keratan sulfate metabolic process,1/173,18/18888,0.152700611491293,0.487383596490854,0.455057387587168,B4GALT4,1
GO:0044539,long-chain fatty acid import into cell,1/173,18/18888,0.152700611491293,0.487383596490854,0.455057387587168,ACSL5,1
GO:0071318,cellular response to ATP,1/173,18/18888,0.152700611491293,0.487383596490854,0.455057387587168,RYR3,1
GO:0090493,catecholamine uptake,1/173,18/18888,0.152700611491293,0.487383596490854,0.455057387587168,SLC22A1,1
GO:1901970,positive regulation of mitotic sister chromatid separation,1/173,18/18888,0.152700611491293,0.487383596490854,0.455057387587168,CDC16,1
GO:0002200,somatic diversification of immune receptors,2/173,76/18888,0.153741444873744,0.487383596490854,0.455057387587168,CLCF1/SANBR,2
GO:0002294,"CD4-positive, alpha-beta T cell differentiation involved in immune response",2/173,76/18888,0.153741444873744,0.487383596490854,0.455057387587168,IL6R/LY9,2
GO:0035924,cellular response to vascular endothelial growth factor stimulus,2/173,76/18888,0.153741444873744,0.487383596490854,0.455057387587168,PRKD2/SMOC2,2
GO:1902373,negative regulation of mRNA catabolic process,2/173,76/18888,0.153741444873744,0.487383596490854,0.455057387587168,SLC11A1/UPF3A,2
GO:0010959,regulation of metal ion transport,6/173,394/18888,0.154147960334698,0.487383596490854,0.455057387587168,GJC2/KCNJ2/KCNMB1/SCN4B/TMEM38A/XCL1,6
GO:0071559,response to transforming growth factor beta,5/173,309/18888,0.154663887215933,0.487383596490854,0.455057387587168,LPXN/PRDM16/PXN/XCL1/ZFP36L1,5
GO:0022412,cellular process involved in reproduction in multicellular organism,7/173,482/18888,0.154694209560618,0.487383596490854,0.455057387587168,MARF1/NECTIN2/PANX1/SEPTIN1/TNFAIP6/TPGS1/VDAC3,7
GO:0010821,regulation of mitochondrion organization,3/173,149/18888,0.156734761291382,0.487383596490854,0.455057387587168,MFF/MIEF2/MLLT11,3
GO:0002287,alpha-beta T cell activation involved in immune response,2/173,77/18888,0.156941762180026,0.487383596490854,0.455057387587168,IL6R/LY9,2
GO:0002293,alpha-beta T cell differentiation involved in immune response,2/173,77/18888,0.156941762180026,0.487383596490854,0.455057387587168,IL6R/LY9,2
GO:0031016,pancreas development,2/173,77/18888,0.156941762180026,0.487383596490854,0.455057387587168,CDK6/IL6R,2
GO:0032729,positive regulation of type II interferon production,2/173,77/18888,0.156941762180026,0.487383596490854,0.455057387587168,CD226/SLC11A1,2
GO:0055117,regulation of cardiac muscle contraction,2/173,77/18888,0.156941762180026,0.487383596490854,0.455057387587168,KCNJ2/TMEM38A,2
GO:0051651,maintenance of location in cell,4/173,228/18888,0.15730319019636,0.487383596490854,0.455057387587168,PLCH1/RYR3/TMEM38A/XCL1,4
GO:0062197,cellular response to chemical stress,5/173,311/18888,0.157573345483254,0.487383596490854,0.455057387587168,NME2/PXN/RHOB/SLC2A4/ZFP36L1,5
GO:0035107,appendage morphogenesis,3/173,150/18888,0.158927334822841,0.487383596490854,0.455057387587168,COL2A1/SEMA3C/SHOX2,3
GO:0035108,limb morphogenesis,3/173,150/18888,0.158927334822841,0.487383596490854,0.455057387587168,COL2A1/SEMA3C/SHOX2,3
GO:0035418,protein localization to synapse,2/173,78/18888,0.160154713884768,0.487383596490854,0.455057387587168,NPTX1/SNAP25,2
GO:0042509,regulation of tyrosine phosphorylation of STAT protein,2/173,78/18888,0.160154713884768,0.487383596490854,0.455057387587168,CLCF1/IL6R,2
GO:0050853,B cell receptor signaling pathway,2/173,78/18888,0.160154713884768,0.487383596490854,0.455057387587168,IGHG4/LPXN,2
GO:2000242,negative regulation of reproductive process,2/173,78/18888,0.160154713884768,0.487383596490854,0.455057387587168,CHFR/FBXO43,2
GO:0000212,meiotic spindle organization,1/173,19/18888,0.160468645100832,0.487383596490854,0.455057387587168,SEPTIN1,1
GO:0001502,cartilage condensation,1/173,19/18888,0.160468645100832,0.487383596490854,0.455057387587168,COL2A1,1
GO:0007620,copulation,1/173,19/18888,0.160468645100832,0.487383596490854,0.455057387587168,OXTR,1
GO:0009148,pyrimidine nucleoside triphosphate biosynthetic process,1/173,19/18888,0.160468645100832,0.487383596490854,0.455057387587168,NME2,1
GO:0010744,positive regulation of macrophage derived foam cell differentiation,1/173,19/18888,0.160468645100832,0.487383596490854,0.455057387587168,MSR1,1
GO:0022410,circadian sleep/wake cycle process,1/173,19/18888,0.160468645100832,0.487383596490854,0.455057387587168,PER3,1
GO:0030540,female genitalia development,1/173,19/18888,0.160468645100832,0.487383596490854,0.455057387587168,MERTK,1
GO:0030903,notochord development,1/173,19/18888,0.160468645100832,0.487383596490854,0.455057387587168,COL2A1,1
GO:0032026,response to magnesium ion,1/173,19/18888,0.160468645100832,0.487383596490854,0.455057387587168,RYR3,1
GO:0035338,long-chain fatty-acyl-CoA biosynthetic process,1/173,19/18888,0.160468645100832,0.487383596490854,0.455057387587168,ACSL5,1
GO:0035743,"CD4-positive, alpha-beta T cell cytokine production",1/173,19/18888,0.160468645100832,0.487383596490854,0.455057387587168,XCL1,1
GO:0042749,regulation of circadian sleep/wake cycle,1/173,19/18888,0.160468645100832,0.487383596490854,0.455057387587168,PER3,1
GO:0045342,MHC class II biosynthetic process,1/173,19/18888,0.160468645100832,0.487383596490854,0.455057387587168,SLC11A1,1
GO:0045618,positive regulation of keratinocyte differentiation,1/173,19/18888,0.160468645100832,0.487383596490854,0.455057387587168,NME2,1
GO:0050965,detection of temperature stimulus involved in sensory perception of pain,1/173,19/18888,0.160468645100832,0.487383596490854,0.455057387587168,MMP24,1
GO:0061158,3'-UTR-mediated mRNA destabilization,1/173,19/18888,0.160468645100832,0.487383596490854,0.455057387587168,ZFP36L1,1
GO:1901881,positive regulation of protein depolymerization,1/173,19/18888,0.160468645100832,0.487383596490854,0.455057387587168,SEMA5A,1
GO:1902001,fatty acid transmembrane transport,1/173,19/18888,0.160468645100832,0.487383596490854,0.455057387587168,ACSL5,1
GO:1902931,negative regulation of alcohol biosynthetic process,1/173,19/18888,0.160468645100832,0.487383596490854,0.455057387587168,GFI1,1
GO:2000434,regulation of protein neddylation,1/173,19/18888,0.160468645100832,0.487383596490854,0.455057387587168,DCUN1D2,1
GO:0001666,response to hypoxia,5/173,313/18888,0.160505355271551,0.487383596490854,0.455057387587168,CRYAB/KCNMB1/MTCO2P12/SLC2A4/ZFP36L1,5
GO:0002685,regulation of leukocyte migration,4/173,230/18888,0.160774862192902,0.487626937746435,0.455284588988393,CD200/IL6R/TNFAIP6/XCL1,4
GO:0120161,regulation of cold-induced thermogenesis,3/173,151/18888,0.161129376850394,0.488127229870312,0.455751698732261,NR1H3/OXTR/PRDM16,3
GO:0034762,regulation of transmembrane transport,7/173,489/18888,0.162785737664361,0.490960446237765,0.458396999164867,ACSL5/GJC2/KCNJ2/KCNMB1/SCN4B/TMEM38A/XCL1,7
GO:0044839,cell cycle G2/M phase transition,3/173,152/18888,0.163340729280934,0.490960446237765,0.458396999164867,ATF5/CDK6/CHFR,3
GO:0106106,cold-induced thermogenesis,3/173,152/18888,0.163340729280934,0.490960446237765,0.458396999164867,NR1H3/OXTR/PRDM16,3
GO:0002752,cell surface pattern recognition receptor signaling pathway,2/173,79/18888,0.163379804250023,0.490960446237765,0.458396999164867,COLEC11/NR1H3,2
GO:0045685,regulation of glial cell differentiation,2/173,79/18888,0.163379804250023,0.490960446237765,0.458396999164867,CLCF1/ZNF365,2
GO:1903533,regulation of protein targeting,2/173,79/18888,0.163379804250023,0.490960446237765,0.458396999164867,MFF/MIEF2,2
GO:0019722,calcium-mediated signaling,4/173,232/18888,0.164274631111529,0.490960446237765,0.458396999164867,ACKR4/FCGR3A/RYR3/TMEM38A,4
GO:0048285,organelle fission,7/173,493/18888,0.167494308236229,0.490960446237765,0.458396999164867,CDC16/CHFR/FBXO43/MARF1/MFF/MIEF2/SEPTIN1,7
GO:0071456,cellular response to hypoxia,3/173,154/18888,0.167790734425496,0.490960446237765,0.458396999164867,KCNMB1/SLC2A4/ZFP36L1,3
GO:0007411,axon guidance,4/173,234/18888,0.167801913656337,0.490960446237765,0.458396999164867,NTN1/SEMA3C/SEMA4C/SEMA5A,4
GO:0010594,regulation of endothelial cell migration,4/173,234/18888,0.167801913656337,0.490960446237765,0.458396999164867,PRKD2/RHOB/SEMA5A/SMOC2,4
GO:0097485,neuron projection guidance,4/173,234/18888,0.167801913656337,0.490960446237765,0.458396999164867,NTN1/SEMA3C/SEMA4C/SEMA5A,4
GO:0002093,auditory receptor cell morphogenesis,1/173,20/18888,0.16816586935212,0.490960446237765,0.458396999164867,SLITRK6,1
GO:0002577,regulation of antigen processing and presentation,1/173,20/18888,0.16816586935212,0.490960446237765,0.458396999164867,SLC11A1,1
GO:0003215,cardiac right ventricle morphogenesis,1/173,20/18888,0.16816586935212,0.490960446237765,0.458396999164867,SEMA3C,1
GO:0007413,axonal fasciculation,1/173,20/18888,0.16816586935212,0.490960446237765,0.458396999164867,SEMA5A,1
GO:0009070,serine family amino acid biosynthetic process,1/173,20/18888,0.16816586935212,0.490960446237765,0.458396999164867,SERINC3,1
GO:0015812,gamma-aminobutyric acid transport,1/173,20/18888,0.16816586935212,0.490960446237765,0.458396999164867,SLC6A12,1
GO:0032253,dense core granule localization,1/173,20/18888,0.16816586935212,0.490960446237765,0.458396999164867,SNAP25,1
GO:0034755,iron ion transmembrane transport,1/173,20/18888,0.16816586935212,0.490960446237765,0.458396999164867,SLC11A1,1
GO:0035461,vitamin transmembrane transport,1/173,20/18888,0.16816586935212,0.490960446237765,0.458396999164867,SLC22A1,1
GO:0044241,lipid digestion,1/173,20/18888,0.16816586935212,0.490960446237765,0.458396999164867,CEL,1
GO:0044794,positive regulation by host of viral process,1/173,20/18888,0.16816586935212,0.490960446237765,0.458396999164867,PC,1
GO:0048643,positive regulation of skeletal muscle tissue development,1/173,20/18888,0.16816586935212,0.490960446237765,0.458396999164867,SHOX2,1
GO:0051546,keratinocyte migration,1/173,20/18888,0.16816586935212,0.490960446237765,0.458396999164867,MAP4K4,1
GO:0051900,regulation of mitochondrial depolarization,1/173,20/18888,0.16816586935212,0.490960446237765,0.458396999164867,MLLT11,1
GO:0070304,positive regulation of stress-activated protein kinase signaling cascade,1/173,20/18888,0.16816586935212,0.490960446237765,0.458396999164867,SEMA4C,1
GO:0098856,intestinal lipid absorption,1/173,20/18888,0.16816586935212,0.490960446237765,0.458396999164867,CEL,1
GO:0106030,neuron projection fasciculation,1/173,20/18888,0.16816586935212,0.490960446237765,0.458396999164867,SEMA5A,1
GO:0140131,positive regulation of lymphocyte chemotaxis,1/173,20/18888,0.16816586935212,0.490960446237765,0.458396999164867,XCL1,1
GO:1901739,regulation of myoblast fusion,1/173,20/18888,0.16816586935212,0.490960446237765,0.458396999164867,TMEM182,1
GO:2001185,"regulation of CD8-positive, alpha-beta T cell activation",1/173,20/18888,0.16816586935212,0.490960446237765,0.458396999164867,XCL1,1
GO:0097193,intrinsic apoptotic signaling pathway,5/173,319/18888,0.169433446407453,0.491938046758268,0.459309759344255,BCL2L10/CUL4A/MLLT11/RRN3/SERINC3,5
GO:0016358,dendrite development,4/173,235/18888,0.169575689333857,0.491938046758268,0.459309759344255,ARC/PAK4/ZMYND8/ZNF365,4
GO:0006970,response to osmotic stress,2/173,81/18888,0.169864457523513,0.491938046758268,0.459309759344255,SLC2A4/ZFP36L1,2
GO:0032088,negative regulation of NF-kappaB transcription factor activity,2/173,81/18888,0.169864457523513,0.491938046758268,0.459309759344255,CD200/GFI1,2
GO:0048644,muscle organ morphogenesis,2/173,81/18888,0.169864457523513,0.491938046758268,0.459309759344255,MYLK2/SHOX2,2
GO:0051304,chromosome separation,2/173,81/18888,0.169864457523513,0.491938046758268,0.459309759344255,CDC16/CHFR,2
GO:0016125,sterol metabolic process,3/173,155/18888,0.17002907247179,0.491938046758268,0.459309759344255,APOL1/APOL2/CYP4V2,3
GO:0045807,positive regulation of endocytosis,3/173,155/18888,0.17002907247179,0.491938046758268,0.459309759344255,COLEC11/MERTK/SLC11A1,3
GO:0050678,regulation of epithelial cell proliferation,6/173,407/18888,0.171028107398888,0.493826557584099,0.461073012783682,CDK6/NME2/PRKD2/SEMA5A/TINF2/ZFP36L1,6
GO:0016049,cell growth,7/173,496/18888,0.17106535509321,0.493826557584099,0.461073012783682,CRYAB/DDX49/NTN1/PAK4/SEMA3C/SEMA4C/SEMA5A,7
GO:0032368,regulation of lipid transport,3/173,156/18888,0.172276091631913,0.494298084658642,0.461513265349141,ACSL5/LRAT/NR1H3,3
GO:0043433,negative regulation of DNA-binding transcription factor activity,3/173,156/18888,0.172276091631913,0.494298084658642,0.461513265349141,CD200/GFI1/XCL1,3
GO:0007260,tyrosine phosphorylation of STAT protein,2/173,82/18888,0.173123068163888,0.494298084658642,0.461513265349141,CLCF1/IL6R,2
GO:0032147,activation of protein kinase activity,2/173,82/18888,0.173123068163888,0.494298084658642,0.461513265349141,IL6R/SLC11A1,2
GO:1904427,positive regulation of calcium ion transmembrane transport,2/173,82/18888,0.173123068163888,0.494298084658642,0.461513265349141,GJC2/XCL1,2
GO:0009615,response to virus,6/173,409/18888,0.173691892231229,0.494298084658642,0.461513265349141,APOBEC3D/APOBEC3H/CDK6/SERINC3/SPON2/XCL1,6
GO:0048872,homeostasis of number of cells,5/173,322/18888,0.173969732291916,0.494298084658642,0.461513265349141,CDIN1/CDK6/MERTK/RRN3/ZFP36L1,5
GO:0048588,developmental cell growth,4/173,238/18888,0.174936670035199,0.494298084658642,0.461513265349141,NTN1/SEMA3C/SEMA4C/SEMA5A,4
GO:0001780,neutrophil homeostasis,1/173,21/18888,0.175792925987804,0.494298084658642,0.461513265349141,MERTK,1
GO:0006098,pentose-phosphate shunt,1/173,21/18888,0.175792925987804,0.494298084658642,0.461513265349141,PGD,1
GO:0006907,pinocytosis,1/173,21/18888,0.175792925987804,0.494298084658642,0.461513265349141,NR1H3,1
GO:0016075,rRNA catabolic process,1/173,21/18888,0.175792925987804,0.494298084658642,0.461513265349141,DDX49,1
GO:0032011,ARF protein signal transduction,1/173,21/18888,0.175792925987804,0.494298084658642,0.461513265349141,MAP4K4,1
GO:0032012,regulation of ARF protein signal transduction,1/173,21/18888,0.175792925987804,0.494298084658642,0.461513265349141,MAP4K4,1
GO:0032211,negative regulation of telomere maintenance via telomerase,1/173,21/18888,0.175792925987804,0.494298084658642,0.461513265349141,TINF2,1
GO:0042359,vitamin D metabolic process,1/173,21/18888,0.175792925987804,0.494298084658642,0.461513265349141,GFI1,1
GO:0042745,circadian sleep/wake cycle,1/173,21/18888,0.175792925987804,0.494298084658642,0.461513265349141,PER3,1
GO:0048791,calcium ion-regulated exocytosis of neurotransmitter,1/173,21/18888,0.175792925987804,0.494298084658642,0.461513265349141,SNAP25,1
GO:0060973,cell migration involved in heart development,1/173,21/18888,0.175792925987804,0.494298084658642,0.461513265349141,SEMA3C,1
GO:0071498,cellular response to fluid shear stress,1/173,21/18888,0.175792925987804,0.494298084658642,0.461513265349141,TFPI2,1
GO:0140354,lipid import into cell,1/173,21/18888,0.175792925987804,0.494298084658642,0.461513265349141,ACSL5,1
GO:1903975,regulation of glial cell migration,1/173,21/18888,0.175792925987804,0.494298084658642,0.461513265349141,NTN1,1
GO:2000001,regulation of DNA damage checkpoint,1/173,21/18888,0.175792925987804,0.494298084658642,0.461513265349141,CUL4A,1
GO:0051279,regulation of release of sequestered calcium ion into cytosol,2/173,83/18888,0.176391912728361,0.494298084658642,0.461513265349141,TMEM38A/XCL1,2
GO:0086003,cardiac muscle cell contraction,2/173,83/18888,0.176391912728361,0.494298084658642,0.461513265349141,KCNJ2/SCN4B,2
GO:1901657,glycosyl compound metabolic process,2/173,83/18888,0.176391912728361,0.494298084658642,0.461513265349141,APOBEC3D/APOBEC3H,2
GO:0097529,myeloid leukocyte migration,4/173,239/18888,0.176736634947341,0.494298084658642,0.461513265349141,CD200/IL6R/TNFAIP6/XCL1,4
GO:0000723,telomere maintenance,3/173,158/18888,0.176795547949751,0.494298084658642,0.461513265349141,TFIP11/TINF2/ZNF365,3
GO:0021915,neural tube development,3/173,158/18888,0.176795547949751,0.494298084658642,0.461513265349141,SEMA3C/SEMA4C/ZFP36L1,3
GO:0048284,organelle fusion,3/173,159/18888,0.179067673453924,0.495873478200066,0.462984169324048,CPLANE2/MFF/SNAP25,3
GO:0086001,cardiac muscle cell action potential,2/173,84/18888,0.179670534084899,0.495873478200066,0.462984169324048,KCNJ2/SCN4B,2
GO:1905897,regulation of response to endoplasmic reticulum stress,2/173,84/18888,0.179670534084899,0.495873478200066,0.462984169324048,NR1H3/SERINC3,2
GO:0006813,potassium ion transport,4/173,241/18888,0.180355576395461,0.495873478200066,0.462984169324048,KCNJ2/KCNMB1/SNAP25/TMEM38A,4
GO:0002292,T cell differentiation involved in immune response,2/173,85/18888,0.182958482525666,0.495873478200066,0.462984169324048,IL6R/LY9,2
GO:0007492,endoderm development,2/173,85/18888,0.182958482525666,0.495873478200066,0.462984169324048,ARC/ZFP36L1,2
GO:0008589,regulation of smoothened signaling pathway,2/173,85/18888,0.182958482525666,0.495873478200066,0.462984169324048,CPLANE2/SHOX2,2
GO:0045069,regulation of viral genome replication,2/173,85/18888,0.182958482525666,0.495873478200066,0.462984169324048,APOBEC3D/APOBEC3H,2
GO:0048041,focal adhesion assembly,2/173,85/18888,0.182958482525666,0.495873478200066,0.462984169324048,ACTN1/MAP4K4,2
GO:1902105,regulation of leukocyte differentiation,5/173,328/18888,0.183181094210434,0.495873478200066,0.462984169324048,CDK6/CUL4A/NME2/TNFAIP6/ZFP36L1,5
GO:0003228,atrial cardiac muscle tissue development,1/173,22/18888,0.183350450968146,0.495873478200066,0.462984169324048,SHOX2,1
GO:0010881,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,1/173,22/18888,0.183350450968146,0.495873478200066,0.462984169324048,TMEM38A,1
GO:0010888,negative regulation of lipid storage,1/173,22/18888,0.183350450968146,0.495873478200066,0.462984169324048,NR1H3,1
GO:0030431,sleep,1/173,22/18888,0.183350450968146,0.495873478200066,0.462984169324048,PER3,1
GO:0035235,ionotropic glutamate receptor signaling pathway,1/173,22/18888,0.183350450968146,0.495873478200066,0.462984169324048,GRIA3,1
GO:0035739,"CD4-positive, alpha-beta T cell proliferation",1/173,22/18888,0.183350450968146,0.495873478200066,0.462984169324048,XCL1,1
GO:0042953,lipoprotein transport,1/173,22/18888,0.183350450968146,0.495873478200066,0.462984169324048,MSR1,1
GO:0060004,reflex,1/173,22/18888,0.183350450968146,0.495873478200066,0.462984169324048,SLITRK6,1
GO:0060445,branching involved in salivary gland morphogenesis,1/173,22/18888,0.183350450968146,0.495873478200066,0.462984169324048,SEMA3C,1
GO:0060713,labyrinthine layer morphogenesis,1/173,22/18888,0.183350450968146,0.495873478200066,0.462984169324048,ZFP36L1,1
GO:0072111,cell proliferation involved in kidney development,1/173,22/18888,0.183350450968146,0.495873478200066,0.462984169324048,IL6R,1
GO:0072234,metanephric nephron tubule development,1/173,22/18888,0.183350450968146,0.495873478200066,0.462984169324048,SLC22A1,1
GO:0090208,positive regulation of triglyceride metabolic process,1/173,22/18888,0.183350450968146,0.495873478200066,0.462984169324048,NR1H3,1
GO:0097062,dendritic spine maintenance,1/173,22/18888,0.183350450968146,0.495873478200066,0.462984169324048,ZMYND8,1
GO:0099010,modification of postsynaptic structure,1/173,22/18888,0.183350450968146,0.495873478200066,0.462984169324048,RHOB,1
GO:2000561,"regulation of CD4-positive, alpha-beta T cell proliferation",1/173,22/18888,0.183350450968146,0.495873478200066,0.462984169324048,XCL1,1
GO:0036294,cellular response to decreased oxygen levels,3/173,161/18888,0.183635943292328,0.495873478200066,0.462984169324048,KCNMB1/SLC2A4/ZFP36L1,3
GO:0050657,nucleic acid transport,3/173,161/18888,0.183635943292328,0.495873478200066,0.462984169324048,ARC/UPF3A/ZFP36L1,3
GO:0050658,RNA transport,3/173,161/18888,0.183635943292328,0.495873478200066,0.462984169324048,ARC/UPF3A/ZFP36L1,3
GO:0071322,cellular response to carbohydrate stimulus,3/173,161/18888,0.183635943292328,0.495873478200066,0.462984169324048,NME2/NPTX1/ZFP36L1,3
GO:0060560,developmental growth involved in morphogenesis,4/173,243/18888,0.183999369982266,0.495873478200066,0.462984169324048,NTN1/SEMA3C/SEMA4C/SEMA5A,4
GO:0043523,regulation of neuron apoptotic process,4/173,244/18888,0.185830399623997,0.495873478200066,0.462984169324048,CLCF1/EN2/FOXQ1/VSTM2L,4
GO:0032024,positive regulation of insulin secretion,2/173,86/18888,0.186255315670713,0.495873478200066,0.462984169324048,NNAT/SNAP25,2
GO:0051851,modulation by host of symbiont process,2/173,86/18888,0.186255315670713,0.495873478200066,0.462984169324048,APOBEC3H/PC,2
GO:1901379,regulation of potassium ion transmembrane transport,2/173,86/18888,0.186255315670713,0.495873478200066,0.462984169324048,KCNJ2/KCNMB1,2
GO:0042742,defense response to bacterium,5/173,330/18888,0.18629141205615,0.495873478200066,0.462984169324048,GSDMB/IGHG4/IL6R/SLC11A1/SPON2,5
GO:0090257,regulation of muscle system process,4/173,245/18888,0.187667418046031,0.495873478200066,0.462984169324048,KCNJ2/MYLK2/OXTR/TMEM38A,4
GO:0030307,positive regulation of cell growth,3/173,163/18888,0.188235209221513,0.495873478200066,0.462984169324048,DDX49/NTN1/SEMA5A,3
GO:0009913,epidermal cell differentiation,4/173,246/18888,0.189510350294663,0.495873478200066,0.462984169324048,KRT86/NME2/SLITRK6/ZFP36L1,4
GO:0002312,B cell activation involved in immune response,2/173,87/18888,0.189560598372792,0.495873478200066,0.462984169324048,CLCF1/SANBR,2
GO:0008306,associative learning,2/173,87/18888,0.189560598372792,0.495873478200066,0.462984169324048,SNAP25/TAFA2,2
GO:0008543,fibroblast growth factor receptor signaling pathway,2/173,87/18888,0.189560598372792,0.495873478200066,0.462984169324048,PRKD2/SMOC2,2
GO:0009791,post-embryonic development,2/173,87/18888,0.189560598372792,0.495873478200066,0.462984169324048,ATF5/SEMA3C,2
GO:0015844,monoamine transport,2/173,87/18888,0.189560598372792,0.495873478200066,0.462984169324048,OXTR/SLC22A1,2
GO:0033077,T cell differentiation in thymus,2/173,87/18888,0.189560598372792,0.495873478200066,0.462984169324048,CDK6/ZFP36L1,2
GO:0046488,phosphatidylinositol metabolic process,3/173,164/18888,0.190546081710694,0.495873478200066,0.462984169324048,EFR3B/PLCH1/VAC14,3
GO:0051236,establishment of RNA localization,3/173,164/18888,0.190546081710694,0.495873478200066,0.462984169324048,ARC/UPF3A/ZFP36L1,3
GO:0070665,positive regulation of leukocyte proliferation,3/173,164/18888,0.190546081710694,0.495873478200066,0.462984169324048,CLCF1/FCGR3A/XCL1,3
GO:0002689,negative regulation of leukocyte chemotaxis,1/173,23/18888,0.190839074522822,0.495873478200066,0.462984169324048,TNFAIP6,1
GO:0006590,thyroid hormone generation,1/173,23/18888,0.190839074522822,0.495873478200066,0.462984169324048,SLC16A2,1
GO:0006837,serotonin transport,1/173,23/18888,0.190839074522822,0.495873478200066,0.462984169324048,SLC22A1,1
GO:0010866,regulation of triglyceride biosynthetic process,1/173,23/18888,0.190839074522822,0.495873478200066,0.462984169324048,NR1H3,1
GO:0021542,dentate gyrus development,1/173,23/18888,0.190839074522822,0.495873478200066,0.462984169324048,CDK6,1
GO:0030220,platelet formation,1/173,23/18888,0.190839074522822,0.495873478200066,0.462984169324048,ACTN1,1
GO:0031338,regulation of vesicle fusion,1/173,23/18888,0.190839074522822,0.495873478200066,0.462984169324048,CPLANE2,1
GO:0031629,synaptic vesicle fusion to presynaptic active zone membrane,1/173,23/18888,0.190839074522822,0.495873478200066,0.462984169324048,SNAP25,1
GO:0032252,secretory granule localization,1/173,23/18888,0.190839074522822,0.495873478200066,0.462984169324048,SNAP25,1
GO:0032816,positive regulation of natural killer cell activation,1/173,23/18888,0.190839074522822,0.495873478200066,0.462984169324048,FCGR3A,1
GO:0035493,SNARE complex assembly,1/173,23/18888,0.190839074522822,0.495873478200066,0.462984169324048,SNAP25,1
GO:0040019,positive regulation of embryonic development,1/173,23/18888,0.190839074522822,0.495873478200066,0.462984169324048,TLE6,1
GO:0044872,lipoprotein localization,1/173,23/18888,0.190839074522822,0.495873478200066,0.462984169324048,MSR1,1
GO:0045723,positive regulation of fatty acid biosynthetic process,1/173,23/18888,0.190839074522822,0.495873478200066,0.462984169324048,NR1H3,1
GO:0048015,phosphatidylinositol-mediated signaling,1/173,23/18888,0.190839074522822,0.495873478200066,0.462984169324048,PLCH1,1
GO:0050961,detection of temperature stimulus involved in sensory perception,1/173,23/18888,0.190839074522822,0.495873478200066,0.462984169324048,MMP24,1
GO:0051354,negative regulation of oxidoreductase activity,1/173,23/18888,0.190839074522822,0.495873478200066,0.462984169324048,GFI1,1
GO:0097107,postsynaptic density assembly,1/173,23/18888,0.190839074522822,0.495873478200066,0.462984169324048,NPTX1,1
GO:0098743,cell aggregation,1/173,23/18888,0.190839074522822,0.495873478200066,0.462984169324048,COL2A1,1
GO:1902254,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,1/173,23/18888,0.190839074522822,0.495873478200066,0.462984169324048,RRN3,1
GO:2000114,regulation of establishment of cell polarity,1/173,23/18888,0.190839074522822,0.495873478200066,0.462984169324048,FLOT2,1
GO:2000193,positive regulation of fatty acid transport,1/173,23/18888,0.190839074522822,0.495873478200066,0.462984169324048,ACSL5,1
GO:0060294,cilium movement involved in cell motility,3/173,165/18888,0.192864243460894,0.499648188385263,0.466508518046782,DNAH5/TPGS1/VDAC3,3
GO:0048708,astrocyte differentiation,2/173,88/18888,0.192873902623282,0.499648188385263,0.466508518046782,CDK6/CLCF1,2
GO:1902369,negative regulation of RNA catabolic process,2/173,88/18888,0.192873902623282,0.499648188385263,0.466508518046782,SLC11A1/UPF3A,2
GO:0048863,stem cell differentiation,4/173,248/18888,0.193213656062496,0.500025290815001,0.466860608777297,CDK6/SEMA3C/SEMA4C/SEMA5A,4
GO:0060485,mesenchyme development,5/173,336/18888,0.195737073218108,0.500899889371721,0.467677198702099,CPLANE2/SEMA3C/SEMA4C/SEMA5A/ZFP36L1,5
GO:0050829,defense response to Gram-negative bacterium,2/173,89/18888,0.196194807459213,0.500899889371721,0.467677198702099,IL6R/SLC11A1,2
GO:2000106,regulation of leukocyte apoptotic process,2/173,89/18888,0.196194807459213,0.500899889371721,0.467677198702099,MERTK/PRKD2,2
GO:0001779,natural killer cell differentiation,1/173,24/18888,0.198259421202257,0.500899889371721,0.467677198702099,MERTK,1
GO:0003148,outflow tract septum morphogenesis,1/173,24/18888,0.198259421202257,0.500899889371721,0.467677198702099,SEMA3C,1
GO:0003323,type B pancreatic cell development,1/173,24/18888,0.198259421202257,0.500899889371721,0.467677198702099,CDK6,1
GO:0006740,NADPH regeneration,1/173,24/18888,0.198259421202257,0.500899889371721,0.467677198702099,PGD,1
GO:0009147,pyrimidine nucleoside triphosphate metabolic process,1/173,24/18888,0.198259421202257,0.500899889371721,0.467677198702099,NME2,1
GO:0009220,pyrimidine ribonucleotide biosynthetic process,1/173,24/18888,0.198259421202257,0.500899889371721,0.467677198702099,NME2,1
GO:0009651,response to salt stress,1/173,24/18888,0.198259421202257,0.500899889371721,0.467677198702099,ZFP36L1,1
GO:0031145,anaphase-promoting complex-dependent catabolic process,1/173,24/18888,0.198259421202257,0.500899889371721,0.467677198702099,CDC16,1
GO:0036158,outer dynein arm assembly,1/173,24/18888,0.198259421202257,0.500899889371721,0.467677198702099,DNAH5,1
GO:0042438,melanin biosynthetic process,1/173,24/18888,0.198259421202257,0.500899889371721,0.467677198702099,PMEL,1
GO:0046641,positive regulation of alpha-beta T cell proliferation,1/173,24/18888,0.198259421202257,0.500899889371721,0.467677198702099,XCL1,1
GO:0046885,regulation of hormone biosynthetic process,1/173,24/18888,0.198259421202257,0.500899889371721,0.467677198702099,GFI1,1
GO:0050855,regulation of B cell receptor signaling pathway,1/173,24/18888,0.198259421202257,0.500899889371721,0.467677198702099,LPXN,1
GO:0060252,positive regulation of glial cell proliferation,1/173,24/18888,0.198259421202257,0.500899889371721,0.467677198702099,NTN1,1
GO:0060307,regulation of ventricular cardiac muscle cell membrane repolarization,1/173,24/18888,0.198259421202257,0.500899889371721,0.467677198702099,SCN4B,1
GO:0061042,vascular wound healing,1/173,24/18888,0.198259421202257,0.500899889371721,0.467677198702099,SMOC2,1
GO:0097150,neuronal stem cell population maintenance,1/173,24/18888,0.198259421202257,0.500899889371721,0.467677198702099,MMP24,1
GO:0099500,vesicle fusion to plasma membrane,1/173,24/18888,0.198259421202257,0.500899889371721,0.467677198702099,SNAP25,1
GO:0002088,lens development in camera-type eye,2/173,90/18888,0.199522898871384,0.500899889371721,0.467677198702099,CRYAB/SLITRK6,2
GO:0031640,killing of cells of another organism,2/173,90/18888,0.199522898871384,0.500899889371721,0.467677198702099,APOL1/GSDMB,2
GO:0141061,disruption of cell in another organism,2/173,90/18888,0.199522898871384,0.500899889371721,0.467677198702099,APOL1/GSDMB,2
GO:0006816,calcium ion transport,6/173,428/18888,0.199825168265604,0.500899889371721,0.467677198702099,GJC2/PANX1/PLCH1/RYR3/TMEM38A/XCL1,6
GO:0042692,muscle cell differentiation,6/173,428/18888,0.199825168265604,0.500899889371721,0.467677198702099,ACTN1/DNER/MYOM2/SEMA4C/SHOX2/TMEM182,6
GO:0050792,regulation of viral process,3/173,168/18888,0.199860945850216,0.500899889371721,0.467677198702099,APOBEC3D/APOBEC3H/NECTIN2,3
GO:1903169,regulation of calcium ion transmembrane transport,3/173,168/18888,0.199860945850216,0.500899889371721,0.467677198702099,GJC2/TMEM38A/XCL1,3
GO:0015698,inorganic anion transport,3/173,169/18888,0.202206749133395,0.500899889371721,0.467677198702099,APOL1/SLC11A1/SLC37A1,3
GO:1990845,adaptive thermogenesis,3/173,169/18888,0.202206749133395,0.500899889371721,0.467677198702099,NR1H3/OXTR/PRDM16,3
GO:0001510,RNA methylation,2/173,91/18888,0.202857769713552,0.500899889371721,0.467677198702099,METTL2A/ZCCHC4,2
GO:1903510,mucopolysaccharide metabolic process,2/173,91/18888,0.202857769713552,0.500899889371721,0.467677198702099,B4GALT4/TNFAIP6,2
GO:0009314,response to radiation,6/173,431/18888,0.204080781280737,0.500899889371721,0.467677198702099,CRYAB/CUL4A/PER3/RBM4B/RHOB/TAFA2,6
GO:0045017,glycerolipid biosynthetic process,4/173,254/18888,0.204457689132891,0.500899889371721,0.467677198702099,EFR3B/NR1H3/TAMM41/VAC14,4
GO:0001539,cilium or flagellum-dependent cell motility,3/173,170/18888,0.204559086894494,0.500899889371721,0.467677198702099,DNAH5/TPGS1/VDAC3,3
GO:0060285,cilium-dependent cell motility,3/173,170/18888,0.204559086894494,0.500899889371721,0.467677198702099,DNAH5/TPGS1/VDAC3,3
GO:0030098,lymphocyte differentiation,6/173,432/18888,0.205506705739854,0.500899889371721,0.467677198702099,CDK6/CLCF1/IL6R/LY9/MERTK/ZFP36L1,6
GO:0006123,"mitochondrial electron transport, cytochrome c to oxygen",1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,MTCO2P12,1
GO:0006582,melanin metabolic process,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,PMEL,1
GO:0007097,nuclear migration,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,NTN1,1
GO:0009110,vitamin biosynthetic process,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,GFI1,1
GO:0018200,peptidyl-glutamic acid modification,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,TPGS1,1
GO:0033617,mitochondrial cytochrome c oxidase assembly,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,TIMM21,1
GO:0034453,microtubule anchoring,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,CEP19,1
GO:0035336,long-chain fatty-acyl-CoA metabolic process,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,ACSL5,1
GO:0036344,platelet morphogenesis,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,ACTN1,1
GO:0045662,negative regulation of myoblast differentiation,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,TMEM182,1
GO:0046514,ceramide catabolic process,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,CEL,1
GO:0050860,negative regulation of T cell receptor signaling pathway,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,SH2D1A,1
GO:0051882,mitochondrial depolarization,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,MLLT11,1
GO:0060117,auditory receptor cell development,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,SLITRK6,1
GO:0060396,growth hormone receptor signaling pathway,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,PXN,1
GO:0060561,apoptotic process involved in morphogenesis,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,CRYAB,1
GO:0060586,multicellular organismal-level iron ion homeostasis,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,SLC11A1,1
GO:0071676,negative regulation of mononuclear cell migration,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,CD200,1
GO:0072170,metanephric tubule development,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,SLC22A1,1
GO:0072243,metanephric nephron epithelium development,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,SLC22A1,1
GO:0090023,positive regulation of neutrophil chemotaxis,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,XCL1,1
GO:0099633,protein localization to postsynaptic specialization membrane,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,NPTX1,1
GO:0099645,neurotransmitter receptor localization to postsynaptic specialization membrane,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,NPTX1,1
GO:1901863,positive regulation of muscle tissue development,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,SHOX2,1
GO:2000178,negative regulation of neural precursor cell proliferation,1/173,25/18888,0.205612109928508,0.500899889371721,0.467677198702099,SLC16A2,1
GO:0006820,monoatomic anion transport,3/173,171/18888,0.206917810015218,0.501110742864387,0.467874067124072,ABCC2/APOL1/VDAC3,3
GO:0044272,sulfur compound biosynthetic process,3/173,172/18888,0.209282770025351,0.501110742864387,0.467874067124072,ACSL5/B4GALT4/MAT1A,3
GO:0002690,positive regulation of leukocyte chemotaxis,2/173,93/18888,0.209546254880288,0.501110742864387,0.467874067124072,IL6R/XCL1,2
GO:0045132,meiotic chromosome segregation,2/173,93/18888,0.209546254880288,0.501110742864387,0.467874067124072,CHFR/SEPTIN1,2
GO:0048525,negative regulation of viral process,2/173,93/18888,0.209546254880288,0.501110742864387,0.467874067124072,APOBEC3D/APOBEC3H,2
GO:0070098,chemokine-mediated signaling pathway,2/173,93/18888,0.209546254880288,0.501110742864387,0.467874067124072,ACKR4/XCL1,2
GO:0141060,disruption of anatomical structure in another organism,2/173,93/18888,0.209546254880288,0.501110742864387,0.467874067124072,APOL1/GSDMB,2
GO:1902099,regulation of metaphase/anaphase transition of cell cycle,2/173,93/18888,0.209546254880288,0.501110742864387,0.467874067124072,CDC16/CHFR,2
GO:0043010,camera-type eye development,5/173,346/18888,0.211840877595227,0.501110742864387,0.467874067124072,CRYAB/MERTK/MYOM2/RPGRIP1/SLITRK6,5
GO:0051259,protein complex oligomerization,4/173,258/18888,0.212059449327634,0.501110742864387,0.467874067124072,ARC/KCNJ2/MAT1A/RYR3,4
GO:0001835,blastocyst hatching,1/173,26/18888,0.212897754045689,0.501110742864387,0.467874067124072,SLC25A34,1
GO:0002053,positive regulation of mesenchymal cell proliferation,1/173,26/18888,0.212897754045689,0.501110742864387,0.467874067124072,SHOX2,1
GO:0002726,positive regulation of T cell cytokine production,1/173,26/18888,0.212897754045689,0.501110742864387,0.467874067124072,XCL1,1
GO:0006929,substrate-dependent cell migration,1/173,26/18888,0.212897754045689,0.501110742864387,0.467874067124072,NTN1,1
GO:0010460,positive regulation of heart rate,1/173,26/18888,0.212897754045689,0.501110742864387,0.467874067124072,ADM5,1
GO:0010882,regulation of cardiac muscle contraction by calcium ion signaling,1/173,26/18888,0.212897754045689,0.501110742864387,0.467874067124072,TMEM38A,1
GO:0016048,detection of temperature stimulus,1/173,26/18888,0.212897754045689,0.501110742864387,0.467874067124072,MMP24,1
GO:0032878,regulation of establishment or maintenance of cell polarity,1/173,26/18888,0.212897754045689,0.501110742864387,0.467874067124072,FLOT2,1
GO:0035188,hatching,1/173,26/18888,0.212897754045689,0.501110742864387,0.467874067124072,SLC25A34,1
GO:0044550,secondary metabolite biosynthetic process,1/173,26/18888,0.212897754045689,0.501110742864387,0.467874067124072,PMEL,1
GO:0044827,modulation by host of viral genome replication,1/173,26/18888,0.212897754045689,0.501110742864387,0.467874067124072,APOBEC3H,1
GO:0048641,regulation of skeletal muscle tissue development,1/173,26/18888,0.212897754045689,0.501110742864387,0.467874067124072,SHOX2,1
GO:0051894,positive regulation of focal adhesion assembly,1/173,26/18888,0.212897754045689,0.501110742864387,0.467874067124072,MAP4K4,1
GO:0060259,regulation of feeding behavior,1/173,26/18888,0.212897754045689,0.501110742864387,0.467874067124072,QRFP,1
GO:0060333,type II interferon-mediated signaling pathway,1/173,26/18888,0.212897754045689,0.501110742864387,0.467874067124072,NR1H3,1
GO:0071280,cellular response to copper ion,1/173,26/18888,0.212897754045689,0.501110742864387,0.467874067124072,MT1X,1
GO:0071378,cellular response to growth hormone stimulus,1/173,26/18888,0.212897754045689,0.501110742864387,0.467874067124072,PXN,1
GO:0071684,organism emergence from protective structure,1/173,26/18888,0.212897754045689,0.501110742864387,0.467874067124072,SLC25A34,1
GO:0086013,membrane repolarization during cardiac muscle cell action potential,1/173,26/18888,0.212897754045689,0.501110742864387,0.467874067124072,KCNJ2,1
GO:0099637,neurotransmitter receptor transport,1/173,26/18888,0.212897754045689,0.501110742864387,0.467874067124072,SNAP25,1
GO:1900151,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",1/173,26/18888,0.212897754045689,0.501110742864387,0.467874067124072,ZFP36L1,1
GO:1901623,regulation of lymphocyte chemotaxis,1/173,26/18888,0.212897754045689,0.501110742864387,0.467874067124072,XCL1,1
GO:2000773,negative regulation of cellular senescence,1/173,26/18888,0.212897754045689,0.501110742864387,0.467874067124072,CDK6,1
GO:0019915,lipid storage,2/173,94/18888,0.212899088424714,0.501110742864387,0.467874067124072,MSR1/NR1H3,2
GO:0043367,"CD4-positive, alpha-beta T cell differentiation",2/173,94/18888,0.212899088424714,0.501110742864387,0.467874067124072,IL6R/LY9,2
GO:0048704,embryonic skeletal system morphogenesis,2/173,94/18888,0.212899088424714,0.501110742864387,0.467874067124072,COL2A1/SHOX2,2
GO:1902807,negative regulation of cell cycle G1/S phase transition,2/173,94/18888,0.212899088424714,0.501110742864387,0.467874067124072,GJC2/SUSD2,2
GO:0006898,receptor-mediated endocytosis,4/173,259/18888,0.213972415957581,0.50317714254865,0.46980341076387,ARC/MSR1/SNAP25/VAC14,4
GO:0032635,interleukin-6 production,3/173,176/18888,0.21880203302354,0.50517038817077,0.471664452358524,CD200/IL6R/SPON2,3
GO:0032675,regulation of interleukin-6 production,3/173,176/18888,0.21880203302354,0.50517038817077,0.471664452358524,CD200/IL6R/SPON2,3
GO:0003073,regulation of systemic arterial blood pressure,2/173,96/18888,0.219620034443166,0.50517038817077,0.471664452358524,ADM5/OXTR,2
GO:0007044,cell-substrate junction assembly,2/173,96/18888,0.219620034443166,0.50517038817077,0.471664452358524,ACTN1/MAP4K4,2
GO:0018107,peptidyl-threonine phosphorylation,2/173,96/18888,0.219620034443166,0.50517038817077,0.471664452358524,MYLK2/PRKD2,2
GO:0046364,monosaccharide biosynthetic process,2/173,96/18888,0.219620034443166,0.50517038817077,0.471664452358524,PC/PGD,2
GO:0072091,regulation of stem cell proliferation,2/173,96/18888,0.219620034443166,0.50517038817077,0.471664452358524,SHOX2/ZFP36L1,2
GO:1990542,mitochondrial transmembrane transport,2/173,96/18888,0.219620034443166,0.50517038817077,0.471664452358524,TIMM21/TOMM40,2
GO:0044843,cell cycle G1/S phase transition,4/173,262/18888,0.219740174935979,0.50517038817077,0.471664452358524,CDK6/CUL4A/GJC2/SUSD2,4
GO:0007274,neuromuscular synaptic transmission,1/173,27/18888,0.220116961369943,0.50517038817077,0.471664452358524,MYLK2,1
GO:0007289,spermatid nucleus differentiation,1/173,27/18888,0.220116961369943,0.50517038817077,0.471664452358524,NECTIN2,1
GO:0010818,T cell chemotaxis,1/173,27/18888,0.220116961369943,0.50517038817077,0.471664452358524,XCL1,1
GO:0010875,positive regulation of cholesterol efflux,1/173,27/18888,0.220116961369943,0.50517038817077,0.471664452358524,NR1H3,1
GO:0010884,positive regulation of lipid storage,1/173,27/18888,0.220116961369943,0.50517038817077,0.471664452358524,MSR1,1
GO:0031167,rRNA methylation,1/173,27/18888,0.220116961369943,0.50517038817077,0.471664452358524,ZCCHC4,1
GO:0032740,positive regulation of interleukin-17 production,1/173,27/18888,0.220116961369943,0.50517038817077,0.471664452358524,LY9,1
GO:0042026,protein refolding,1/173,27/18888,0.220116961369943,0.50517038817077,0.471664452358524,CRYAB,1
GO:0042832,defense response to protozoan,1/173,27/18888,0.220116961369943,0.50517038817077,0.471664452358524,SLC11A1,1
GO:0046618,xenobiotic export from cell,1/173,27/18888,0.220116961369943,0.50517038817077,0.471664452358524,ABCC2,1
GO:0046949,fatty-acyl-CoA biosynthetic process,1/173,27/18888,0.220116961369943,0.50517038817077,0.471664452358524,ACSL5,1
GO:0048245,eosinophil chemotaxis,1/173,27/18888,0.220116961369943,0.50517038817077,0.471664452358524,XCL1,1
GO:0060669,embryonic placenta morphogenesis,1/173,27/18888,0.220116961369943,0.50517038817077,0.471664452358524,ZFP36L1,1
GO:0071480,cellular response to gamma radiation,1/173,27/18888,0.220116961369943,0.50517038817077,0.471664452358524,CRYAB,1
GO:0071624,positive regulation of granulocyte chemotaxis,1/173,27/18888,0.220116961369943,0.50517038817077,0.471664452358524,XCL1,1
GO:0099170,postsynaptic modulation of chemical synaptic transmission,1/173,27/18888,0.220116961369943,0.50517038817077,0.471664452358524,FBXO2,1
GO:0150146,cell junction disassembly,1/173,27/18888,0.220116961369943,0.50517038817077,0.471664452358524,MAP4K4,1
GO:2001032,regulation of double-strand break repair via nonhomologous end joining,1/173,27/18888,0.220116961369943,0.50517038817077,0.471664452358524,TFIP11,1
GO:0030216,keratinocyte differentiation,3/173,177/18888,0.221195974082776,0.50629300734502,0.472712612683097,KRT86/NME2/ZFP36L1,3
GO:0050806,positive regulation of synaptic transmission,3/173,177/18888,0.221195974082776,0.50629300734502,0.472712612683097,ARC/OXTR/SNAP25,3
GO:0071453,cellular response to oxygen levels,3/173,177/18888,0.221195974082776,0.50629300734502,0.472712612683097,KCNMB1/SLC2A4/ZFP36L1,3
GO:0021675,nerve development,2/173,97/18888,0.222987404943775,0.509487637737551,0.475695355990829,NPTX1/SLITRK6,2
GO:0044784,metaphase/anaphase transition of cell cycle,2/173,97/18888,0.222987404943775,0.509487637737551,0.475695355990829,CDC16/CHFR,2
GO:0045765,regulation of angiogenesis,5/173,353/18888,0.22336148690201,0.509889919124713,0.476070955659007,PAK4/PRKD2/RHOB/SEMA5A/SMOC2,5
GO:0006942,regulation of striated muscle contraction,2/173,98/18888,0.226358889606185,0.511110140319116,0.477210244451246,KCNJ2/TMEM38A,2
GO:0030101,natural killer cell activation,2/173,98/18888,0.226358889606185,0.511110140319116,0.477210244451246,FCGR3A/MERTK,2
GO:0001675,acrosome assembly,1/173,28/18888,0.227270334238985,0.511110140319116,0.477210244451246,NECTIN2,1
GO:0001964,startle response,1/173,28/18888,0.227270334238985,0.511110140319116,0.477210244451246,SLITRK6,1
GO:0006817,phosphate ion transport,1/173,28/18888,0.227270334238985,0.511110140319116,0.477210244451246,SLC37A1,1
GO:0015732,prostaglandin transport,1/173,28/18888,0.227270334238985,0.511110140319116,0.477210244451246,SLC22A1,1
GO:0032703,negative regulation of interleukin-2 production,1/173,28/18888,0.227270334238985,0.511110140319116,0.477210244451246,XCL1,1
GO:0036037,"CD8-positive, alpha-beta T cell activation",1/173,28/18888,0.227270334238985,0.511110140319116,0.477210244451246,XCL1,1
GO:0045116,protein neddylation,1/173,28/18888,0.227270334238985,0.511110140319116,0.477210244451246,DCUN1D2,1
GO:0045606,positive regulation of epidermal cell differentiation,1/173,28/18888,0.227270334238985,0.511110140319116,0.477210244451246,NME2,1
GO:0045830,positive regulation of isotype switching,1/173,28/18888,0.227270334238985,0.511110140319116,0.477210244451246,CLCF1,1
GO:0048499,synaptic vesicle membrane organization,1/173,28/18888,0.227270334238985,0.511110140319116,0.477210244451246,SNAP25,1
GO:0048714,positive regulation of oligodendrocyte differentiation,1/173,28/18888,0.227270334238985,0.511110140319116,0.477210244451246,ZNF365,1
GO:0051873,killing by host of symbiont cells,1/173,28/18888,0.227270334238985,0.511110140319116,0.477210244451246,APOL1,1
GO:0062149,detection of stimulus involved in sensory perception of pain,1/173,28/18888,0.227270334238985,0.511110140319116,0.477210244451246,MMP24,1
GO:1904357,negative regulation of telomere maintenance via telomere lengthening,1/173,28/18888,0.227270334238985,0.511110140319116,0.477210244451246,TINF2,1
GO:2000819,regulation of nucleotide-excision repair,1/173,28/18888,0.227270334238985,0.511110140319116,0.477210244451246,CUL4A,1
GO:1990778,protein localization to cell periphery,5/173,356/18888,0.228356832941298,0.513105449235464,0.479073212490056,EFR3B/FLOT2/KIF13A/NPTX1/SNAP25,5
GO:0002709,regulation of T cell mediated immunity,2/173,99/18888,0.22973413304401,0.514031566541778,0.479937904131393,NECTIN2/XCL1,2
GO:0060349,bone morphogenesis,2/173,99/18888,0.22973413304401,0.514031566541778,0.479937904131393,COL2A1/SHOX2,2
GO:0061337,cardiac conduction,2/173,99/18888,0.22973413304401,0.514031566541778,0.479937904131393,KCNJ2/SCN4B,2
GO:1901992,positive regulation of mitotic cell cycle phase transition,2/173,99/18888,0.22973413304401,0.514031566541778,0.479937904131393,CDC16/CUL4A,2
GO:0046631,alpha-beta T cell activation,3/173,181/18888,0.230823910947939,0.514031566541778,0.479937904131393,IL6R/LY9/XCL1,3
GO:0071478,cellular response to radiation,3/173,181/18888,0.230823910947939,0.514031566541778,0.479937904131393,CRYAB/CUL4A/RHOB,3
GO:0002220,innate immune response activating cell surface receptor signaling pathway,2/173,100/18888,0.233112785963063,0.514031566541778,0.479937904131393,COLEC11/NR1H3,2
GO:0006304,DNA modification,2/173,100/18888,0.233112785963063,0.514031566541778,0.479937904131393,APOBEC3D/APOBEC3H,2
GO:0007029,endoplasmic reticulum organization,2/173,100/18888,0.233112785963063,0.514031566541778,0.479937904131393,TLE6/TMEM38A,2
GO:1903312,negative regulation of mRNA metabolic process,2/173,100/18888,0.233112785963063,0.514031566541778,0.479937904131393,SLC11A1/UPF3A,2
GO:0006839,mitochondrial transport,3/173,182/18888,0.233243226204504,0.514031566541778,0.479937904131393,NPTX1/TIMM21/TOMM40,3
GO:0044772,mitotic cell cycle phase transition,6/173,451/18888,0.233256706611443,0.514031566541778,0.479937904131393,CDC16/CDK6/CHFR/CUL4A/GJC2/ZFP36L1,6
GO:0050708,regulation of protein secretion,4/173,269/18888,0.233356984228225,0.514031566541778,0.479937904131393,CD200/NNAT/NR1H3/SNAP25,4
GO:0002710,negative regulation of T cell mediated immunity,1/173,29/18888,0.234358469561183,0.514031566541778,0.479937904131393,XCL1,1
GO:0003209,cardiac atrium morphogenesis,1/173,29/18888,0.234358469561183,0.514031566541778,0.479937904131393,SHOX2,1
GO:0003309,type B pancreatic cell differentiation,1/173,29/18888,0.234358469561183,0.514031566541778,0.479937904131393,CDK6,1
GO:0007288,sperm axoneme assembly,1/173,29/18888,0.234358469561183,0.514031566541778,0.479937904131393,TPGS1,1
GO:0019076,viral release from host cell,1/173,29/18888,0.234358469561183,0.514031566541778,0.479937904131393,PC,1
GO:0035891,exit from host cell,1/173,29/18888,0.234358469561183,0.514031566541778,0.479937904131393,PC,1
GO:0042403,thyroid hormone metabolic process,1/173,29/18888,0.234358469561183,0.514031566541778,0.479937904131393,SLC16A2,1
GO:0050951,sensory perception of temperature stimulus,1/173,29/18888,0.234358469561183,0.514031566541778,0.479937904131393,MMP24,1
GO:0060142,regulation of syncytium formation by plasma membrane fusion,1/173,29/18888,0.234358469561183,0.514031566541778,0.479937904131393,TMEM182,1
GO:0072207,metanephric epithelium development,1/173,29/18888,0.234358469561183,0.514031566541778,0.479937904131393,SLC22A1,1
GO:0098698,postsynaptic specialization assembly,1/173,29/18888,0.234358469561183,0.514031566541778,0.479937904131393,NPTX1,1
GO:0099563,modification of synaptic structure,1/173,29/18888,0.234358469561183,0.514031566541778,0.479937904131393,RHOB,1
GO:0099623,regulation of cardiac muscle cell membrane repolarization,1/173,29/18888,0.234358469561183,0.514031566541778,0.479937904131393,SCN4B,1
GO:0099625,ventricular cardiac muscle cell membrane repolarization,1/173,29/18888,0.234358469561183,0.514031566541778,0.479937904131393,SCN4B,1
GO:1905820,positive regulation of chromosome separation,1/173,29/18888,0.234358469561183,0.514031566541778,0.479937904131393,CDC16,1
GO:0031346,positive regulation of cell projection organization,5/173,360/18888,0.23506836720132,0.514335600154356,0.480221772407787,NME2/NTN1/SEMA5A/SHOX2/ZMYND8,5
GO:0001659,temperature homeostasis,3/173,183/18888,0.235667191724306,0.514335600154356,0.480221772407787,NR1H3/OXTR/PRDM16,3
GO:0007219,Notch signaling pathway,3/173,183/18888,0.235667191724306,0.514335600154356,0.480221772407787,CDK6/DLK2/DNER,3
GO:0007565,female pregnancy,3/173,183/18888,0.235667191724306,0.514335600154356,0.480221772407787,APOL2/OXTR/TLE6,3
GO:0061025,membrane fusion,3/173,183/18888,0.235667191724306,0.514335600154356,0.480221772407787,CPLANE2/NECTIN2/SNAP25,3
GO:0032755,positive regulation of interleukin-6 production,2/173,101/18888,0.236494505080682,0.514335600154356,0.480221772407787,IL6R/SPON2,2
GO:0042542,response to hydrogen peroxide,2/173,101/18888,0.236494505080682,0.514335600154356,0.480221772407787,CRYAB/RHOB,2
GO:0120162,positive regulation of cold-induced thermogenesis,2/173,101/18888,0.236494505080682,0.514335600154356,0.480221772407787,OXTR/PRDM16,2
GO:1990868,response to chemokine,2/173,101/18888,0.236494505080682,0.514335600154356,0.480221772407787,ACKR4/XCL1,2
GO:1990869,cellular response to chemokine,2/173,101/18888,0.236494505080682,0.514335600154356,0.480221772407787,ACKR4/XCL1,2
GO:1901342,regulation of vasculature development,5/173,362/18888,0.238445191554072,0.516244637936345,0.482004191332289,PAK4/PRKD2/RHOB/SEMA5A/SMOC2,5
GO:0048568,embryonic organ development,6/173,455/18888,0.239246586793554,0.516244637936345,0.482004191332289,COL2A1/EN2/NTN1/SHOX2/SLITRK6/ZFP36L1,6
GO:0043266,regulation of potassium ion transport,2/173,102/18888,0.239878953046006,0.516244637936345,0.482004191332289,KCNJ2/KCNMB1,2
GO:2000177,regulation of neural precursor cell proliferation,2/173,102/18888,0.239878953046006,0.516244637936345,0.482004191332289,GJC2/SLC16A2,2
GO:0032102,negative regulation of response to external stimulus,6/173,456/18888,0.240751460354157,0.516244637936345,0.482004191332289,CD200/NR1H3/SEMA3C/SEMA4C/SEMA5A/TNFAIP6,6
GO:0001562,response to protozoan,1/173,30/18888,0.241381958864217,0.516244637936345,0.482004191332289,SLC11A1,1
GO:0002438,acute inflammatory response to antigenic stimulus,1/173,30/18888,0.241381958864217,0.516244637936345,0.482004191332289,FCGR3A,1
GO:0008209,androgen metabolic process,1/173,30/18888,0.241381958864217,0.516244637936345,0.482004191332289,HSD17B11,1
GO:0008535,respiratory chain complex IV assembly,1/173,30/18888,0.241381958864217,0.516244637936345,0.482004191332289,TIMM21,1
GO:0010894,negative regulation of steroid biosynthetic process,1/173,30/18888,0.241381958864217,0.516244637936345,0.482004191332289,GFI1,1
GO:0015721,bile acid and bile salt transport,1/173,30/18888,0.241381958864217,0.516244637936345,0.482004191332289,ABCC2,1
GO:0038094,Fc-gamma receptor signaling pathway,1/173,30/18888,0.241381958864217,0.516244637936345,0.482004191332289,FCGR3A,1
GO:0043247,telomere maintenance in response to DNA damage,1/173,30/18888,0.241381958864217,0.516244637936345,0.482004191332289,TFIP11,1
GO:0045987,positive regulation of smooth muscle contraction,1/173,30/18888,0.241381958864217,0.516244637936345,0.482004191332289,OXTR,1
GO:0051156,glucose 6-phosphate metabolic process,1/173,30/18888,0.241381958864217,0.516244637936345,0.482004191332289,PGD,1
GO:0060603,mammary gland duct morphogenesis,1/173,30/18888,0.241381958864217,0.516244637936345,0.482004191332289,NTN1,1
GO:0072012,glomerulus vasculature development,1/173,30/18888,0.241381958864217,0.516244637936345,0.482004191332289,IL6R,1
GO:0086011,membrane repolarization during action potential,1/173,30/18888,0.241381958864217,0.516244637936345,0.482004191332289,KCNJ2,1
GO:0099505,regulation of presynaptic membrane potential,1/173,30/18888,0.241381958864217,0.516244637936345,0.482004191332289,GRIA3,1
GO:1900746,regulation of vascular endothelial growth factor signaling pathway,1/173,30/18888,0.241381958864217,0.516244637936345,0.482004191332289,SMOC2,1
GO:0051302,regulation of cell division,3/173,186/18888,0.242965596872627,0.518980472891524,0.484558569273067,KIF13A/SUSD2/TLE6,3
GO:0099175,regulation of postsynapse organization,2/173,103/18888,0.243265798361192,0.518980472891524,0.484558569273067,ARC/ZMYND8,2
GO:0150115,cell-substrate junction organization,2/173,103/18888,0.243265798361192,0.518980472891524,0.484558569273067,ACTN1/MAP4K4,2
GO:0021537,telencephalon development,4/173,275/18888,0.245189823522192,0.522023734680808,0.487399983652925,ATF5/CDK6/DNAH5/OXTR,4
GO:0008217,regulation of blood pressure,3/173,187/18888,0.245406774499511,0.522023734680808,0.487399983652925,ADM5/OXTR/QRFP,3
GO:0010389,regulation of G2/M transition of mitotic cell cycle,2/173,104/18888,0.246654715303568,0.522023734680808,0.487399983652925,CDK6/CHFR,2
GO:0022600,digestive system process,2/173,104/18888,0.246654715303568,0.522023734680808,0.487399983652925,CEL/NR1H3,2
GO:0033045,regulation of sister chromatid segregation,2/173,104/18888,0.246654715303568,0.522023734680808,0.487399983652925,CDC16/CHFR,2
GO:0000910,cytokinesis,3/173,188/18888,0.247851911992348,0.522023734680808,0.487399983652925,KIF13A/RHOB/SEPTIN1,3
GO:0002431,Fc receptor mediated stimulatory signaling pathway,1/173,31/18888,0.248341388343297,0.522023734680808,0.487399983652925,CD226,1
GO:0006783,heme biosynthetic process,1/173,31/18888,0.248341388343297,0.522023734680808,0.487399983652925,SRRD,1
GO:0010765,positive regulation of sodium ion transport,1/173,31/18888,0.248341388343297,0.522023734680808,0.487399983652925,SCN4B,1
GO:0010880,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,1/173,31/18888,0.248341388343297,0.522023734680808,0.487399983652925,TMEM38A,1
GO:0010996,response to auditory stimulus,1/173,31/18888,0.248341388343297,0.522023734680808,0.487399983652925,SLITRK6,1
GO:0051491,positive regulation of filopodium assembly,1/173,31/18888,0.248341388343297,0.522023734680808,0.487399983652925,ZMYND8,1
GO:0070198,"protein localization to chromosome, telomeric region",1/173,31/18888,0.248341388343297,0.522023734680808,0.487399983652925,TINF2,1
GO:0070979,protein K11-linked ubiquitination,1/173,31/18888,0.248341388343297,0.522023734680808,0.487399983652925,CDC16,1
GO:0072677,eosinophil migration,1/173,31/18888,0.248341388343297,0.522023734680808,0.487399983652925,XCL1,1
GO:0150117,positive regulation of cell-substrate junction organization,1/173,31/18888,0.248341388343297,0.522023734680808,0.487399983652925,MAP4K4,1
GO:1990806,ligand-gated ion channel signaling pathway,1/173,31/18888,0.248341388343297,0.522023734680808,0.487399983652925,GRIA3,1
GO:2000191,regulation of fatty acid transport,1/173,31/18888,0.248341388343297,0.522023734680808,0.487399983652925,ACSL5,1
GO:0021549,cerebellum development,2/173,105/18888,0.250045383848703,0.52517688695792,0.490343999923102,SEMA4C/ZNF365,2
GO:0032200,telomere organization,3/173,189/18888,0.250300873747149,0.525285044742386,0.490444984033361,TFIP11/TINF2/ZNF365,3
GO:0090596,sensory organ morphogenesis,4/173,278/18888,0.251156725976332,0.526209886061297,0.491308484318448,COL2A1/NTN1/RPGRIP1/SLITRK6,4
GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,4/173,279/18888,0.253152680981409,0.526209886061297,0.491308484318448,CPLANE2/MMP24/NECTIN2/PCDHGB6,4
GO:0018210,peptidyl-threonine modification,2/173,106/18888,0.253437489594394,0.526209886061297,0.491308484318448,MYLK2/PRKD2,2
GO:0034308,primary alcohol metabolic process,2/173,106/18888,0.253437489594394,0.526209886061297,0.491308484318448,CEL/LRAT,2
GO:0048709,oligodendrocyte differentiation,2/173,106/18888,0.253437489594394,0.526209886061297,0.491308484318448,CERS5/ZNF365,2
GO:0001958,endochondral ossification,1/173,32/18888,0.255237338908955,0.526209886061297,0.491308484318448,COL2A1,1
GO:0006221,pyrimidine nucleotide biosynthetic process,1/173,32/18888,0.255237338908955,0.526209886061297,0.491308484318448,NME2,1
GO:0006734,NADH metabolic process,1/173,32/18888,0.255237338908955,0.526209886061297,0.491308484318448,PC,1
GO:0008053,mitochondrial fusion,1/173,32/18888,0.255237338908955,0.526209886061297,0.491308484318448,MFF,1
GO:0009218,pyrimidine ribonucleotide metabolic process,1/173,32/18888,0.255237338908955,0.526209886061297,0.491308484318448,NME2,1
GO:0010644,cell communication by electrical coupling,1/173,32/18888,0.255237338908955,0.526209886061297,0.491308484318448,GJC2,1
GO:0036075,replacement ossification,1/173,32/18888,0.255237338908955,0.526209886061297,0.491308484318448,COL2A1,1
GO:0045684,positive regulation of epidermis development,1/173,32/18888,0.255237338908955,0.526209886061297,0.491308484318448,NME2,1
GO:0048710,regulation of astrocyte differentiation,1/173,32/18888,0.255237338908955,0.526209886061297,0.491308484318448,CLCF1,1
GO:0060219,camera-type eye photoreceptor cell differentiation,1/173,32/18888,0.255237338908955,0.526209886061297,0.491308484318448,RPGRIP1,1
GO:0060292,long-term synaptic depression,1/173,32/18888,0.255237338908955,0.526209886061297,0.491308484318448,ARC,1
GO:0061437,renal system vasculature development,1/173,32/18888,0.255237338908955,0.526209886061297,0.491308484318448,IL6R,1
GO:0061440,kidney vasculature development,1/173,32/18888,0.255237338908955,0.526209886061297,0.491308484318448,IL6R,1
GO:0140058,neuron projection arborization,1/173,32/18888,0.255237338908955,0.526209886061297,0.491308484318448,ZNF365,1
GO:1902235,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,1/173,32/18888,0.255237338908955,0.526209886061297,0.491308484318448,SERINC3,1
GO:1902547,regulation of cellular response to vascular endothelial growth factor stimulus,1/173,32/18888,0.255237338908955,0.526209886061297,0.491308484318448,SMOC2,1
GO:1902992,negative regulation of amyloid precursor protein catabolic process,1/173,32/18888,0.255237338908955,0.526209886061297,0.491308484318448,FLOT2,1
GO:0007631,feeding behavior,2/173,107/18888,0.256830723685546,0.528263220721341,0.493225629484944,OXTR/QRFP,2
GO:0030593,neutrophil chemotaxis,2/173,107/18888,0.256830723685546,0.528263220721341,0.493225629484944,TNFAIP6/XCL1,2
GO:0006066,alcohol metabolic process,5/173,373/18888,0.25724990928246,0.528263220721341,0.493225629484944,APOL1/APOL2/CEL/GFI1/LRAT,5
GO:0044282,small molecule catabolic process,5/173,373/18888,0.25724990928246,0.528263220721341,0.493225629484944,APOBEC3D/APOBEC3H/GALM/MAT1A/PGD,5
GO:0007015,actin filament organization,6/173,467/18888,0.25748931470308,0.528263220721341,0.493225629484944,ACTN1/GDPD2/PXN/RHOB/SEMA5A/TLE6,6
GO:0046777,protein autophosphorylation,3/173,192/18888,0.257669361252817,0.528263220721341,0.493225629484944,MYLK2/PRKD2/SRMS,3
GO:0071897,DNA biosynthetic process,3/173,192/18888,0.257669361252817,0.528263220721341,0.493225629484944,PRKD2/SMOC2/TINF2,3
GO:0060291,long-term synaptic potentiation,2/173,108/18888,0.260224782739955,0.530606780765005,0.495413750543596,ARC/SNAP25,2
GO:1902414,protein localization to cell junction,2/173,108/18888,0.260224782739955,0.530606780765005,0.495413750543596,NPTX1/SNAP25,2
GO:0001975,response to amphetamine,1/173,33/18888,0.262070386234409,0.530606780765005,0.495413750543596,OXTR,1
GO:0002063,chondrocyte development,1/173,33/18888,0.262070386234409,0.530606780765005,0.495413750543596,SHOX2,1
GO:0010464,regulation of mesenchymal cell proliferation,1/173,33/18888,0.262070386234409,0.530606780765005,0.495413750543596,SHOX2,1
GO:0031069,hair follicle morphogenesis,1/173,33/18888,0.262070386234409,0.530606780765005,0.495413750543596,FOXQ1,1
GO:0034121,regulation of toll-like receptor signaling pathway,1/173,33/18888,0.262070386234409,0.530606780765005,0.495413750543596,GFI1,1
GO:0035115,embryonic forelimb morphogenesis,1/173,33/18888,0.262070386234409,0.530606780765005,0.495413750543596,SHOX2,1
GO:0045671,negative regulation of osteoclast differentiation,1/173,33/18888,0.262070386234409,0.530606780765005,0.495413750543596,TNFAIP6,1
GO:0045907,positive regulation of vasoconstriction,1/173,33/18888,0.262070386234409,0.530606780765005,0.495413750543596,OXTR,1
GO:0048566,embryonic digestive tract development,1/173,33/18888,0.262070386234409,0.530606780765005,0.495413750543596,SHOX2,1
GO:0051647,nucleus localization,1/173,33/18888,0.262070386234409,0.530606780765005,0.495413750543596,NTN1,1
GO:0051654,establishment of mitochondrion localization,1/173,33/18888,0.262070386234409,0.530606780765005,0.495413750543596,NECTIN2,1
GO:0060055,angiogenesis involved in wound healing,1/173,33/18888,0.262070386234409,0.530606780765005,0.495413750543596,SMOC2,1
GO:2000515,"negative regulation of CD4-positive, alpha-beta T cell activation",1/173,33/18888,0.262070386234409,0.530606780765005,0.495413750543596,XCL1,1
GO:0043269,regulation of monoatomic ion transport,6/173,470/18888,0.262109446653626,0.530606780765005,0.495413750543596,GJC2/KCNJ2/KCNMB1/SCN4B/TMEM38A/XCL1,6
GO:0032760,positive regulation of tumor necrosis factor production,2/173,109/18888,0.263619368774957,0.532922120528444,0.497575523060589,FCGR3A/SPON2,2
GO:1901991,negative regulation of mitotic cell cycle phase transition,3/173,195/18888,0.265067467260944,0.532922120528444,0.497575523060589,CHFR/GJC2/ZFP36L1,3
GO:0048144,fibroblast proliferation,2/173,110/18888,0.267014189134967,0.532922120528444,0.497575523060589,CDK6/RRN3,2
GO:0048839,inner ear development,3/173,196/18888,0.267539473772112,0.532922120528444,0.497575523060589,COL2A1/NTN1/SLITRK6,3
GO:0000096,sulfur amino acid metabolic process,1/173,34/18888,0.268841100802504,0.532922120528444,0.497575523060589,MAT1A,1
GO:0002323,natural killer cell activation involved in immune response,1/173,34/18888,0.268841100802504,0.532922120528444,0.497575523060589,FCGR3A,1
GO:0002828,regulation of type 2 immune response,1/173,34/18888,0.268841100802504,0.532922120528444,0.497575523060589,XCL1,1
GO:0007435,salivary gland morphogenesis,1/173,34/18888,0.268841100802504,0.532922120528444,0.497575523060589,SEMA3C,1
GO:0010526,retrotransposon silencing,1/173,34/18888,0.268841100802504,0.532922120528444,0.497575523060589,APOBEC3H,1
GO:0019068,virion assembly,1/173,34/18888,0.268841100802504,0.532922120528444,0.497575523060589,PC,1
GO:0030212,hyaluronan metabolic process,1/173,34/18888,0.268841100802504,0.532922120528444,0.497575523060589,TNFAIP6,1
GO:0032743,positive regulation of interleukin-2 production,1/173,34/18888,0.268841100802504,0.532922120528444,0.497575523060589,PRKD2,1
GO:0034405,response to fluid shear stress,1/173,34/18888,0.268841100802504,0.532922120528444,0.497575523060589,TFPI2,1
GO:0035459,vesicle cargo loading,1/173,34/18888,0.268841100802504,0.532922120528444,0.497575523060589,KIF13A,1
GO:0045939,negative regulation of steroid metabolic process,1/173,34/18888,0.268841100802504,0.532922120528444,0.497575523060589,GFI1,1
GO:0048199,"vesicle targeting, to, from or within Golgi",1/173,34/18888,0.268841100802504,0.532922120528444,0.497575523060589,CEP19,1
GO:0055075,potassium ion homeostasis,1/173,34/18888,0.268841100802504,0.532922120528444,0.497575523060589,KCNJ2,1
GO:0071353,cellular response to interleukin-4,1/173,34/18888,0.268841100802504,0.532922120528444,0.497575523060589,XCL1,1
GO:0086004,regulation of cardiac muscle cell contraction,1/173,34/18888,0.268841100802504,0.532922120528444,0.497575523060589,KCNJ2,1
GO:0086019,cell-cell signaling involved in cardiac conduction,1/173,34/18888,0.268841100802504,0.532922120528444,0.497575523060589,SCN4B,1
GO:0090075,relaxation of muscle,1/173,34/18888,0.268841100802504,0.532922120528444,0.497575523060589,KCNJ2,1
GO:0090151,establishment of protein localization to mitochondrial membrane,1/173,34/18888,0.268841100802504,0.532922120528444,0.497575523060589,TOMM40,1
GO:1901797,negative regulation of signal transduction by p53 class mediator,1/173,34/18888,0.268841100802504,0.532922120528444,0.497575523060589,RRN3,1
GO:1902253,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,1/173,34/18888,0.268841100802504,0.532922120528444,0.497575523060589,RRN3,1
GO:1902624,positive regulation of neutrophil migration,1/173,34/18888,0.268841100802504,0.532922120528444,0.497575523060589,XCL1,1
GO:1904861,excitatory synapse assembly,1/173,34/18888,0.268841100802504,0.532922120528444,0.497575523060589,NPTX1,1
GO:2000279,negative regulation of DNA biosynthetic process,1/173,34/18888,0.268841100802504,0.532922120528444,0.497575523060589,TINF2,1
GO:0001938,positive regulation of endothelial cell proliferation,2/173,111/18888,0.270408956419861,0.534794979094579,0.499324162392241,PRKD2/SEMA5A,2
GO:0030203,glycosaminoglycan metabolic process,2/173,111/18888,0.270408956419861,0.534794979094579,0.499324162392241,B4GALT4/TNFAIP6,2
GO:0090277,positive regulation of peptide hormone secretion,2/173,111/18888,0.270408956419861,0.534794979094579,0.499324162392241,NNAT/SNAP25,2
GO:0002444,myeloid leukocyte mediated immunity,2/173,112/18888,0.273803388414228,0.537938872992438,0.502259534354513,FCGR3A/SPON2,2
GO:0006644,phospholipid metabolic process,5/173,383/18888,0.274648837382584,0.537938872992438,0.502259534354513,EFR3B/NR1H3/PLCH1/TAMM41/VAC14,5
GO:0002719,negative regulation of cytokine production involved in immune response,1/173,35/18888,0.275550047952243,0.537938872992438,0.502259534354513,XCL1,1
GO:0006779,porphyrin-containing compound biosynthetic process,1/173,35/18888,0.275550047952243,0.537938872992438,0.502259534354513,SRRD,1
GO:0019228,neuronal action potential,1/173,35/18888,0.275550047952243,0.537938872992438,0.502259534354513,SCN4B,1
GO:0021772,olfactory bulb development,1/173,35/18888,0.275550047952243,0.537938872992438,0.502259534354513,ATF5,1
GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway,1/173,35/18888,0.275550047952243,0.537938872992438,0.502259534354513,PRKD2,1
GO:0032228,"regulation of synaptic transmission, GABAergic",1/173,35/18888,0.275550047952243,0.537938872992438,0.502259534354513,OXTR,1
GO:0032872,regulation of stress-activated MAPK cascade,1/173,35/18888,0.275550047952243,0.537938872992438,0.502259534354513,SEMA4C,1
GO:0033014,tetrapyrrole biosynthetic process,1/173,35/18888,0.275550047952243,0.537938872992438,0.502259534354513,SRRD,1
GO:0045577,regulation of B cell differentiation,1/173,35/18888,0.275550047952243,0.537938872992438,0.502259534354513,ZFP36L1,1
GO:0046471,phosphatidylglycerol metabolic process,1/173,35/18888,0.275550047952243,0.537938872992438,0.502259534354513,TAMM41,1
GO:0071398,cellular response to fatty acid,1/173,35/18888,0.275550047952243,0.537938872992438,0.502259534354513,NME2,1
GO:0099174,regulation of presynapse organization,1/173,35/18888,0.275550047952243,0.537938872992438,0.502259534354513,SLITRK6,1
GO:1901099,negative regulation of signal transduction in absence of ligand,1/173,35/18888,0.275550047952243,0.537938872992438,0.502259534354513,COL2A1,1
GO:1905606,regulation of presynapse assembly,1/173,35/18888,0.275550047952243,0.537938872992438,0.502259534354513,SLITRK6,1
GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,1/173,35/18888,0.275550047952243,0.537938872992438,0.502259534354513,COL2A1,1
GO:0002793,positive regulation of peptide secretion,2/173,113/18888,0.277197208017451,0.539064765509335,0.503310750913979,NNAT/SNAP25,2
GO:0018958,phenol-containing compound metabolic process,2/173,113/18888,0.277197208017451,0.539064765509335,0.503310750913979,PMEL/SLC16A2,2
GO:0035249,"synaptic transmission, glutamatergic",2/173,113/18888,0.277197208017451,0.539064765509335,0.503310750913979,GRIA3/OXTR,2
GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,2/173,113/18888,0.277197208017451,0.539064765509335,0.503310750913979,FCGR3A/SPON2,2
GO:0006403,RNA localization,3/173,200/18888,0.277453930957558,0.539064765509335,0.503310750913979,ARC/UPF3A/ZFP36L1,3
GO:0051402,neuron apoptotic process,4/173,292/18888,0.279380517382355,0.539064765509335,0.503310750913979,CLCF1/EN2/FOXQ1/VSTM2L,4
GO:0050728,negative regulation of inflammatory response,3/173,201/18888,0.279938521031343,0.539064765509335,0.503310750913979,CD200/NR1H3/TNFAIP6,3
GO:0043473,pigmentation,2/173,114/18888,0.280590143174629,0.539064765509335,0.503310750913979,KIF13A/PMEL,2
GO:0050673,epithelial cell proliferation,6/173,482/18888,0.280801727909739,0.539064765509335,0.503310750913979,CDK6/NME2/PRKD2/SEMA5A/TINF2/ZFP36L1,6
GO:0051345,positive regulation of hydrolase activity,6/173,482/18888,0.280801727909739,0.539064765509335,0.503310750913979,BCL2L10/CD200/MAP4K4/NR1H3/RGL4/XCL1,6
GO:0000154,rRNA modification,1/173,36/18888,0.282197787924887,0.539064765509335,0.503310750913979,ZCCHC4,1
GO:0002068,glandular epithelial cell development,1/173,36/18888,0.282197787924887,0.539064765509335,0.503310750913979,CDK6,1
GO:0006516,glycoprotein catabolic process,1/173,36/18888,0.282197787924887,0.539064765509335,0.503310750913979,FBXO2,1
GO:0006882,intracellular zinc ion homeostasis,1/173,36/18888,0.282197787924887,0.539064765509335,0.503310750913979,MT1X,1
GO:0007035,vacuolar acidification,1/173,36/18888,0.282197787924887,0.539064765509335,0.503310750913979,SLC11A1,1
GO:0007617,mating behavior,1/173,36/18888,0.282197787924887,0.539064765509335,0.503310750913979,OXTR,1
GO:0009069,serine family amino acid metabolic process,1/173,36/18888,0.282197787924887,0.539064765509335,0.503310750913979,SERINC3,1
GO:0032197,retrotransposition,1/173,36/18888,0.282197787924887,0.539064765509335,0.503310750913979,APOBEC3H,1
GO:0032205,negative regulation of telomere maintenance,1/173,36/18888,0.282197787924887,0.539064765509335,0.503310750913979,TINF2,1
GO:0034143,regulation of toll-like receptor 4 signaling pathway,1/173,36/18888,0.282197787924887,0.539064765509335,0.503310750913979,NR1H3,1
GO:0035883,enteroendocrine cell differentiation,1/173,36/18888,0.282197787924887,0.539064765509335,0.503310750913979,CDK6,1
GO:0040020,regulation of meiotic nuclear division,1/173,36/18888,0.282197787924887,0.539064765509335,0.503310750913979,FBXO43,1
GO:0042462,eye photoreceptor cell development,1/173,36/18888,0.282197787924887,0.539064765509335,0.503310750913979,RPGRIP1,1
GO:0048026,"positive regulation of mRNA splicing, via spliceosome",1/173,36/18888,0.282197787924887,0.539064765509335,0.503310750913979,UPF3A,1
GO:0051968,"positive regulation of synaptic transmission, glutamatergic",1/173,36/18888,0.282197787924887,0.539064765509335,0.503310750913979,OXTR,1
GO:0060218,hematopoietic stem cell differentiation,1/173,36/18888,0.282197787924887,0.539064765509335,0.503310750913979,CDK6,1
GO:0070633,transepithelial transport,1/173,36/18888,0.282197787924887,0.539064765509335,0.503310750913979,ABCC2,1
GO:2000406,positive regulation of T cell migration,1/173,36/18888,0.282197787924887,0.539064765509335,0.503310750913979,XCL1,1
GO:2000780,negative regulation of double-strand break repair,1/173,36/18888,0.282197787924887,0.539064765509335,0.503310750913979,TFIP11,1
GO:0007626,locomotory behavior,3/173,202/18888,0.282425251799126,0.539099350172535,0.50334304171449,QRFP/SLITRK6/SNAP25,3
GO:1903131,mononuclear cell differentiation,6/173,484/18888,0.283947489854505,0.540069026241827,0.504248403039891,CDK6/CLCF1/IL6R/LY9/MERTK/ZFP36L1,6
GO:0015908,fatty acid transport,2/173,115/18888,0.283981926808324,0.540069026241827,0.504248403039891,ACSL5/SLC22A1,2
GO:0022037,metencephalon development,2/173,115/18888,0.283981926808324,0.540069026241827,0.504248403039891,SEMA4C/ZNF365,2
GO:0032355,response to estradiol,2/173,115/18888,0.283981926808324,0.540069026241827,0.504248403039891,CRYAB/OXTR,2
GO:0048259,regulation of receptor-mediated endocytosis,2/173,115/18888,0.283981926808324,0.540069026241827,0.504248403039891,ARC/VAC14,2
GO:0000302,response to reactive oxygen species,3/173,203/18888,0.284914000057995,0.541441734427556,0.505530064969867,CRYAB/PXN/RHOB,3
GO:0002062,chondrocyte differentiation,2/173,116/18888,0.287372296751115,0.5419978538392,0.506049299200299,COL2A1/SHOX2,2
GO:0071887,leukocyte apoptotic process,2/173,116/18888,0.287372296751115,0.5419978538392,0.506049299200299,MERTK/PRKD2,2
GO:0044703,multi-organism reproductive process,3/173,204/18888,0.287404643529062,0.5419978538392,0.506049299200299,APOL2/OXTR/TLE6,3
GO:0003161,cardiac conduction system development,1/173,37/18888,0.288784875909663,0.5419978538392,0.506049299200299,SHOX2,1
GO:0003230,cardiac atrium development,1/173,37/18888,0.288784875909663,0.5419978538392,0.506049299200299,SHOX2,1
GO:0007031,peroxisome organization,1/173,37/18888,0.288784875909663,0.5419978538392,0.506049299200299,MFF,1
GO:0007431,salivary gland development,1/173,37/18888,0.288784875909663,0.5419978538392,0.506049299200299,SEMA3C,1
GO:0021696,cerebellar cortex morphogenesis,1/173,37/18888,0.288784875909663,0.5419978538392,0.506049299200299,ZNF365,1
GO:0021988,olfactory lobe development,1/173,37/18888,0.288784875909663,0.5419978538392,0.506049299200299,ATF5,1
GO:0043243,positive regulation of protein-containing complex disassembly,1/173,37/18888,0.288784875909663,0.5419978538392,0.506049299200299,SEMA5A,1
GO:0044058,regulation of digestive system process,1/173,37/18888,0.288784875909663,0.5419978538392,0.506049299200299,NR1H3,1
GO:0045191,regulation of isotype switching,1/173,37/18888,0.288784875909663,0.5419978538392,0.506049299200299,CLCF1,1
GO:0045880,positive regulation of smoothened signaling pathway,1/173,37/18888,0.288784875909663,0.5419978538392,0.506049299200299,SHOX2,1
GO:0048730,epidermis morphogenesis,1/173,37/18888,0.288784875909663,0.5419978538392,0.506049299200299,FOXQ1,1
GO:0070269,pyroptosis,1/173,37/18888,0.288784875909663,0.5419978538392,0.506049299200299,GSDMB,1
GO:0070670,response to interleukin-4,1/173,37/18888,0.288784875909663,0.5419978538392,0.506049299200299,XCL1,1
GO:1905898,positive regulation of response to endoplasmic reticulum stress,1/173,37/18888,0.288784875909663,0.5419978538392,0.506049299200299,SERINC3,1
GO:0048562,embryonic organ morphogenesis,4/173,297/18888,0.289586397461372,0.543106317161714,0.507084242574289,COL2A1/NTN1/SHOX2/SLITRK6,4
GO:0051928,positive regulation of calcium ion transport,2/173,117/18888,0.290760995678974,0.544120322582382,0.508030993062099,GJC2/XCL1,2
GO:0061640,cytoskeleton-dependent cytokinesis,2/173,117/18888,0.290760995678974,0.544120322582382,0.508030993062099,RHOB/SEPTIN1,2
GO:1901989,positive regulation of cell cycle phase transition,2/173,117/18888,0.290760995678974,0.544120322582382,0.508030993062099,CDC16/CUL4A,2
GO:0002218,activation of innate immune response,4/173,298/18888,0.291634116709571,0.545357916141719,0.509186501979636,COLEC11/GFI1/NR1H3/PSPC1,4
GO:0001654,eye development,5/173,393/18888,0.292289458936975,0.545500749554738,0.50931986182239,CRYAB/MERTK/MYOM2/RPGRIP1/SLITRK6,5
GO:0006836,neurotransmitter transport,3/173,206/18888,0.292391131634487,0.545500749554738,0.50931986182239,SLC22A1/SLC6A12/SNAP25,3
GO:0071674,mononuclear cell migration,3/173,206/18888,0.292391131634487,0.545500749554738,0.50931986182239,CD200/IL6R/XCL1,3
GO:0043491,phosphatidylinositol 3-kinase/protein kinase B signal transduction,4/173,299/18888,0.293683855280296,0.545500749554738,0.50931986182239,FCGR3A/MERTK/SEMA5A/ZFP36L1,4
GO:0007088,regulation of mitotic nuclear division,2/173,118/18888,0.294147771045415,0.545500749554738,0.50931986182239,CDC16/FBXO43,2
GO:0051224,negative regulation of protein transport,2/173,118/18888,0.294147771045415,0.545500749554738,0.50931986182239,CD200/NR1H3,2
GO:0002369,T cell cytokine production,1/173,38/18888,0.29531186208905,0.545500749554738,0.50931986182239,XCL1,1
GO:0002385,mucosal immune response,1/173,38/18888,0.29531186208905,0.545500749554738,0.50931986182239,XCL1,1
GO:0002724,regulation of T cell cytokine production,1/173,38/18888,0.29531186208905,0.545500749554738,0.50931986182239,XCL1,1
GO:0006688,glycosphingolipid biosynthetic process,1/173,38/18888,0.29531186208905,0.545500749554738,0.50931986182239,B4GALT4,1
GO:0032196,transposition,1/173,38/18888,0.29531186208905,0.545500749554738,0.50931986182239,APOBEC3H,1
GO:0042755,eating behavior,1/173,38/18888,0.29531186208905,0.545500749554738,0.50931986182239,OXTR,1
GO:0043001,Golgi to plasma membrane protein transport,1/173,38/18888,0.29531186208905,0.545500749554738,0.50931986182239,KIF13A,1
GO:0045738,negative regulation of DNA repair,1/173,38/18888,0.29531186208905,0.545500749554738,0.50931986182239,TFIP11,1
GO:0045823,positive regulation of heart contraction,1/173,38/18888,0.29531186208905,0.545500749554738,0.50931986182239,ADM5,1
GO:0046688,response to copper ion,1/173,38/18888,0.29531186208905,0.545500749554738,0.50931986182239,MT1X,1
GO:0070302,regulation of stress-activated protein kinase signaling cascade,1/173,38/18888,0.29531186208905,0.545500749554738,0.50931986182239,SEMA4C,1
GO:0006906,vesicle fusion,2/173,119/18888,0.297532375016462,0.548399206835182,0.512026075998592,CPLANE2/SNAP25,2
GO:0051054,positive regulation of DNA metabolic process,4/173,301/18888,0.297789115446325,0.548399206835182,0.512026075998592,CLCF1/PRKD2/SMOC2/TINF2,4
GO:0050804,modulation of chemical synaptic transmission,6/173,493/18888,0.298198612230528,0.548399206835182,0.512026075998592,ARC/FBXO2/GRIA3/OXTR/SNAP25/ZMYND8,6
GO:0150063,visual system development,5/173,397/18888,0.299403167125209,0.548399206835182,0.512026075998592,CRYAB/MERTK/MYOM2/RPGRIP1/SLITRK6,5
GO:0099177,regulation of trans-synaptic signaling,6/173,494/18888,0.299791042942639,0.548399206835182,0.512026075998592,ARC/FBXO2/GRIA3/OXTR/SNAP25/ZMYND8,6
GO:0006874,intracellular calcium ion homeostasis,4/173,302/18888,0.299844500243381,0.548399206835182,0.512026075998592,PLCH1/RYR3/TMEM38A/XCL1,4
GO:0003341,cilium movement,3/173,209/18888,0.299882074438266,0.548399206835182,0.512026075998592,DNAH5/TPGS1/VDAC3,3
GO:0007265,Ras protein signal transduction,2/173,120/18888,0.300914564406362,0.548399206835182,0.512026075998592,NTN1/RGL4,2
GO:0071346,cellular response to type II interferon,2/173,120/18888,0.300914564406362,0.548399206835182,0.512026075998592,NR1H3/XCL1,2
GO:0001990,regulation of systemic arterial blood pressure by hormone,1/173,39/18888,0.301779291683671,0.548399206835182,0.512026075998592,OXTR,1
GO:0030149,sphingolipid catabolic process,1/173,39/18888,0.301779291683671,0.548399206835182,0.512026075998592,CEL,1
GO:0032350,regulation of hormone metabolic process,1/173,39/18888,0.301779291683671,0.548399206835182,0.512026075998592,GFI1,1
GO:0032373,positive regulation of sterol transport,1/173,39/18888,0.301779291683671,0.548399206835182,0.512026075998592,NR1H3,1
GO:0032376,positive regulation of cholesterol transport,1/173,39/18888,0.301779291683671,0.548399206835182,0.512026075998592,NR1H3,1
GO:0045746,negative regulation of Notch signaling pathway,1/173,39/18888,0.301779291683671,0.548399206835182,0.512026075998592,DLK2,1
GO:0050685,positive regulation of mRNA processing,1/173,39/18888,0.301779291683671,0.548399206835182,0.512026075998592,UPF3A,1
GO:0050892,intestinal absorption,1/173,39/18888,0.301779291683671,0.548399206835182,0.512026075998592,CEL,1
GO:0051954,positive regulation of amine transport,1/173,39/18888,0.301779291683671,0.548399206835182,0.512026075998592,OXTR,1
GO:0060999,positive regulation of dendritic spine development,1/173,39/18888,0.301779291683671,0.548399206835182,0.512026075998592,ZMYND8,1
GO:0070232,regulation of T cell apoptotic process,1/173,39/18888,0.301779291683671,0.548399206835182,0.512026075998592,PRKD2,1
GO:0072530,purine-containing compound transmembrane transport,1/173,39/18888,0.301779291683671,0.548399206835182,0.512026075998592,SLC22A1,1
GO:0097242,amyloid-beta clearance,1/173,39/18888,0.301779291683671,0.548399206835182,0.512026075998592,MSR1,1
GO:1903524,positive regulation of blood circulation,1/173,39/18888,0.301779291683671,0.548399206835182,0.512026075998592,ADM5,1
GO:0046474,glycerophospholipid biosynthetic process,3/173,210/18888,0.302381573511937,0.54910617192753,0.512686150917723,EFR3B/TAMM41/VAC14,3
GO:0046660,female sex differentiation,2/173,121/18888,0.304294100614103,0.551099541921318,0.514547308634968,MERTK/TNFAIP6,2
GO:0090174,organelle membrane fusion,2/173,121/18888,0.304294100614103,0.551099541921318,0.514547308634968,CPLANE2/SNAP25,2
GO:0046486,glycerolipid metabolic process,5/173,400/18888,0.304757311395828,0.551099541921318,0.514547308634968,EFR3B/NR1H3/PLCH1/TAMM41/VAC14,5
GO:1902806,regulation of cell cycle G1/S phase transition,3/173,211/18888,0.30488213800257,0.551099541921318,0.514547308634968,CUL4A/GJC2/SUSD2,3
GO:0001701,in utero embryonic development,5/173,401/18888,0.306545380630416,0.551099541921318,0.514547308634968,CUL4A/RRN3/SLC25A34/UPF3A/ZFP36L1,5
GO:0044706,multi-multicellular organism process,3/173,212/18888,0.307383653138613,0.551099541921318,0.514547308634968,APOL2/OXTR/TLE6,3
GO:0006022,aminoglycan metabolic process,2/173,122/18888,0.307670749560666,0.551099541921318,0.514547308634968,B4GALT4/TNFAIP6,2
GO:0045471,response to ethanol,2/173,122/18888,0.307670749560666,0.551099541921318,0.514547308634968,KCNMB1/SLC2A4,2
GO:0022613,ribonucleoprotein complex biogenesis,6/173,499/18888,0.307777711226981,0.551099541921318,0.514547308634968,CUL4A/DDX49/EFL1/RRN3/ZCCHC4/ZNF658,6
GO:0001953,negative regulation of cell-matrix adhesion,1/173,40/18888,0.308187704996776,0.551099541921318,0.514547308634968,MAP4K4,1
GO:0006730,one-carbon metabolic process,1/173,40/18888,0.308187704996776,0.551099541921318,0.514547308634968,MAT1A,1
GO:0008210,estrogen metabolic process,1/173,40/18888,0.308187704996776,0.551099541921318,0.514547308634968,HSD17B11,1
GO:0009303,rRNA transcription,1/173,40/18888,0.308187704996776,0.551099541921318,0.514547308634968,GTF3C1,1
GO:0017004,cytochrome complex assembly,1/173,40/18888,0.308187704996776,0.551099541921318,0.514547308634968,TIMM21,1
GO:0030488,tRNA methylation,1/173,40/18888,0.308187704996776,0.551099541921318,0.514547308634968,METTL2A,1
GO:0035337,fatty-acyl-CoA metabolic process,1/173,40/18888,0.308187704996776,0.551099541921318,0.514547308634968,ACSL5,1
GO:0043403,skeletal muscle tissue regeneration,1/173,40/18888,0.308187704996776,0.551099541921318,0.514547308634968,TMEM182,1
GO:0045923,positive regulation of fatty acid metabolic process,1/173,40/18888,0.308187704996776,0.551099541921318,0.514547308634968,NR1H3,1
GO:0070286,axonemal dynein complex assembly,1/173,40/18888,0.308187704996776,0.551099541921318,0.514547308634968,DNAH5,1
GO:0150077,regulation of neuroinflammatory response,1/173,40/18888,0.308187704996776,0.551099541921318,0.514547308634968,CD200,1
GO:1901532,regulation of hematopoietic progenitor cell differentiation,1/173,40/18888,0.308187704996776,0.551099541921318,0.514547308634968,CDK6,1
GO:1902742,apoptotic process involved in development,1/173,40/18888,0.308187704996776,0.551099541921318,0.514547308634968,CRYAB,1
GO:0099111,microtubule-based transport,3/173,213/18888,0.309886005098045,0.553448801350643,0.516740751061776,DNAH5/FLOT2/KIF13A,3
GO:0048880,sensory system development,5/173,403/18888,0.310126283972216,0.553448801350643,0.516740751061776,CRYAB/MERTK/MYOM2/RPGRIP1/SLITRK6,5
GO:0051607,defense response to virus,4/173,307/18888,0.3101462603297,0.553448801350643,0.516740751061776,APOBEC3D/APOBEC3H/SERINC3/SPON2,4
GO:0071675,regulation of mononuclear cell migration,2/173,123/18888,0.311044281627046,0.554666914951277,0.51787807204853,CD200/XCL1,2
GO:0046651,lymphocyte proliferation,4/173,308/18888,0.312211109613154,0.555129826220168,0.518310280260342,CLCF1/FCGR3A/SLC11A1/XCL1,4
GO:0007286,spermatid development,3/173,214/18888,0.312389081010156,0.555129826220168,0.518310280260342,NECTIN2/TPGS1/VDAC3,3
GO:0010811,positive regulation of cell-substrate adhesion,2/173,124/18888,0.31441447159302,0.555129826220168,0.518310280260342,CDK6/MAP4K4,2
GO:0034502,protein localization to chromosome,2/173,124/18888,0.31441447159302,0.555129826220168,0.518310280260342,TINF2/ZMYND8,2
GO:0001941,postsynaptic membrane organization,1/173,41/18888,0.31453763745834,0.555129826220168,0.518310280260342,ZMYND8,1
GO:0003203,endocardial cushion morphogenesis,1/173,41/18888,0.31453763745834,0.555129826220168,0.518310280260342,CPLANE2,1
GO:0030851,granulocyte differentiation,1/173,41/18888,0.31453763745834,0.555129826220168,0.518310280260342,CUL4A,1
GO:0032814,regulation of natural killer cell activation,1/173,41/18888,0.31453763745834,0.555129826220168,0.518310280260342,FCGR3A,1
GO:0035136,forelimb morphogenesis,1/173,41/18888,0.31453763745834,0.555129826220168,0.518310280260342,SHOX2,1
GO:0045454,cell redox homeostasis,1/173,41/18888,0.31453763745834,0.555129826220168,0.518310280260342,SLC11A1,1
GO:0045730,respiratory burst,1/173,41/18888,0.31453763745834,0.555129826220168,0.518310280260342,SLC11A1,1
GO:0048489,synaptic vesicle transport,1/173,41/18888,0.31453763745834,0.555129826220168,0.518310280260342,SLC2A4,1
GO:0051281,positive regulation of release of sequestered calcium ion into cytosol,1/173,41/18888,0.31453763745834,0.555129826220168,0.518310280260342,XCL1,1
GO:0071542,dopaminergic neuron differentiation,1/173,41/18888,0.31453763745834,0.555129826220168,0.518310280260342,EN2,1
GO:0099068,postsynapse assembly,1/173,41/18888,0.31453763745834,0.555129826220168,0.518310280260342,NPTX1,1
GO:0006282,regulation of DNA repair,3/173,215/18888,0.314892768957132,0.555375945249736,0.518540075196892,CUL4A/TFIP11/ZNF365,3
GO:0007162,negative regulation of cell adhesion,4/173,310/18888,0.316344773613008,0.557173592375852,0.520218491563186,LPXN/MAP4K4/SEMA5A/XCL1,4
GO:0030217,T cell differentiation,4/173,310/18888,0.316344773613008,0.557173592375852,0.520218491563186,CDK6/IL6R/LY9/ZFP36L1,4
GO:0001952,regulation of cell-matrix adhesion,2/173,125/18888,0.317781098576636,0.557616763913829,0.52063226930166,CDK6/MAP4K4,2
GO:0022612,gland morphogenesis,2/173,125/18888,0.317781098576636,0.557616763913829,0.52063226930166,NTN1/SEMA3C,2
GO:0046632,alpha-beta T cell differentiation,2/173,125/18888,0.317781098576636,0.557616763913829,0.52063226930166,IL6R/LY9,2
GO:0072676,lymphocyte migration,2/173,125/18888,0.317781098576636,0.557616763913829,0.52063226930166,CD200/XCL1,2
GO:0044403,biological process involved in symbiotic interaction,4/173,311/18888,0.318413456715676,0.557616763913829,0.52063226930166,APOBEC3H/APOL1/NECTIN2/PC,4
GO:0030900,forebrain development,5/173,408/18888,0.319104275460181,0.557616763913829,0.52063226930166,ATF5/CDK6/DNAH5/OXTR/SEMA5A,5
GO:0006302,double-strand break repair,4/173,312/18888,0.320483286653105,0.557616763913829,0.52063226930166,MARF1/TFIP11/ZMYND8/ZNF365,4
GO:0001662,behavioral fear response,1/173,42/18888,0.320829619668756,0.557616763913829,0.52063226930166,VDAC3,1
GO:0006904,vesicle docking involved in exocytosis,1/173,42/18888,0.320829619668756,0.557616763913829,0.52063226930166,SNAP25,1
GO:0006958,"complement activation, classical pathway",1/173,42/18888,0.320829619668756,0.557616763913829,0.52063226930166,IGHG4,1
GO:0032733,positive regulation of interleukin-10 production,1/173,42/18888,0.320829619668756,0.557616763913829,0.52063226930166,XCL1,1
GO:0042092,type 2 immune response,1/173,42/18888,0.320829619668756,0.557616763913829,0.52063226930166,XCL1,1
GO:0048512,circadian behavior,1/173,42/18888,0.320829619668756,0.557616763913829,0.52063226930166,PER3,1
GO:0060251,regulation of glial cell proliferation,1/173,42/18888,0.320829619668756,0.557616763913829,0.52063226930166,NTN1,1
GO:0070328,triglyceride homeostasis,1/173,42/18888,0.320829619668756,0.557616763913829,0.52063226930166,NR1H3,1
GO:0071364,cellular response to epidermal growth factor stimulus,1/173,42/18888,0.320829619668756,0.557616763913829,0.52063226930166,ZFP36L1,1
GO:0072528,pyrimidine-containing compound biosynthetic process,1/173,42/18888,0.320829619668756,0.557616763913829,0.52063226930166,NME2,1
GO:1990000,amyloid fibril formation,1/173,42/18888,0.320829619668756,0.557616763913829,0.52063226930166,CRYAB,1
GO:0000956,nuclear-transcribed mRNA catabolic process,2/173,126/18888,0.32114394597445,0.557616763913829,0.52063226930166,UPF3A/ZFP36L1,2
GO:0006805,xenobiotic metabolic process,2/173,126/18888,0.32114394597445,0.557616763913829,0.52063226930166,ABCC2/SLC22A1,2
GO:0072089,stem cell proliferation,2/173,126/18888,0.32114394597445,0.557616763913829,0.52063226930166,SHOX2/ZFP36L1,2
GO:0050821,protein stabilization,3/173,218/18888,0.322406400150556,0.559311152083813,0.522214275466297,CRYAB/FLOT2/PER3,3
GO:0051146,striated muscle cell differentiation,4/173,313/18888,0.322554198386199,0.559311152083813,0.522214275466297,DNER/MYOM2/SHOX2/TMEM182,4
GO:0003206,cardiac chamber morphogenesis,2/173,127/18888,0.324502801402472,0.562311381972655,0.525015512079936,SEMA3C/SHOX2,2
GO:0050679,positive regulation of epithelial cell proliferation,3/173,219/18888,0.324911436161721,0.562640852801904,0.525323130423934,NME2/PRKD2/SEMA5A,3
GO:0032943,mononuclear cell proliferation,4/173,315/18888,0.326699008648779,0.562961401680164,0.525622418574346,CLCF1/FCGR3A/SLC11A1/XCL1,4
GO:0002209,behavioral defense response,1/173,43/18888,0.327064177442146,0.562961401680164,0.525622418574346,VDAC3,1
GO:0003351,epithelial cilium movement involved in extracellular fluid movement,1/173,43/18888,0.327064177442146,0.562961401680164,0.525622418574346,DNAH5,1
GO:0019098,reproductive behavior,1/173,43/18888,0.327064177442146,0.562961401680164,0.525622418574346,OXTR,1
GO:0032768,regulation of monooxygenase activity,1/173,43/18888,0.327064177442146,0.562961401680164,0.525622418574346,GFI1,1
GO:0046640,regulation of alpha-beta T cell proliferation,1/173,43/18888,0.327064177442146,0.562961401680164,0.525622418574346,XCL1,1
GO:0055090,acylglycerol homeostasis,1/173,43/18888,0.327064177442146,0.562961401680164,0.525622418574346,NR1H3,1
GO:0061001,regulation of dendritic spine morphogenesis,1/173,43/18888,0.327064177442146,0.562961401680164,0.525622418574346,ARC,1
GO:2000403,positive regulation of lymphocyte migration,1/173,43/18888,0.327064177442146,0.562961401680164,0.525622418574346,XCL1,1
GO:0006612,protein targeting to membrane,2/173,128/18888,0.327857456637826,0.563197432183056,0.525842794115933,MFF/MIEF2,2
GO:0048706,embryonic skeletal system development,2/173,128/18888,0.327857456637826,0.563197432183056,0.525842794115933,COL2A1/SHOX2,2
GO:0071621,granulocyte chemotaxis,2/173,128/18888,0.327857456637826,0.563197432183056,0.525842794115933,TNFAIP6/XCL1,2
GO:0002456,T cell mediated immunity,2/173,129/18888,0.331207707561117,0.566401133341191,0.528834006561586,NECTIN2/XCL1,2
GO:0019079,viral genome replication,2/173,129/18888,0.331207707561117,0.566401133341191,0.528834006561586,APOBEC3D/APOBEC3H,2
GO:1990266,neutrophil migration,2/173,129/18888,0.331207707561117,0.566401133341191,0.528834006561586,TNFAIP6/XCL1,2
GO:0048515,spermatid differentiation,3/173,222/18888,0.332426521133651,0.566401133341191,0.528834006561586,NECTIN2/TPGS1/VDAC3,3
GO:0043588,skin development,4/173,318/18888,0.332922729659837,0.566401133341191,0.528834006561586,FOXQ1/KRT86/NME2/ZFP36L1,4
GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",1/173,44/18888,0.333241831849283,0.566401133341191,0.528834006561586,UPF3A,1
GO:0007622,rhythmic behavior,1/173,44/18888,0.333241831849283,0.566401133341191,0.528834006561586,PER3,1
GO:0014002,astrocyte development,1/173,44/18888,0.333241831849283,0.566401133341191,0.528834006561586,CDK6,1
GO:0019320,hexose catabolic process,1/173,44/18888,0.333241831849283,0.566401133341191,0.528834006561586,GALM,1
GO:0030890,positive regulation of B cell proliferation,1/173,44/18888,0.333241831849283,0.566401133341191,0.528834006561586,CLCF1,1
GO:0032689,negative regulation of type II interferon production,1/173,44/18888,0.333241831849283,0.566401133341191,0.528834006561586,XCL1,1
GO:0045840,positive regulation of mitotic nuclear division,1/173,44/18888,0.333241831849283,0.566401133341191,0.528834006561586,CDC16,1
GO:0060443,mammary gland morphogenesis,1/173,44/18888,0.333241831849283,0.566401133341191,0.528834006561586,NTN1,1
GO:0120178,steroid hormone biosynthetic process,1/173,44/18888,0.333241831849283,0.566401133341191,0.528834006561586,HSD17B11,1
GO:1901976,regulation of cell cycle checkpoint,1/173,44/18888,0.333241831849283,0.566401133341191,0.528834006561586,CUL4A,1
GO:1905521,regulation of macrophage migration,1/173,44/18888,0.333241831849283,0.566401133341191,0.528834006561586,CD200,1
GO:0050864,regulation of B cell activation,2/173,130/18888,0.334553354099493,0.567506513047559,0.529866070843383,CLCF1/ZFP36L1,2
GO:0098661,inorganic anion transmembrane transport,2/173,130/18888,0.334553354099493,0.567506513047559,0.529866070843383,APOL1/SLC37A1,2
GO:1903322,positive regulation of protein modification by small protein conjugation or removal,2/173,130/18888,0.334553354099493,0.567506513047559,0.529866070843383,CHFR/DCUN1D2,2
GO:0043583,ear development,3/173,223/18888,0.334931191041738,0.567514387453708,0.529873422971597,COL2A1/NTN1/SLITRK6,3
GO:0019058,viral life cycle,4/173,319/18888,0.334998784050344,0.567514387453708,0.529873422971597,APOBEC3D/APOBEC3H/NECTIN2/PC,4
GO:0006661,phosphatidylinositol biosynthetic process,2/173,131/18888,0.337894200170397,0.570032603127753,0.532224615449683,EFR3B/VAC14,2
GO:0051983,regulation of chromosome segregation,2/173,131/18888,0.337894200170397,0.570032603127753,0.532224615449683,CDC16/CHFR,2
GO:1901875,positive regulation of post-translational protein modification,2/173,131/18888,0.337894200170397,0.570032603127753,0.532224615449683,CHFR/DCUN1D2,2
GO:0009416,response to light stimulus,4/173,321/18888,0.339152736668295,0.570032603127753,0.532224615449683,CUL4A/PER3/RBM4B/TAFA2,4
GO:0008038,neuron recognition,1/173,45/18888,0.339363099260134,0.570032603127753,0.532224615449683,SEMA5A,1
GO:0009066,aspartate family amino acid metabolic process,1/173,45/18888,0.339363099260134,0.570032603127753,0.532224615449683,MAT1A,1
GO:0010463,mesenchymal cell proliferation,1/173,45/18888,0.339363099260134,0.570032603127753,0.532224615449683,SHOX2,1
GO:0019432,triglyceride biosynthetic process,1/173,45/18888,0.339363099260134,0.570032603127753,0.532224615449683,NR1H3,1
GO:0021587,cerebellum morphogenesis,1/173,45/18888,0.339363099260134,0.570032603127753,0.532224615449683,ZNF365,1
GO:0030574,collagen catabolic process,1/173,45/18888,0.339363099260134,0.570032603127753,0.532224615449683,MMP24,1
GO:0046466,membrane lipid catabolic process,1/173,45/18888,0.339363099260134,0.570032603127753,0.532224615449683,CEL,1
GO:0046636,negative regulation of alpha-beta T cell activation,1/173,45/18888,0.339363099260134,0.570032603127753,0.532224615449683,XCL1,1
GO:1903573,negative regulation of response to endoplasmic reticulum stress,1/173,45/18888,0.339363099260134,0.570032603127753,0.532224615449683,NR1H3,1
GO:0071222,cellular response to lipopolysaccharide,3/173,225/18888,0.339939371991987,0.570628346075206,0.532780845144924,GFI1/NR1H3/SPON2,3
GO:0000018,regulation of DNA recombination,2/173,132/18888,0.341230053625997,0.572011810494529,0.534072549890446,CLCF1/ZNF365,2
GO:2000779,regulation of double-strand break repair,2/173,132/18888,0.341230053625997,0.572011810494529,0.534072549890446,TFIP11/ZNF365,2
GO:0021782,glial cell development,2/173,133/18888,0.344560726198294,0.572011810494529,0.534072549890446,CDK6/CERS5,2
GO:0048565,digestive tract development,2/173,133/18888,0.344560726198294,0.572011810494529,0.534072549890446,OXTR/SHOX2,2
GO:1904950,negative regulation of establishment of protein localization,2/173,133/18888,0.344560726198294,0.572011810494529,0.534072549890446,CD200/NR1H3,2
GO:0002701,negative regulation of production of molecular mediator of immune response,1/173,46/18888,0.345428491386016,0.572011810494529,0.534072549890446,XCL1,1
GO:0003009,skeletal muscle contraction,1/173,46/18888,0.345428491386016,0.572011810494529,0.534072549890446,KCNJ2,1
GO:0006858,extracellular transport,1/173,46/18888,0.345428491386016,0.572011810494529,0.534072549890446,DNAH5,1
GO:0031146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,1/173,46/18888,0.345428491386016,0.572011810494529,0.534072549890446,FBXO2,1
GO:0032892,positive regulation of organic acid transport,1/173,46/18888,0.345428491386016,0.572011810494529,0.534072549890446,ACSL5,1
GO:0042491,inner ear auditory receptor cell differentiation,1/173,46/18888,0.345428491386016,0.572011810494529,0.534072549890446,SLITRK6,1
GO:0042789,mRNA transcription by RNA polymerase II,1/173,46/18888,0.345428491386016,0.572011810494529,0.534072549890446,NR1H3,1
GO:0046633,alpha-beta T cell proliferation,1/173,46/18888,0.345428491386016,0.572011810494529,0.534072549890446,XCL1,1
GO:0047496,vesicle transport along microtubule,1/173,46/18888,0.345428491386016,0.572011810494529,0.534072549890446,KIF13A,1
GO:0048713,regulation of oligodendrocyte differentiation,1/173,46/18888,0.345428491386016,0.572011810494529,0.534072549890446,ZNF365,1
GO:0070849,response to epidermal growth factor,1/173,46/18888,0.345428491386016,0.572011810494529,0.534072549890446,ZFP36L1,1
GO:0071763,nuclear membrane organization,1/173,46/18888,0.345428491386016,0.572011810494529,0.534072549890446,TMEM43,1
GO:0090207,regulation of triglyceride metabolic process,1/173,46/18888,0.345428491386016,0.572011810494529,0.534072549890446,NR1H3,1
GO:1990573,potassium ion import across plasma membrane,1/173,46/18888,0.345428491386016,0.572011810494529,0.534072549890446,KCNJ2,1
GO:2000516,"positive regulation of CD4-positive, alpha-beta T cell activation",1/173,46/18888,0.345428491386016,0.572011810494529,0.534072549890446,XCL1,1
GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand,1/173,46/18888,0.345428491386016,0.572011810494529,0.534072549890446,COL2A1,1
GO:0045727,positive regulation of translation,2/173,134/18888,0.347886033444894,0.573834244443765,0.535774109068803,UPF3A/ZCCHC4,2
GO:0050684,regulation of mRNA processing,2/173,134/18888,0.347886033444894,0.573834244443765,0.535774109068803,UPF3A/ZFP36L1,2
GO:1903706,regulation of hemopoiesis,5/173,424/18888,0.348024884082178,0.573834244443765,0.535774109068803,CDK6/CUL4A/NME2/TNFAIP6/ZFP36L1,5
GO:0031647,regulation of protein stability,4/173,326/18888,0.349545482602551,0.573834244443765,0.535774109068803,CHFR/CRYAB/FLOT2/PER3,4
GO:0055074,calcium ion homeostasis,4/173,326/18888,0.349545482602551,0.573834244443765,0.535774109068803,PLCH1/RYR3/TMEM38A/XCL1,4
GO:1904951,positive regulation of establishment of protein localization,4/173,326/18888,0.349545482602551,0.573834244443765,0.535774109068803,MFF/MIEF2/NNAT/SNAP25,4
GO:0010927,cellular component assembly involved in morphogenesis,2/173,135/18888,0.351205794695433,0.573834244443765,0.535774109068803,MYOM2/NECTIN2,2
GO:0003044,regulation of systemic arterial blood pressure mediated by a chemical signal,1/173,47/18888,0.351438515321385,0.573834244443765,0.535774109068803,OXTR,1
GO:0010830,regulation of myotube differentiation,1/173,47/18888,0.351438515321385,0.573834244443765,0.535774109068803,SHOX2,1
GO:0010837,regulation of keratinocyte proliferation,1/173,47/18888,0.351438515321385,0.573834244443765,0.535774109068803,ZFP36L1,1
GO:0014003,oligodendrocyte development,1/173,47/18888,0.351438515321385,0.573834244443765,0.535774109068803,CERS5,1
GO:0031577,spindle checkpoint signaling,1/173,47/18888,0.351438515321385,0.573834244443765,0.535774109068803,CHFR,1
GO:0035384,thioester biosynthetic process,1/173,47/18888,0.351438515321385,0.573834244443765,0.535774109068803,ACSL5,1
GO:0045292,"mRNA cis splicing, via spliceosome",1/173,47/18888,0.351438515321385,0.573834244443765,0.535774109068803,UPF3A,1
GO:0045933,positive regulation of muscle contraction,1/173,47/18888,0.351438515321385,0.573834244443765,0.535774109068803,OXTR,1
GO:0048806,genitalia development,1/173,47/18888,0.351438515321385,0.573834244443765,0.535774109068803,MERTK,1
GO:0060119,inner ear receptor cell development,1/173,47/18888,0.351438515321385,0.573834244443765,0.535774109068803,SLITRK6,1
GO:0060711,labyrinthine layer development,1/173,47/18888,0.351438515321385,0.573834244443765,0.535774109068803,ZFP36L1,1
GO:0071616,acyl-CoA biosynthetic process,1/173,47/18888,0.351438515321385,0.573834244443765,0.535774109068803,ACSL5,1
GO:1900271,regulation of long-term synaptic potentiation,1/173,47/18888,0.351438515321385,0.573834244443765,0.535774109068803,ARC,1
GO:1901861,regulation of muscle tissue development,1/173,47/18888,0.351438515321385,0.573834244443765,0.535774109068803,SHOX2,1
GO:0006605,protein targeting,4/173,327/18888,0.351624890416735,0.573834244443765,0.535774109068803,MFF/MIEF2/TIMM21/TOMM40,4
GO:0007018,microtubule-based movement,5/173,426/18888,0.35165453892515,0.573834244443765,0.535774109068803,DNAH5/FLOT2/KIF13A/TPGS1/VDAC3,5
GO:0043547,positive regulation of GTPase activity,3/173,230/18888,0.352448355445603,0.574765367493621,0.53664347444269,MAP4K4/RGL4/XCL1,3
GO:0051251,positive regulation of lymphocyte activation,4/173,328/18888,0.353704443456319,0.575900318824786,0.537703148981425,CLCF1/FCGR3A/FLOT2/XCL1,4
GO:0000086,G2/M transition of mitotic cell cycle,2/173,136/18888,0.354519832998662,0.575900318824786,0.537703148981425,CDK6/CHFR,2
GO:0007041,lysosomal transport,2/173,136/18888,0.354519832998662,0.575900318824786,0.537703148981425,KIF13A/RHOB,2
GO:0007586,digestion,2/173,136/18888,0.354519832998662,0.575900318824786,0.537703148981425,CEL/NR1H3,2
GO:0015931,nucleobase-containing compound transport,3/173,231/18888,0.354947396031591,0.575900318824786,0.537703148981425,ARC/UPF3A/ZFP36L1,3
GO:0003254,regulation of membrane depolarization,1/173,48/18888,0.357393673585246,0.575900318824786,0.537703148981425,MLLT11,1
GO:0007520,myoblast fusion,1/173,48/18888,0.357393673585246,0.575900318824786,0.537703148981425,TMEM182,1
GO:0021575,hindbrain morphogenesis,1/173,48/18888,0.357393673585246,0.575900318824786,0.537703148981425,ZNF365,1
GO:0032620,interleukin-17 production,1/173,48/18888,0.357393673585246,0.575900318824786,0.537703148981425,LY9,1
GO:0032660,regulation of interleukin-17 production,1/173,48/18888,0.357393673585246,0.575900318824786,0.537703148981425,LY9,1
GO:0032968,positive regulation of transcription elongation by RNA polymerase II,1/173,48/18888,0.357393673585246,0.575900318824786,0.537703148981425,ZMYND8,1
GO:0042311,vasodilation,1/173,48/18888,0.357393673585246,0.575900318824786,0.537703148981425,KCNMB1,1
GO:0042596,fear response,1/173,48/18888,0.357393673585246,0.575900318824786,0.537703148981425,VDAC3,1
GO:0044273,sulfur compound catabolic process,1/173,48/18888,0.357393673585246,0.575900318824786,0.537703148981425,MAT1A,1
GO:0044331,cell-cell adhesion mediated by cadherin,1/173,48/18888,0.357393673585246,0.575900318824786,0.537703148981425,MMP24,1
GO:0046189,phenol-containing compound biosynthetic process,1/173,48/18888,0.357393673585246,0.575900318824786,0.537703148981425,PMEL,1
GO:0046365,monosaccharide catabolic process,1/173,48/18888,0.357393673585246,0.575900318824786,0.537703148981425,GALM,1
GO:0120163,negative regulation of cold-induced thermogenesis,1/173,48/18888,0.357393673585246,0.575900318824786,0.537703148981425,NR1H3,1
GO:2000378,negative regulation of reactive oxygen species metabolic process,1/173,48/18888,0.357393673585246,0.575900318824786,0.537703148981425,CRYAB,1
GO:0035270,endocrine system development,2/173,137/18888,0.357827975070175,0.575936967275452,0.537737366686615,CDK6/IL6R,2
GO:0048638,regulation of developmental growth,4/173,330/18888,0.357863746656591,0.575936967275452,0.537737366686615,NTN1/SEMA3C/SEMA4C/SEMA5A,4
GO:0010212,response to ionizing radiation,2/173,138/18888,0.361130051240761,0.57781546956001,0.53949127541137,CRYAB/RHOB,2
GO:0030198,extracellular matrix organization,4/173,332/18888,0.362022918614661,0.57781546956001,0.53949127541137,C6orf15/COL2A1/MMP24/SMOC2,4
GO:0070371,ERK1 and ERK2 cascade,4/173,332/18888,0.362022918614661,0.57781546956001,0.53949127541137,OXTR/PRKD2/XCL1/ZFP36L1,4
GO:0000082,G1/S transition of mitotic cell cycle,3/173,234/18888,0.362437275353183,0.57781546956001,0.53949127541137,CDK6/CUL4A/GJC2,3
GO:0006911,"phagocytosis, engulfment",1/173,49/18888,0.363294464162197,0.57781546956001,0.53949127541137,MSR1,1
GO:0008542,visual learning,1/173,49/18888,0.363294464162197,0.57781546956001,0.53949127541137,TAFA2,1
GO:0014075,response to amine,1/173,49/18888,0.363294464162197,0.57781546956001,0.53949127541137,OXTR,1
GO:0031297,replication fork processing,1/173,49/18888,0.363294464162197,0.57781546956001,0.53949127541137,ZNF365,1
GO:0031648,protein destabilization,1/173,49/18888,0.363294464162197,0.57781546956001,0.53949127541137,CHFR,1
GO:0032369,negative regulation of lipid transport,1/173,49/18888,0.363294464162197,0.57781546956001,0.53949127541137,NR1H3,1
GO:0033628,regulation of cell adhesion mediated by integrin,1/173,49/18888,0.363294464162197,0.57781546956001,0.53949127541137,LPXN,1
GO:0035272,exocrine system development,1/173,49/18888,0.363294464162197,0.57781546956001,0.53949127541137,SEMA3C,1
GO:0046427,positive regulation of receptor signaling pathway via JAK-STAT,1/173,49/18888,0.363294464162197,0.57781546956001,0.53949127541137,IL6R,1
GO:0046596,regulation of viral entry into host cell,1/173,49/18888,0.363294464162197,0.57781546956001,0.53949127541137,NECTIN2,1
GO:0048546,digestive tract morphogenesis,1/173,49/18888,0.363294464162197,0.57781546956001,0.53949127541137,SHOX2,1
GO:0051489,regulation of filopodium assembly,1/173,49/18888,0.363294464162197,0.57781546956001,0.53949127541137,ZMYND8,1
GO:0098815,modulation of excitatory postsynaptic potential,1/173,49/18888,0.363294464162197,0.57781546956001,0.53949127541137,ZMYND8,1
GO:0099054,presynapse assembly,1/173,49/18888,0.363294464162197,0.57781546956001,0.53949127541137,SLITRK6,1
GO:2000649,regulation of sodium ion transmembrane transporter activity,1/173,49/18888,0.363294464162197,0.57781546956001,0.53949127541137,SCN4B,1
GO:0043062,extracellular structure organization,4/173,333/18888,0.364102308931492,0.578742867591723,0.540357162832701,C6orf15/COL2A1/MMP24/SMOC2,4
GO:0042157,lipoprotein metabolic process,2/173,139/18888,0.3644258954054,0.578899864693957,0.540503746943689,APOL1/APOL2,2
GO:0045229,external encapsulating structure organization,4/173,334/18888,0.366181491416263,0.581330049566509,0.542772747352031,C6orf15/COL2A1/MMP24/SMOC2,4
GO:0048813,dendrite morphogenesis,2/173,140/18888,0.367715344972875,0.581369452537307,0.542809536881026,ARC/ZNF365,2
GO:0060562,epithelial tube morphogenesis,4/173,335/18888,0.368260408475241,0.581369452537307,0.542809536881026,NTN1/PRKD2/RHOB/SEMA4C,4
GO:0001754,eye photoreceptor cell differentiation,1/173,50/18888,0.369141380543106,0.581369452537307,0.542809536881026,RPGRIP1,1
GO:0007215,glutamate receptor signaling pathway,1/173,50/18888,0.369141380543106,0.581369452537307,0.542809536881026,GRIA3,1
GO:0009299,mRNA transcription,1/173,50/18888,0.369141380543106,0.581369452537307,0.542809536881026,NR1H3,1
GO:0022602,ovulation cycle process,1/173,50/18888,0.369141380543106,0.581369452537307,0.542809536881026,TNFAIP6,1
GO:0033120,positive regulation of RNA splicing,1/173,50/18888,0.369141380543106,0.581369452537307,0.542809536881026,UPF3A,1
GO:0043457,regulation of cellular respiration,1/173,50/18888,0.369141380543106,0.581369452537307,0.542809536881026,PRDM16,1
GO:0051985,negative regulation of chromosome segregation,1/173,50/18888,0.369141380543106,0.581369452537307,0.542809536881026,CHFR,1
GO:0071320,cellular response to cAMP,1/173,50/18888,0.369141380543106,0.581369452537307,0.542809536881026,ZFP36L1,1
GO:0090102,cochlea development,1/173,50/18888,0.369141380543106,0.581369452537307,0.542809536881026,SLITRK6,1
GO:1902100,negative regulation of metaphase/anaphase transition of cell cycle,1/173,50/18888,0.369141380543106,0.581369452537307,0.542809536881026,CHFR,1
GO:1905819,negative regulation of chromosome separation,1/173,50/18888,0.369141380543106,0.581369452537307,0.542809536881026,CHFR,1
GO:0030595,leukocyte chemotaxis,3/173,237/18888,0.369914332385397,0.581875018871348,0.543281571017745,IL6R/TNFAIP6/XCL1,3
GO:0050670,regulation of lymphocyte proliferation,3/173,237/18888,0.369914332385397,0.581875018871348,0.543281571017745,CLCF1/FCGR3A/XCL1,3
GO:0008203,cholesterol metabolic process,2/173,141/18888,0.370998240816,0.582867889018426,0.544208588050315,APOL1/APOL2,2
GO:0070828,heterochromatin organization,2/173,141/18888,0.370998240816,0.582867889018426,0.544208588050315,LRIF1/PRDM16,2
GO:0071219,cellular response to molecule of bacterial origin,3/173,238/18888,0.372403408926038,0.584028219063673,0.545291958034309,GFI1/NR1H3/SPON2,3
GO:0000377,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",4/173,337/18888,0.372417217748563,0.584028219063673,0.545291958034309,LSM8/RBM4B/TFIP11/UPF3A,4
GO:0000398,"mRNA splicing, via spliceosome",4/173,337/18888,0.372417217748563,0.584028219063673,0.545291958034309,LSM8/RBM4B/TFIP11/UPF3A,4
GO:0043434,response to peptide hormone,5/173,438/18888,0.373465704460342,0.584063761522062,0.545325143103276,NME2/OXTR/PXN/SLC2A4/ZFP36L1,5
GO:0060537,muscle tissue development,5/173,438/18888,0.373465704460342,0.584063761522062,0.545325143103276,DNER/MYLK2/MYOM2/SEMA3C/SHOX2,5
GO:0051053,negative regulation of DNA metabolic process,2/173,142/18888,0.374274427222452,0.584063761522062,0.545325143103276,TFIP11/TINF2,2
GO:0009743,response to carbohydrate,3/173,239/18888,0.374890698425767,0.584063761522062,0.545325143103276,NME2/NPTX1/ZFP36L1,3
GO:0001974,blood vessel remodeling,1/173,51/18888,0.374934911765424,0.584063761522062,0.545325143103276,SEMA3C,1
GO:0032387,negative regulation of intracellular transport,1/173,51/18888,0.374934911765424,0.584063761522062,0.545325143103276,CRYAB,1
GO:0042220,response to cocaine,1/173,51/18888,0.374934911765424,0.584063761522062,0.545325143103276,OXTR,1
GO:0042461,photoreceptor cell development,1/173,51/18888,0.374934911765424,0.584063761522062,0.545325143103276,RPGRIP1,1
GO:0045214,sarcomere organization,1/173,51/18888,0.374934911765424,0.584063761522062,0.545325143103276,MYOM2,1
GO:0051496,positive regulation of stress fiber assembly,1/173,51/18888,0.374934911765424,0.584063761522062,0.545325143103276,PXN,1
GO:1901570,fatty acid derivative biosynthetic process,1/173,51/18888,0.374934911765424,0.584063761522062,0.545325143103276,ACSL5,1
GO:0006310,DNA recombination,4/173,339/18888,0.376572283252822,0.586259751738825,0.547375482052724,CLCF1/SANBR/ZMYND8/ZNF365,4
GO:0003158,endothelium development,2/173,143/18888,0.377543751846212,0.587171029385304,0.548226318289641,PRKD2/RHOB,2
GO:0016042,lipid catabolic process,4/173,340/18888,0.378649021971206,0.587171029385304,0.548226318289641,CEL/HSD11B1/HSD17B11/PLCH1,4
GO:0007160,cell-matrix adhesion,3/173,241/18888,0.379859564952253,0.587171029385304,0.548226318289641,ACTN1/CDK6/MAP4K4,3
GO:0032944,regulation of mononuclear cell proliferation,3/173,241/18888,0.379859564952253,0.587171029385304,0.548226318289641,CLCF1/FCGR3A/XCL1,3
GO:0071356,cellular response to tumor necrosis factor,3/173,241/18888,0.379859564952253,0.587171029385304,0.548226318289641,SLC2A4/XCL1/ZFP36L1,3
GO:1903320,regulation of protein modification by small protein conjugation or removal,3/173,241/18888,0.379859564952253,0.587171029385304,0.548226318289641,CHFR/DCUN1D2/FBXO2,3
GO:0003197,endocardial cushion development,1/173,52/18888,0.380675542453144,0.587171029385304,0.548226318289641,CPLANE2,1
GO:0006968,cellular defense response,1/173,52/18888,0.380675542453144,0.587171029385304,0.548226318289641,SH2D1A,1
GO:0010332,response to gamma radiation,1/173,52/18888,0.380675542453144,0.587171029385304,0.548226318289641,CRYAB,1
GO:0021695,cerebellar cortex development,1/173,52/18888,0.380675542453144,0.587171029385304,0.548226318289641,ZNF365,1
GO:0035176,social behavior,1/173,52/18888,0.380675542453144,0.587171029385304,0.548226318289641,OXTR,1
GO:0051155,positive regulation of striated muscle cell differentiation,1/173,52/18888,0.380675542453144,0.587171029385304,0.548226318289641,SHOX2,1
GO:1904263,positive regulation of TORC1 signaling,1/173,52/18888,0.380675542453144,0.587171029385304,0.548226318289641,SRMS,1
GO:0000375,"RNA splicing, via transesterification reactions",4/173,341/18888,0.380725157337647,0.587171029385304,0.548226318289641,LSM8/RBM4B/TFIP11/UPF3A,4
GO:0030534,adult behavior,2/173,144/18888,0.380806065659595,0.587171029385304,0.548226318289641,SLITRK6/TPGS1,2
GO:0046887,positive regulation of hormone secretion,2/173,144/18888,0.380806065659595,0.587171029385304,0.548226318289641,NNAT/SNAP25,2
GO:0030072,peptide hormone secretion,3/173,242/18888,0.382340968646407,0.589184915777677,0.55010663163463,NNAT/SLC16A2/SNAP25,3
GO:0007266,Rho protein signal transduction,2/173,145/18888,0.384061222905871,0.590437189083213,0.551275846649385,NTN1/RHOB,2
GO:0055123,digestive system development,2/173,145/18888,0.384061222905871,0.590437189083213,0.551275846649385,OXTR/SHOX2,2
GO:0071333,cellular response to glucose stimulus,2/173,145/18888,0.384061222905871,0.590437189083213,0.551275846649385,NME2/NPTX1,2
GO:0009410,response to xenobiotic stimulus,5/173,444/18888,0.384378249406527,0.590437189083213,0.551275846649385,ABCC2/OXTR/SEMA3C/SLC22A1/TGIF1,5
GO:0002066,columnar/cuboidal epithelial cell development,1/173,53/18888,0.386363752856394,0.590437189083213,0.551275846649385,CDK6,1
GO:0006220,pyrimidine nucleotide metabolic process,1/173,53/18888,0.386363752856394,0.590437189083213,0.551275846649385,NME2,1
GO:0030834,regulation of actin filament depolymerization,1/173,53/18888,0.386363752856394,0.590437189083213,0.551275846649385,SEMA5A,1
GO:0032330,regulation of chondrocyte differentiation,1/173,53/18888,0.386363752856394,0.590437189083213,0.551275846649385,SHOX2,1
GO:0044818,mitotic G2/M transition checkpoint,1/173,53/18888,0.386363752856394,0.590437189083213,0.551275846649385,CHFR,1
GO:0050433,regulation of catecholamine secretion,1/173,53/18888,0.386363752856394,0.590437189083213,0.551275846649385,OXTR,1
GO:0060193,positive regulation of lipase activity,1/173,53/18888,0.386363752856394,0.590437189083213,0.551275846649385,NR1H3,1
GO:0060688,regulation of morphogenesis of a branching structure,1/173,53/18888,0.386363752856394,0.590437189083213,0.551275846649385,SHOX2,1
GO:1902930,regulation of alcohol biosynthetic process,1/173,53/18888,0.386363752856394,0.590437189083213,0.551275846649385,GFI1,1
GO:1904894,positive regulation of receptor signaling pathway via STAT,1/173,53/18888,0.386363752856394,0.590437189083213,0.551275846649385,IL6R,1
GO:0006814,sodium ion transport,3/173,244/18888,0.38729729056754,0.59048009692723,0.551315908587345,SCN4B/SLC38A4/SLC6A12,3
GO:0007224,smoothened signaling pathway,2/173,146/18888,0.387309081052463,0.59048009692723,0.551315908587345,CPLANE2/SHOX2,2
GO:0045598,regulation of fat cell differentiation,2/173,146/18888,0.387309081052463,0.59048009692723,0.551315908587345,DLK2/ZFP36L1,2
GO:0051592,response to calcium ion,2/173,146/18888,0.387309081052463,0.59048009692723,0.551315908587345,KCNMB1/RYR3,2
GO:0000280,nuclear division,5/173,446/18888,0.388014711396919,0.590856228176858,0.551667092552251,CDC16/CHFR/FBXO43/MARF1/SEPTIN1,5
GO:0042391,regulation of membrane potential,5/173,446/18888,0.388014711396919,0.590856228176858,0.551667092552251,GRIA3/KCNJ2/MLLT11/SCN4B/ZMYND8,5
GO:0007179,transforming growth factor beta receptor signaling pathway,3/173,245/18888,0.389772041053343,0.591676464621049,0.5524329259865,LPXN/PRDM16/PXN,3
GO:0031333,negative regulation of protein-containing complex assembly,2/173,147/18888,0.390549500744723,0.591676464621049,0.5524329259865,CRYAB/TFIP11,2
GO:0050714,positive regulation of protein secretion,2/173,147/18888,0.390549500744723,0.591676464621049,0.5524329259865,NNAT/SNAP25,2
GO:0051783,regulation of nuclear division,2/173,147/18888,0.390549500744723,0.591676464621049,0.5524329259865,CDC16/FBXO43,2
GO:0170039,proteinogenic amino acid metabolic process,2/173,147/18888,0.390549500744723,0.591676464621049,0.5524329259865,MAT1A/SERINC3,2
GO:0010874,regulation of cholesterol efflux,1/173,54/18888,0.392000018890683,0.591676464621049,0.5524329259865,NR1H3,1
GO:0035315,hair cell differentiation,1/173,54/18888,0.392000018890683,0.591676464621049,0.5524329259865,SLITRK6,1
GO:0038093,Fc receptor signaling pathway,1/173,54/18888,0.392000018890683,0.591676464621049,0.5524329259865,FCGR3A,1
GO:0042304,regulation of fatty acid biosynthetic process,1/173,54/18888,0.392000018890683,0.591676464621049,0.5524329259865,NR1H3,1
GO:0046605,regulation of centrosome cycle,1/173,54/18888,0.392000018890683,0.591676464621049,0.5524329259865,ATF5,1
GO:0048146,positive regulation of fibroblast proliferation,1/173,54/18888,0.392000018890683,0.591676464621049,0.5524329259865,CDK6,1
GO:0050805,negative regulation of synaptic transmission,1/173,54/18888,0.392000018890683,0.591676464621049,0.5524329259865,ARC,1
GO:0051703,biological process involved in intraspecies interaction between organisms,1/173,54/18888,0.392000018890683,0.591676464621049,0.5524329259865,OXTR,1
GO:0071385,cellular response to glucocorticoid stimulus,1/173,54/18888,0.392000018890683,0.591676464621049,0.5524329259865,ZFP36L1,1
GO:0099172,presynapse organization,1/173,54/18888,0.392000018890683,0.591676464621049,0.5524329259865,SLITRK6,1
GO:1901873,regulation of post-translational protein modification,3/173,246/18888,0.39224440760592,0.591698505908169,0.552453505363008,CHFR/DCUN1D2/FBXO2,3
GO:0060078,regulation of postsynaptic membrane potential,2/173,148/18888,0.393782345760281,0.591780862053577,0.552530399153958,GRIA3/ZMYND8,2
GO:0071331,cellular response to hexose stimulus,2/173,148/18888,0.393782345760281,0.591780862053577,0.552530399153958,NME2/NPTX1,2
GO:0002790,peptide secretion,3/173,247/18888,0.394714308666622,0.591780862053577,0.552530399153958,NNAT/SLC16A2/SNAP25,3
GO:0033044,regulation of chromosome organization,3/173,247/18888,0.394714308666622,0.591780862053577,0.552530399153958,CDC16/CHFR/TINF2,3
GO:0051924,regulation of calcium ion transport,3/173,247/18888,0.394714308666622,0.591780862053577,0.552530399153958,GJC2/TMEM38A/XCL1,3
GO:0006887,exocytosis,4/173,348/18888,0.395236634867685,0.591780862053577,0.552530399153958,CPLANE2/FCGR3A/SEPTIN1/SNAP25,4
GO:0032496,response to lipopolysaccharide,4/173,348/18888,0.395236634867685,0.591780862053577,0.552530399153958,GFI1/NR1H3/SLC11A1/SPON2,4
GO:0001508,action potential,2/173,149/18888,0.397007482963939,0.591780862053577,0.552530399153958,KCNJ2/SCN4B,2
GO:0002687,positive regulation of leukocyte migration,2/173,149/18888,0.397007482963939,0.591780862053577,0.552530399153958,IL6R/XCL1,2
GO:0034599,cellular response to oxidative stress,3/173,248/18888,0.397181663596468,0.591780862053577,0.552530399153958,NME2/PXN/RHOB,3
GO:0045930,negative regulation of mitotic cell cycle,3/173,248/18888,0.397181663596468,0.591780862053577,0.552530399153958,CHFR/GJC2/ZFP36L1,3
GO:0002043,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,1/173,55/18888,0.397584812175801,0.591780862053577,0.552530399153958,SEMA5A,1
GO:0002448,mast cell mediated immunity,1/173,55/18888,0.397584812175801,0.591780862053577,0.552530399153958,SPON2,1
GO:0006998,nuclear envelope organization,1/173,55/18888,0.397584812175801,0.591780862053577,0.552530399153958,TMEM43,1
GO:0032210,regulation of telomere maintenance via telomerase,1/173,55/18888,0.397584812175801,0.591780862053577,0.552530399153958,TINF2,1
GO:0034381,plasma lipoprotein particle clearance,1/173,55/18888,0.397584812175801,0.591780862053577,0.552530399153958,MSR1,1
GO:0034661,ncRNA catabolic process,1/173,55/18888,0.397584812175801,0.591780862053577,0.552530399153958,DDX49,1
GO:0046460,neutral lipid biosynthetic process,1/173,55/18888,0.397584812175801,0.591780862053577,0.552530399153958,NR1H3,1
GO:0046463,acylglycerol biosynthetic process,1/173,55/18888,0.397584812175801,0.591780862053577,0.552530399153958,NR1H3,1
GO:0097479,synaptic vesicle localization,1/173,55/18888,0.397584812175801,0.591780862053577,0.552530399153958,SLC2A4,1
GO:1900087,positive regulation of G1/S transition of mitotic cell cycle,1/173,55/18888,0.397584812175801,0.591780862053577,0.552530399153958,CUL4A,1
GO:1902991,regulation of amyloid precursor protein catabolic process,1/173,55/18888,0.397584812175801,0.591780862053577,0.552530399153958,FLOT2,1
GO:2000772,regulation of cellular senescence,1/173,55/18888,0.397584812175801,0.591780862053577,0.552530399153958,CDK6,1
GO:0071326,cellular response to monosaccharide stimulus,2/173,150/18888,0.400224782263143,0.595366155013052,0.555877893939627,NME2/NPTX1,2
GO:0002455,humoral immune response mediated by circulating immunoglobulin,1/173,56/18888,0.403118600074362,0.596456775938079,0.556896178331148,IGHG4,1
GO:0002823,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1/173,56/18888,0.403118600074362,0.596456775938079,0.556896178331148,XCL1,1
GO:0015872,dopamine transport,1/173,56/18888,0.403118600074362,0.596456775938079,0.556896178331148,SLC22A1,1
GO:0050832,defense response to fungus,1/173,56/18888,0.403118600074362,0.596456775938079,0.556896178331148,SPON2,1
GO:0052372,modulation by symbiont of entry into host,1/173,56/18888,0.403118600074362,0.596456775938079,0.556896178331148,NECTIN2,1
GO:0070231,T cell apoptotic process,1/173,56/18888,0.403118600074362,0.596456775938079,0.556896178331148,PRKD2,1
GO:0170038,proteinogenic amino acid biosynthetic process,1/173,56/18888,0.403118600074362,0.596456775938079,0.556896178331148,SERINC3,1
GO:2000648,positive regulation of stem cell proliferation,1/173,56/18888,0.403118600074362,0.596456775938079,0.556896178331148,SHOX2,1
GO:0034614,cellular response to reactive oxygen species,2/173,151/18888,0.403434116563985,0.596456775938079,0.556896178331148,PXN/RHOB,2
GO:0098876,vesicle-mediated transport to the plasma membrane,2/173,151/18888,0.403434116563985,0.596456775938079,0.556896178331148,KIF13A/SNAP25,2
GO:0070661,leukocyte proliferation,4/173,352/18888,0.403507351173063,0.596456775938079,0.556896178331148,CLCF1/FCGR3A/SLC11A1/XCL1,4
GO:0031023,microtubule organizing center organization,2/173,152/18888,0.406635361727759,0.596456775938079,0.556896178331148,ATF5/BCL2L10,2
GO:0035296,regulation of tube diameter,2/173,152/18888,0.406635361727759,0.596456775938079,0.556896178331148,KCNMB1/OXTR,2
GO:0097746,blood vessel diameter maintenance,2/173,152/18888,0.406635361727759,0.596456775938079,0.556896178331148,KCNMB1/OXTR,2
GO:1902652,secondary alcohol metabolic process,2/173,152/18888,0.406635361727759,0.596456775938079,0.556896178331148,APOL1/APOL2,2
GO:1903531,negative regulation of secretion by cell,2/173,152/18888,0.406635361727759,0.596456775938079,0.556896178331148,CD200/NR1H3,2
GO:0005996,monosaccharide metabolic process,3/173,252/18888,0.40702404124697,0.596456775938079,0.556896178331148,GALM/PC/PGD,3
GO:0001541,ovarian follicle development,1/173,57/18888,0.408601845730008,0.596456775938079,0.556896178331148,TNFAIP6,1
GO:0002707,negative regulation of lymphocyte mediated immunity,1/173,57/18888,0.408601845730008,0.596456775938079,0.556896178331148,XCL1,1
GO:0006893,Golgi to plasma membrane transport,1/173,57/18888,0.408601845730008,0.596456775938079,0.556896178331148,KIF13A,1
GO:0007632,visual behavior,1/173,57/18888,0.408601845730008,0.596456775938079,0.556896178331148,TAFA2,1
GO:0019748,secondary metabolic process,1/173,57/18888,0.408601845730008,0.596456775938079,0.556896178331148,PMEL,1
GO:0031124,mRNA 3'-end processing,1/173,57/18888,0.408601845730008,0.596456775938079,0.556896178331148,ZFP36L1,1
GO:0033866,nucleoside bisphosphate biosynthetic process,1/173,57/18888,0.408601845730008,0.596456775938079,0.556896178331148,ACSL5,1
GO:0034030,ribonucleoside bisphosphate biosynthetic process,1/173,57/18888,0.408601845730008,0.596456775938079,0.556896178331148,ACSL5,1
GO:0034033,purine nucleoside bisphosphate biosynthetic process,1/173,57/18888,0.408601845730008,0.596456775938079,0.556896178331148,ACSL5,1
GO:0045005,DNA-templated DNA replication maintenance of fidelity,1/173,57/18888,0.408601845730008,0.596456775938079,0.556896178331148,ZNF365,1
GO:0051293,establishment of spindle localization,1/173,57/18888,0.408601845730008,0.596456775938079,0.556896178331148,TLE6,1
GO:0051452,intracellular pH reduction,1/173,57/18888,0.408601845730008,0.596456775938079,0.556896178331148,SLC11A1,1
GO:0070542,response to fatty acid,1/173,57/18888,0.408601845730008,0.596456775938079,0.556896178331148,NME2,1
GO:0170034,L-amino acid biosynthetic process,1/173,57/18888,0.408601845730008,0.596456775938079,0.556896178331148,SERINC3,1
GO:0170040,proteinogenic amino acid catabolic process,1/173,57/18888,0.408601845730008,0.596456775938079,0.556896178331148,MAT1A,1
GO:2000107,negative regulation of leukocyte apoptotic process,1/173,57/18888,0.408601845730008,0.596456775938079,0.556896178331148,MERTK,1
GO:0008654,phospholipid biosynthetic process,3/173,253/18888,0.409477487913146,0.597396335057423,0.557773420243701,EFR3B/TAMM41/VAC14,3
GO:0035150,regulation of tube size,2/173,153/18888,0.409828396528048,0.597569717474363,0.55793530289686,KCNMB1/OXTR,2
GO:0097530,granulocyte migration,2/173,154/18888,0.413013102608345,0.600304136188677,0.560488358530379,TNFAIP6/XCL1,2
GO:0006826,iron ion transport,1/173,58/18888,0.414035008105278,0.600304136188677,0.560488358530379,SLC11A1,1
GO:0030042,actin filament depolymerization,1/173,58/18888,0.414035008105278,0.600304136188677,0.560488358530379,SEMA5A,1
GO:0032786,"positive regulation of DNA-templated transcription, elongation",1/173,58/18888,0.414035008105278,0.600304136188677,0.560488358530379,ZMYND8,1
GO:0048168,regulation of neuronal synaptic plasticity,1/173,58/18888,0.414035008105278,0.600304136188677,0.560488358530379,ARC,1
GO:0060998,regulation of dendritic spine development,1/173,58/18888,0.414035008105278,0.600304136188677,0.560488358530379,ZMYND8,1
GO:0070228,regulation of lymphocyte apoptotic process,1/173,58/18888,0.414035008105278,0.600304136188677,0.560488358530379,PRKD2,1
GO:0072132,mesenchyme morphogenesis,1/173,58/18888,0.414035008105278,0.600304136188677,0.560488358530379,CPLANE2,1
GO:0086065,cell communication involved in cardiac conduction,1/173,58/18888,0.414035008105278,0.600304136188677,0.560488358530379,SCN4B,1
GO:0099024,plasma membrane invagination,1/173,58/18888,0.414035008105278,0.600304136188677,0.560488358530379,MSR1,1
GO:0030183,B cell differentiation,2/173,155/18888,0.416189364440196,0.603088133614803,0.563087704517612,CLCF1/ZFP36L1,2
GO:0010965,regulation of mitotic sister chromatid separation,1/173,59/18888,0.419418542019128,0.60470478482601,0.564597129705716,CDC16,1
GO:0038066,p38MAPK cascade,1/173,59/18888,0.419418542019128,0.60470478482601,0.564597129705716,ZFP36L1,1
GO:0043616,keratinocyte proliferation,1/173,59/18888,0.419418542019128,0.60470478482601,0.564597129705716,ZFP36L1,1
GO:0050432,catecholamine secretion,1/173,59/18888,0.419418542019128,0.60470478482601,0.564597129705716,OXTR,1
GO:0050881,musculoskeletal movement,1/173,59/18888,0.419418542019128,0.60470478482601,0.564597129705716,KCNJ2,1
GO:0051932,"synaptic transmission, GABAergic",1/173,59/18888,0.419418542019128,0.60470478482601,0.564597129705716,OXTR,1
GO:0060135,maternal process involved in female pregnancy,1/173,59/18888,0.419418542019128,0.60470478482601,0.564597129705716,APOL2,1
GO:0098900,regulation of action potential,1/173,59/18888,0.419418542019128,0.60470478482601,0.564597129705716,KCNJ2,1
GO:1902305,regulation of sodium ion transmembrane transport,1/173,59/18888,0.419418542019128,0.60470478482601,0.564597129705716,SCN4B,1
GO:0042593,glucose homeostasis,3/173,258/18888,0.421698086480122,0.60731128226304,0.567030748569763,NME2/NPTX1/SLC2A4,3
GO:0045927,positive regulation of growth,3/173,258/18888,0.421698086480122,0.60731128226304,0.567030748569763,DDX49/NTN1/SEMA5A,3
GO:2001236,regulation of extrinsic apoptotic signaling pathway,2/173,157/18888,0.422516107137496,0.607589193234938,0.567290226815983,BCL2L14/COL2A1,2
GO:0002221,pattern recognition receptor signaling pathway,3/173,259/18888,0.424132371681559,0.607589193234938,0.567290226815983,COLEC11/GFI1/NR1H3,3
GO:0033500,carbohydrate homeostasis,3/173,259/18888,0.424132371681559,0.607589193234938,0.567290226815983,NME2/NPTX1/SLC2A4,3
GO:0001961,positive regulation of cytokine-mediated signaling pathway,1/173,60/18888,0.424752898184122,0.607589193234938,0.567290226815983,GFI1,1
GO:0006940,regulation of smooth muscle contraction,1/173,60/18888,0.424752898184122,0.607589193234938,0.567290226815983,OXTR,1
GO:0010257,NADH dehydrogenase complex assembly,1/173,60/18888,0.424752898184122,0.607589193234938,0.567290226815983,TIMM21,1
GO:0014009,glial cell proliferation,1/173,60/18888,0.424752898184122,0.607589193234938,0.567290226815983,NTN1,1
GO:0032981,mitochondrial respiratory chain complex I assembly,1/173,60/18888,0.424752898184122,0.607589193234938,0.567290226815983,TIMM21,1
GO:0043113,receptor clustering,1/173,60/18888,0.424752898184122,0.607589193234938,0.567290226815983,TNFAIP6,1
GO:0071168,protein localization to chromatin,1/173,60/18888,0.424752898184122,0.607589193234938,0.567290226815983,ZMYND8,1
GO:0099518,vesicle cytoskeletal trafficking,1/173,60/18888,0.424752898184122,0.607589193234938,0.567290226815983,KIF13A,1
GO:1905517,macrophage migration,1/173,60/18888,0.424752898184122,0.607589193234938,0.567290226815983,CD200,1
GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,2/173,158/18888,0.425666370716827,0.607589193234938,0.567290226815983,ADM5/NME2,2
GO:0016052,carbohydrate catabolic process,2/173,158/18888,0.425666370716827,0.607589193234938,0.567290226815983,GALM/PGD,2
GO:0072006,nephron development,2/173,158/18888,0.425666370716827,0.607589193234938,0.567290226815983,IL6R/SLC22A1,2
GO:0098754,detoxification,2/173,158/18888,0.425666370716827,0.607589193234938,0.567290226815983,MT1X/SLC11A1,2
GO:0009636,response to toxic substance,3/173,260/18888,0.426563213655304,0.608532008400226,0.568170508813947,GJC2/MT1X/SLC11A1,3
GO:0008643,carbohydrate transport,2/173,159/18888,0.428807755395335,0.610109750606882,0.569643605676492,SLC2A4/SLC37A1,2
GO:0002820,negative regulation of adaptive immune response,1/173,61/18888,0.430038523243297,0.610109750606882,0.569643605676492,XCL1,1
GO:0006383,transcription by RNA polymerase III,1/173,61/18888,0.430038523243297,0.610109750606882,0.569643605676492,GTF3C1,1
GO:0008347,glial cell migration,1/173,61/18888,0.430038523243297,0.610109750606882,0.569643605676492,NTN1,1
GO:0032233,positive regulation of actin filament bundle assembly,1/173,61/18888,0.430038523243297,0.610109750606882,0.569643605676492,PXN,1
GO:0048010,vascular endothelial growth factor receptor signaling pathway,1/173,61/18888,0.430038523243297,0.610109750606882,0.569643605676492,PRKD2,1
GO:0050879,multicellular organismal movement,1/173,61/18888,0.430038523243297,0.610109750606882,0.569643605676492,KCNJ2,1
GO:0051785,positive regulation of nuclear division,1/173,61/18888,0.430038523243297,0.610109750606882,0.569643605676492,CDC16,1
GO:0055008,cardiac muscle tissue morphogenesis,1/173,61/18888,0.430038523243297,0.610109750606882,0.569643605676492,MYLK2,1
GO:0170035,L-amino acid catabolic process,1/173,61/18888,0.430038523243297,0.610109750606882,0.569643605676492,MAT1A,1
GO:0032259,methylation,3/173,262/18888,0.431414292860704,0.611724561738057,0.571151312829728,METTL2A/PRDM16/ZCCHC4,3
GO:0060041,retina development in camera-type eye,2/173,160/18888,0.431940159174939,0.612133136970539,0.571532788897582,MERTK/RPGRIP1,2
GO:0034612,response to tumor necrosis factor,3/173,263/18888,0.433834394736753,0.612478327323615,0.571855084152126,SLC2A4/XCL1/ZFP36L1,3
GO:0007605,sensory perception of sound,2/173,161/18888,0.435063482645161,0.612478327323615,0.571855084152126,COL2A1/SLITRK6,2
GO:1902600,proton transmembrane transport,2/173,161/18888,0.435063482645161,0.612478327323615,0.571855084152126,MTCO2P12/SLC11A1,2
GO:0000768,syncytium formation by plasma membrane fusion,1/173,62/18888,0.435275859806686,0.612478327323615,0.571855084152126,TMEM182,1
GO:0002763,positive regulation of myeloid leukocyte differentiation,1/173,62/18888,0.435275859806686,0.612478327323615,0.571855084152126,ZFP36L1,1
GO:0006767,water-soluble vitamin metabolic process,1/173,62/18888,0.435275859806686,0.612478327323615,0.571855084152126,MMAA,1
GO:0032731,positive regulation of interleukin-1 beta production,1/173,62/18888,0.435275859806686,0.612478327323615,0.571855084152126,PANX1,1
GO:0034113,heterotypic cell-cell adhesion,1/173,62/18888,0.435275859806686,0.612478327323615,0.571855084152126,CD200,1
GO:0042255,ribosome assembly,1/173,62/18888,0.435275859806686,0.612478327323615,0.571855084152126,EFL1,1
GO:0051306,mitotic sister chromatid separation,1/173,62/18888,0.435275859806686,0.612478327323615,0.571855084152126,CDC16,1
GO:0051653,spindle localization,1/173,62/18888,0.435275859806686,0.612478327323615,0.571855084152126,TLE6,1
GO:0072348,sulfur compound transport,1/173,62/18888,0.435275859806686,0.612478327323615,0.571855084152126,SLC22A1,1
GO:0140253,cell-cell fusion,1/173,62/18888,0.435275859806686,0.612478327323615,0.571855084152126,TMEM182,1
GO:0120254,olefinic compound metabolic process,2/173,162/18888,0.438177628944776,0.615548454544509,0.574721582086728,CEL/LRAT,2
GO:0002237,response to molecule of bacterial origin,4/173,369/18888,0.438398822875011,0.615548454544509,0.574721582086728,GFI1/NR1H3/SLC11A1/SPON2,4
GO:0014706,striated muscle tissue development,3/173,265/18888,0.4386633911263,0.615548454544509,0.574721582086728,MYLK2/SEMA3C/SHOX2,3
GO:0071216,cellular response to biotic stimulus,3/173,265/18888,0.4386633911263,0.615548454544509,0.574721582086728,GFI1/NR1H3/SPON2,3
GO:0009306,protein secretion,4/173,370/18888,0.440435047891172,0.615548454544509,0.574721582086728,CD200/NNAT/NR1H3/SNAP25,4
GO:0032535,regulation of cellular component size,4/173,370/18888,0.440435047891172,0.615548454544509,0.574721582086728,NTN1/SEMA3C/SEMA4C/SEMA5A,4
GO:0032757,positive regulation of interleukin-8 production,1/173,63/18888,0.440465346487523,0.615548454544509,0.574721582086728,PRKD2,1
GO:0051784,negative regulation of nuclear division,1/173,63/18888,0.440465346487523,0.615548454544509,0.574721582086728,FBXO43,1
GO:0051893,regulation of focal adhesion assembly,1/173,63/18888,0.440465346487523,0.615548454544509,0.574721582086728,MAP4K4,1
GO:0061951,establishment of protein localization to plasma membrane,1/173,63/18888,0.440465346487523,0.615548454544509,0.574721582086728,KIF13A,1
GO:0090109,regulation of cell-substrate junction assembly,1/173,63/18888,0.440465346487523,0.615548454544509,0.574721582086728,MAP4K4,1
GO:1904356,regulation of telomere maintenance via telomere lengthening,1/173,63/18888,0.440465346487523,0.615548454544509,0.574721582086728,TINF2,1
GO:0016072,rRNA metabolic process,3/173,266/18888,0.441072155450925,0.615548454544509,0.574721582086728,DDX49/GTF3C1/ZCCHC4,3
GO:0034250,positive regulation of amide metabolic process,2/173,163/18888,0.441282503723947,0.615548454544509,0.574721582086728,UPF3A/ZCCHC4,2
GO:0051017,actin filament bundle assembly,2/173,163/18888,0.441282503723947,0.615548454544509,0.574721582086728,ACTN1/PXN,2
GO:0170033,L-amino acid metabolic process,2/173,163/18888,0.441282503723947,0.615548454544509,0.574721582086728,MAT1A/SERINC3,2
GO:0035592,establishment of protein localization to extracellular region,4/173,371/18888,0.442469182783117,0.616571252654854,0.575676542080199,CD200/NNAT/NR1H3/SNAP25,4
GO:0070663,regulation of leukocyte proliferation,3/173,267/18888,0.443477011823679,0.616571252654854,0.575676542080199,CLCF1/FCGR3A/XCL1,3
GO:0019362,pyridine nucleotide metabolic process,2/173,164/18888,0.444378015106826,0.616571252654854,0.575676542080199,PC/PGD,2
GO:0046496,nicotinamide nucleotide metabolic process,2/173,164/18888,0.444378015106826,0.616571252654854,0.575676542080199,PC/PGD,2
GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,2/173,164/18888,0.444378015106826,0.616571252654854,0.575676542080199,CLCF1/IL6R,2
GO:0019674,NAD metabolic process,1/173,64/18888,0.445607417938129,0.616571252654854,0.575676542080199,PC,1
GO:0021545,cranial nerve development,1/173,64/18888,0.445607417938129,0.616571252654854,0.575676542080199,SLITRK6,1
GO:0030888,regulation of B cell proliferation,1/173,64/18888,0.445607417938129,0.616571252654854,0.575676542080199,CLCF1,1
GO:0034142,toll-like receptor 4 signaling pathway,1/173,64/18888,0.445607417938129,0.616571252654854,0.575676542080199,NR1H3,1
GO:0048247,lymphocyte chemotaxis,1/173,64/18888,0.445607417938129,0.616571252654854,0.575676542080199,XCL1,1
GO:0048278,vesicle docking,1/173,64/18888,0.445607417938129,0.616571252654854,0.575676542080199,SNAP25,1
GO:0062208,positive regulation of pattern recognition receptor signaling pathway,1/173,64/18888,0.445607417938129,0.616571252654854,0.575676542080199,NR1H3,1
GO:0071384,cellular response to corticosteroid stimulus,1/173,64/18888,0.445607417938129,0.616571252654854,0.575676542080199,ZFP36L1,1
GO:2000179,positive regulation of neural precursor cell proliferation,1/173,64/18888,0.445607417938129,0.616571252654854,0.575676542080199,GJC2,1
GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,1/173,64/18888,0.445607417938129,0.616571252654854,0.575676542080199,SERINC3,1
GO:0090287,regulation of cellular response to growth factor stimulus,4/173,373/18888,0.446531008028939,0.616990404082977,0.576067892866845,PRDM16/PRKD2/SMOC2/TNFAIP6,4
GO:0035051,cardiocyte differentiation,2/173,165/18888,0.447464073654629,0.616990404082977,0.576067892866845,SEMA3C/SHOX2,2
GO:0050905,neuromuscular process,2/173,165/18888,0.447464073654629,0.616990404082977,0.576067892866845,KCNJ2/SLITRK6,2
GO:0051250,negative regulation of lymphocyte activation,2/173,165/18888,0.447464073654629,0.616990404082977,0.576067892866845,MERTK/XCL1,2
GO:0018108,peptidyl-tyrosine phosphorylation,3/173,269/18888,0.448274749677822,0.616990404082977,0.576067892866845,CLCF1/IL6R/SRMS,3
GO:0034976,response to endoplasmic reticulum stress,3/173,269/18888,0.448274749677822,0.616990404082977,0.576067892866845,FBXO2/NR1H3/SERINC3,3
GO:0048762,mesenchymal cell differentiation,3/173,269/18888,0.448274749677822,0.616990404082977,0.576067892866845,SEMA3C/SEMA4C/SEMA5A,3
GO:0001678,intracellular glucose homeostasis,2/173,166/18888,0.450540592329165,0.616990404082977,0.576067892866845,NME2/NPTX1,2
GO:0062207,regulation of pattern recognition receptor signaling pathway,2/173,166/18888,0.450540592329165,0.616990404082977,0.576067892866845,GFI1/NR1H3,2
GO:0002931,response to ischemia,1/173,65/18888,0.450702504885468,0.616990404082977,0.576067892866845,PANX1,1
GO:0010324,membrane invagination,1/173,65/18888,0.450702504885468,0.616990404082977,0.576067892866845,MSR1,1
GO:0010573,vascular endothelial growth factor production,1/173,65/18888,0.450702504885468,0.616990404082977,0.576067892866845,IL6R,1
GO:0010812,negative regulation of cell-substrate adhesion,1/173,65/18888,0.450702504885468,0.616990404082977,0.576067892866845,MAP4K4,1
GO:0032613,interleukin-10 production,1/173,65/18888,0.450702504885468,0.616990404082977,0.576067892866845,XCL1,1
GO:0032653,regulation of interleukin-10 production,1/173,65/18888,0.450702504885468,0.616990404082977,0.576067892866845,XCL1,1
GO:0033363,secretory granule organization,1/173,65/18888,0.450702504885468,0.616990404082977,0.576067892866845,NECTIN2,1
GO:0043903,regulation of biological process involved in symbiotic interaction,1/173,65/18888,0.450702504885468,0.616990404082977,0.576067892866845,NECTIN2,1
GO:0060113,inner ear receptor cell differentiation,1/173,65/18888,0.450702504885468,0.616990404082977,0.576067892866845,SLITRK6,1
GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,1/173,65/18888,0.450702504885468,0.616990404082977,0.576067892866845,SERINC3,1
GO:0090303,positive regulation of wound healing,1/173,65/18888,0.450702504885468,0.616990404082977,0.576067892866845,SMOC2,1
GO:0051347,positive regulation of transferase activity,4/173,376/18888,0.452606991486073,0.618639384806777,0.577607503279992,CD200/IL6R/MERTK/SLC11A1,4
GO:0015833,peptide transport,3/173,271/18888,0.45305611101473,0.618639384806777,0.577607503279992,NNAT/SLC16A2/SNAP25,3
GO:0018212,peptidyl-tyrosine modification,3/173,271/18888,0.45305611101473,0.618639384806777,0.577607503279992,CLCF1/IL6R/SRMS,3
GO:0050796,regulation of insulin secretion,2/173,167/18888,0.453607486456832,0.618639384806777,0.577607503279992,NNAT/SNAP25,2
GO:0061572,actin filament bundle organization,2/173,167/18888,0.453607486456832,0.618639384806777,0.577607503279992,ACTN1/PXN,2
GO:1903829,positive regulation of protein localization,5/173,483/18888,0.454799540769122,0.618639384806777,0.577607503279992,MFF/MIEF2/NNAT/SNAP25/TNFAIP6,5
GO:0001756,somitogenesis,1/173,66/18888,0.455751034166391,0.618639384806777,0.577607503279992,SEMA3C,1
GO:0006949,syncytium formation,1/173,66/18888,0.455751034166391,0.618639384806777,0.577607503279992,TMEM182,1
GO:0015909,long-chain fatty acid transport,1/173,66/18888,0.455751034166391,0.618639384806777,0.577607503279992,ACSL5,1
GO:0017156,calcium-ion regulated exocytosis,1/173,66/18888,0.455751034166391,0.618639384806777,0.577607503279992,SNAP25,1
GO:0030199,collagen fibril organization,1/173,66/18888,0.455751034166391,0.618639384806777,0.577607503279992,COL2A1,1
GO:0046530,photoreceptor cell differentiation,1/173,66/18888,0.455751034166391,0.618639384806777,0.577607503279992,RPGRIP1,1
GO:0046854,phosphatidylinositol phosphate biosynthetic process,1/173,66/18888,0.455751034166391,0.618639384806777,0.577607503279992,EFR3B,1
GO:0048255,mRNA stabilization,1/173,66/18888,0.455751034166391,0.618639384806777,0.577607503279992,SLC11A1,1
GO:0060042,retina morphogenesis in camera-type eye,1/173,66/18888,0.455751034166391,0.618639384806777,0.577607503279992,RPGRIP1,1
GO:1905515,non-motile cilium assembly,1/173,66/18888,0.455751034166391,0.618639384806777,0.577607503279992,RPGRIP1,1
GO:0003205,cardiac chamber development,2/173,168/18888,0.456664673693057,0.619226716566415,0.578155879667937,SEMA3C/SHOX2,2
GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2/173,168/18888,0.456664673693057,0.619226716566415,0.578155879667937,NECTIN2/PCDHGB6,2
GO:1901136,carbohydrate derivative catabolic process,3/173,273/18888,0.457820615498935,0.620467413110398,0.579314285761533,APOBEC3D/APOBEC3H/FBXO2,3
GO:0045785,positive regulation of cell adhesion,5/173,485/18888,0.458364835734375,0.620523053903561,0.579366236122936,CDK6/FLOT2/MAP4K4/PRKD2/XCL1,5
GO:0071692,protein localization to extracellular region,4/173,379/18888,0.458661861396487,0.620523053903561,0.579366236122936,CD200/NNAT/NR1H3/SNAP25,4
GO:0007204,positive regulation of cytosolic calcium ion concentration,2/173,169/18888,0.459712073987184,0.620523053903561,0.579366236122936,ACKR4/OXTR,2
GO:0048639,positive regulation of developmental growth,2/173,169/18888,0.459712073987184,0.620523053903561,0.579366236122936,NTN1/SEMA5A,2
GO:0000288,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",1/173,67/18888,0.460753428762566,0.620523053903561,0.579366236122936,ZFP36L1,1
GO:0006903,vesicle targeting,1/173,67/18888,0.460753428762566,0.620523053903561,0.579366236122936,CEP19,1
GO:0008652,amino acid biosynthetic process,1/173,67/18888,0.460753428762566,0.620523053903561,0.579366236122936,SERINC3,1
GO:0009620,response to fungus,1/173,67/18888,0.460753428762566,0.620523053903561,0.579366236122936,SPON2,1
GO:0060760,positive regulation of response to cytokine stimulus,1/173,67/18888,0.460753428762566,0.620523053903561,0.579366236122936,GFI1,1
GO:0061180,mammary gland epithelium development,1/173,67/18888,0.460753428762566,0.620523053903561,0.579366236122936,NTN1,1
GO:0070301,cellular response to hydrogen peroxide,1/173,67/18888,0.460753428762566,0.620523053903561,0.579366236122936,RHOB,1
GO:1905953,negative regulation of lipid localization,1/173,67/18888,0.460753428762566,0.620523053903561,0.579366236122936,NR1H3,1
GO:0001818,negative regulation of cytokine production,4/173,381/18888,0.462686164172569,0.621438498643535,0.580220963066667,CD200/MERTK/SLC11A1/XCL1,4
GO:0030336,negative regulation of cell migration,4/173,381/18888,0.462686164172569,0.621438498643535,0.580220963066667,CD200/RHOB/TNFAIP6/ZMYND8,4
GO:0051090,regulation of DNA-binding transcription factor activity,4/173,381/18888,0.462686164172569,0.621438498643535,0.580220963066667,CD200/GFI1/PRKD2/XCL1,4
GO:0072524,pyridine-containing compound metabolic process,2/173,170/18888,0.462749609547812,0.621438498643535,0.580220963066667,PC/PGD,2
GO:0002704,negative regulation of leukocyte mediated immunity,1/173,68/18888,0.465710107835096,0.621438498643535,0.580220963066667,XCL1,1
GO:0006303,double-strand break repair via nonhomologous end joining,1/173,68/18888,0.465710107835096,0.621438498643535,0.580220963066667,TFIP11,1
GO:0006687,glycosphingolipid metabolic process,1/173,68/18888,0.465710107835096,0.621438498643535,0.580220963066667,B4GALT4,1
GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,1/173,68/18888,0.465710107835096,0.621438498643535,0.580220963066667,BCL2L10,1
GO:0010972,negative regulation of G2/M transition of mitotic cell cycle,1/173,68/18888,0.465710107835096,0.621438498643535,0.580220963066667,CHFR,1
GO:0032715,negative regulation of interleukin-6 production,1/173,68/18888,0.465710107835096,0.621438498643535,0.580220963066667,CD200,1
GO:0035019,somatic stem cell population maintenance,1/173,68/18888,0.465710107835096,0.621438498643535,0.580220963066667,CUL4A,1
GO:0042987,amyloid precursor protein catabolic process,1/173,68/18888,0.465710107835096,0.621438498643535,0.580220963066667,FLOT2,1
GO:0046847,filopodium assembly,1/173,68/18888,0.465710107835096,0.621438498643535,0.580220963066667,ZMYND8,1
GO:0051055,negative regulation of lipid biosynthetic process,1/173,68/18888,0.465710107835096,0.621438498643535,0.580220963066667,GFI1,1
GO:0150116,regulation of cell-substrate junction organization,1/173,68/18888,0.465710107835096,0.621438498643535,0.580220963066667,MAP4K4,1
GO:1902808,positive regulation of cell cycle G1/S phase transition,1/173,68/18888,0.465710107835096,0.621438498643535,0.580220963066667,CUL4A,1
GO:0007034,vacuolar transport,2/173,171/18888,0.465777204808552,0.621438498643535,0.580220963066667,KIF13A/RHOB,2
GO:0030856,regulation of epithelial cell differentiation,2/173,171/18888,0.465777204808552,0.621438498643535,0.580220963066667,NME2/ZFP36L1,2
GO:0009266,response to temperature stimulus,2/173,172/18888,0.468794786394237,0.624774463448975,0.583335666639738,CRYAB/MMP24,2
GO:0010970,transport along microtubule,2/173,172/18888,0.468794786394237,0.624774463448975,0.583335666639738,FLOT2/KIF13A,2
GO:0002758,innate immune response-activating signaling pathway,3/173,278/18888,0.469655094473323,0.624774463448975,0.583335666639738,COLEC11/GFI1/NR1H3,3
GO:0042113,B cell activation,3/173,278/18888,0.469655094473323,0.624774463448975,0.583335666639738,CLCF1/SANBR/ZFP36L1,3
GO:0006414,translational elongation,1/173,69/18888,0.470621486758822,0.624774463448975,0.583335666639738,EFL1,1
GO:0019229,regulation of vasoconstriction,1/173,69/18888,0.470621486758822,0.624774463448975,0.583335666639738,OXTR,1
GO:0045911,positive regulation of DNA recombination,1/173,69/18888,0.470621486758822,0.624774463448975,0.583335666639738,CLCF1,1
GO:0060191,regulation of lipase activity,1/173,69/18888,0.470621486758822,0.624774463448975,0.583335666639738,NR1H3,1
GO:1901607,alpha-amino acid biosynthetic process,1/173,69/18888,0.470621486758822,0.624774463448975,0.583335666639738,SERINC3,1
GO:0032970,regulation of actin filament-based process,4/173,385/18888,0.47070386760816,0.624774463448975,0.583335666639738,KCNJ2/MYLK2/PXN/SEMA5A,4
GO:0050680,negative regulation of epithelial cell proliferation,2/173,173/18888,0.471802283087539,0.625587476287545,0.584094755581299,CDK6/TINF2,2
GO:0051048,negative regulation of secretion,2/173,173/18888,0.471802283087539,0.625587476287545,0.584094755581299,CD200/NR1H3,2
GO:0007259,receptor signaling pathway via JAK-STAT,2/173,174/18888,0.474799625796018,0.629237795380723,0.587502963576729,CLCF1/IL6R,2
GO:0042490,mechanoreceptor differentiation,1/173,70/18888,0.475487977156331,0.629502077726248,0.587749717128973,SLITRK6,1
GO:0050918,positive chemotaxis,1/173,70/18888,0.475487977156331,0.629502077726248,0.587749717128973,SEMA5A,1
GO:0141091,transforming growth factor beta receptor superfamily signaling pathway,4/173,388/18888,0.476688884344928,0.630767665564331,0.588931363576467,LPXN/PRDM16/PXN/TNFAIP6,4
GO:1902905,positive regulation of supramolecular fiber organization,2/173,175/18888,0.477786747519589,0.6318956727596,0.589984554556127,PXN/SEMA5A,2
GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,4/173,389/18888,0.478678305127424,0.631986824910066,0.590069660948223,CDC16/CHFR/CUL4A/FBXO2,4
GO:0003208,cardiac ventricle morphogenesis,1/173,71/18888,0.48030998693165,0.631986824910066,0.590069660948223,SEMA3C,1
GO:0007004,telomere maintenance via telomerase,1/173,71/18888,0.48030998693165,0.631986824910066,0.590069660948223,TINF2,1
GO:0032091,negative regulation of protein binding,1/173,71/18888,0.48030998693165,0.631986824910066,0.590069660948223,TFIP11,1
GO:0032206,positive regulation of telomere maintenance,1/173,71/18888,0.48030998693165,0.631986824910066,0.590069660948223,TINF2,1
GO:0032835,glomerulus development,1/173,71/18888,0.48030998693165,0.631986824910066,0.590069660948223,IL6R,1
GO:0045600,positive regulation of fat cell differentiation,1/173,71/18888,0.48030998693165,0.631986824910066,0.590069660948223,ZFP36L1,1
GO:0045670,regulation of osteoclast differentiation,1/173,71/18888,0.48030998693165,0.631986824910066,0.590069660948223,TNFAIP6,1
GO:0048488,synaptic vesicle endocytosis,1/173,71/18888,0.48030998693165,0.631986824910066,0.590069660948223,SLC2A4,1
GO:0071677,positive regulation of mononuclear cell migration,1/173,71/18888,0.48030998693165,0.631986824910066,0.590069660948223,XCL1,1
GO:0000724,double-strand break repair via homologous recombination,2/173,176/18888,0.480763583318394,0.632260585824751,0.590325264393963,ZMYND8/ZNF365,2
GO:0001959,regulation of cytokine-mediated signaling pathway,2/173,177/18888,0.483730070281087,0.633097513827616,0.591106682302412,GFI1/NR1H3,2
GO:0002067,glandular epithelial cell differentiation,1/173,72/18888,0.485087920303645,0.633097513827616,0.591106682302412,CDK6,1
GO:0006024,glycosaminoglycan biosynthetic process,1/173,72/18888,0.485087920303645,0.633097513827616,0.591106682302412,B4GALT4,1
GO:0010569,regulation of double-strand break repair via homologous recombination,1/173,72/18888,0.485087920303645,0.633097513827616,0.591106682302412,ZNF365,1
GO:0030514,negative regulation of BMP signaling pathway,1/173,72/18888,0.485087920303645,0.633097513827616,0.591106682302412,TNFAIP6,1
GO:0032008,positive regulation of TOR signaling,1/173,72/18888,0.485087920303645,0.633097513827616,0.591106682302412,SRMS,1
GO:0032722,positive regulation of chemokine production,1/173,72/18888,0.485087920303645,0.633097513827616,0.591106682302412,IL6R,1
GO:0043954,cellular component maintenance,1/173,72/18888,0.485087920303645,0.633097513827616,0.591106682302412,ZMYND8,1
GO:0048002,antigen processing and presentation of peptide antigen,1/173,72/18888,0.485087920303645,0.633097513827616,0.591106682302412,SLC11A1,1
GO:0051341,regulation of oxidoreductase activity,1/173,72/18888,0.485087920303645,0.633097513827616,0.591106682302412,GFI1,1
GO:0060411,cardiac septum morphogenesis,1/173,72/18888,0.485087920303645,0.633097513827616,0.591106682302412,SEMA3C,1
GO:0061035,regulation of cartilage development,1/173,72/18888,0.485087920303645,0.633097513827616,0.591106682302412,SHOX2,1
GO:0140238,presynaptic endocytosis,1/173,72/18888,0.485087920303645,0.633097513827616,0.591106682302412,SLC2A4,1
GO:0140895,cell surface toll-like receptor signaling pathway,1/173,72/18888,0.485087920303645,0.633097513827616,0.591106682302412,NR1H3,1
GO:1904888,cranial skeletal system development,1/173,72/18888,0.485087920303645,0.633097513827616,0.591106682302412,CPLANE2,1
GO:0043487,regulation of RNA stability,3/173,285/18888,0.486028394289337,0.634003604506101,0.591952675602222,DDX49/SLC11A1/ZFP36L1,3
GO:0003170,heart valve development,1/173,73/18888,0.489822177839118,0.635411641277446,0.593267322913719,SHOX2,1
GO:0006360,transcription by RNA polymerase I,1/173,73/18888,0.489822177839118,0.635411641277446,0.593267322913719,RRN3,1
GO:0006879,intracellular iron ion homeostasis,1/173,73/18888,0.489822177839118,0.635411641277446,0.593267322913719,SLC11A1,1
GO:0019226,transmission of nerve impulse,1/173,73/18888,0.489822177839118,0.635411641277446,0.593267322913719,SCN4B,1
GO:0030858,positive regulation of epithelial cell differentiation,1/173,73/18888,0.489822177839118,0.635411641277446,0.593267322913719,NME2,1
GO:0032732,positive regulation of interleukin-1 production,1/173,73/18888,0.489822177839118,0.635411641277446,0.593267322913719,PANX1,1
GO:0042130,negative regulation of T cell proliferation,1/173,73/18888,0.489822177839118,0.635411641277446,0.593267322913719,XCL1,1
GO:0045109,intermediate filament organization,1/173,73/18888,0.489822177839118,0.635411641277446,0.593267322913719,KRT86,1
GO:0046635,positive regulation of alpha-beta T cell activation,1/173,73/18888,0.489822177839118,0.635411641277446,0.593267322913719,XCL1,1
GO:0071260,cellular response to mechanical stimulus,1/173,73/18888,0.489822177839118,0.635411641277446,0.593267322913719,KCNJ2,1
GO:0140962,multicellular organismal-level chemical homeostasis,1/173,73/18888,0.489822177839118,0.635411641277446,0.593267322913719,SLC11A1,1
GO:0050900,leukocyte migration,4/173,396/18888,0.492522323649714,0.63725051605362,0.594984232464576,CD200/IL6R/TNFAIP6/XCL1,4
GO:2000146,negative regulation of cell motility,4/173,396/18888,0.492522323649714,0.63725051605362,0.594984232464576,CD200/RHOB/TNFAIP6/ZMYND8,4
GO:2001233,regulation of apoptotic signaling pathway,4/173,396/18888,0.492522323649714,0.63725051605362,0.594984232464576,BCL2L14/COL2A1/RRN3/SERINC3,4
GO:0071772,response to BMP,2/173,180/18888,0.492566838811862,0.63725051605362,0.594984232464576,COL2A1/TNFAIP6,2
GO:0071773,cellular response to BMP stimulus,2/173,180/18888,0.492566838811862,0.63725051605362,0.594984232464576,COL2A1/TNFAIP6,2
GO:0061448,connective tissue development,3/173,288/18888,0.492972049700509,0.63725051605362,0.594984232464576,COL2A1/IL6R/SHOX2,3
GO:1903532,positive regulation of secretion by cell,3/173,288/18888,0.492972049700509,0.63725051605362,0.594984232464576,NNAT/OXTR/SNAP25,3
GO:0033344,cholesterol efflux,1/173,74/18888,0.494513156485615,0.638601493455596,0.596245604926962,NR1H3,1
GO:0051881,regulation of mitochondrial membrane potential,1/173,74/18888,0.494513156485615,0.638601493455596,0.596245604926962,MLLT11,1
GO:0000725,recombinational repair,2/173,181/18888,0.495491340799168,0.638903456463624,0.596527539933743,ZMYND8/ZNF365,2
GO:0001936,regulation of endothelial cell proliferation,2/173,181/18888,0.495491340799168,0.638903456463624,0.596527539933743,PRKD2/SEMA5A,2
GO:0043414,macromolecule methylation,2/173,181/18888,0.495491340799168,0.638903456463624,0.596527539933743,METTL2A/ZCCHC4,2
GO:0006979,response to oxidative stress,4/173,398/18888,0.496450367374127,0.63981966766185,0.597382982499607,CRYAB/NME2/PXN/RHOB,4
GO:0061013,regulation of mRNA catabolic process,3/173,290/18888,0.497575703547206,0.640949192913485,0.598437590849014,SLC11A1/UPF3A/ZFP36L1,3
GO:0019827,stem cell population maintenance,2/173,182/18888,0.498405208739109,0.641376018242482,0.598836106557313,CUL4A/MMP24,2
GO:0035725,sodium ion transmembrane transport,2/173,182/18888,0.498405208739109,0.641376018242482,0.598836106557313,SCN4B/SLC6A12,2
GO:0043489,RNA stabilization,1/173,75/18888,0.499161249603931,0.641707547543745,0.599145646843092,SLC11A1,1
GO:0045806,negative regulation of endocytosis,1/173,75/18888,0.499161249603931,0.641707547543745,0.599145646843092,NR1H3,1
GO:0031348,negative regulation of defense response,3/173,291/18888,0.49986975906953,0.642297719363293,0.599696674921109,CD200/NR1H3/TNFAIP6,3
GO:0001764,neuron migration,2/173,183/18888,0.50130839124756,0.643824991253101,0.601122648961505,DNER/NTN1,2
GO:0002224,toll-like receptor signaling pathway,1/173,76/18888,0.503766847000333,0.645372950759133,0.602567938491103,GFI1,1
GO:0006023,aminoglycan biosynthetic process,1/173,76/18888,0.503766847000333,0.645372950759133,0.602567938491103,B4GALT4,1
GO:0008088,axo-dendritic transport,1/173,76/18888,0.503766847000333,0.645372950759133,0.602567938491103,FLOT2,1
GO:0046470,phosphatidylcholine metabolic process,1/173,76/18888,0.503766847000333,0.645372950759133,0.602567938491103,NR1H3,1
GO:0051057,positive regulation of small GTPase mediated signal transduction,1/173,76/18888,0.503766847000333,0.645372950759133,0.602567938491103,MAP4K4,1
GO:0051495,positive regulation of cytoskeleton organization,2/173,184/18888,0.5042008387579,0.64559563923074,0.602775856925094,PXN/SEMA5A,2
GO:0072659,protein localization to plasma membrane,3/173,293/18888,0.504442107235825,0.64559563923074,0.602775856925094,EFR3B/FLOT2/KIF13A,3
GO:0006694,steroid biosynthetic process,2/173,185/18888,0.50708250349239,0.647354407773553,0.604417973369359,GFI1/HSD17B11,2
GO:0050954,sensory perception of mechanical stimulus,2/173,185/18888,0.50708250349239,0.647354407773553,0.604417973369359,COL2A1/SLITRK6,2
GO:2000045,regulation of G1/S transition of mitotic cell cycle,2/173,185/18888,0.50708250349239,0.647354407773553,0.604417973369359,CUL4A/GJC2,2
GO:0006401,RNA catabolic process,4/173,404/18888,0.508157409525748,0.647354407773553,0.604417973369359,DDX49/SLC11A1/UPF3A/ZFP36L1,4
GO:0030239,myofibril assembly,1/173,77/18888,0.508330334958495,0.647354407773553,0.604417973369359,MYOM2,1
GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,1/173,77/18888,0.508330334958495,0.647354407773553,0.604417973369359,CHFR,1
GO:0032890,regulation of organic acid transport,1/173,77/18888,0.508330334958495,0.647354407773553,0.604417973369359,ACSL5,1
GO:0035914,skeletal muscle cell differentiation,1/173,77/18888,0.508330334958495,0.647354407773553,0.604417973369359,MYLK2,1
GO:0043536,positive regulation of blood vessel endothelial cell migration,1/173,77/18888,0.508330334958495,0.647354407773553,0.604417973369359,PRKD2,1
GO:1901568,fatty acid derivative metabolic process,1/173,77/18888,0.508330334958495,0.647354407773553,0.604417973369359,ACSL5,1
GO:0006520,amino acid metabolic process,3/173,295/18888,0.508993153288606,0.647878086860188,0.604906918912078,MAT1A/SERINC3/SLC16A2,3
GO:0098727,maintenance of cell number,2/173,186/18888,0.509953339433909,0.648779569684939,0.605748609978702,CUL4A/MMP24,2
GO:0046890,regulation of lipid biosynthetic process,2/173,187/18888,0.512813302298065,0.650859609609752,0.607690689156331,GFI1/NR1H3,2
GO:0006278,RNA-templated DNA biosynthetic process,1/173,78/18888,0.512852096271141,0.650859609609752,0.607690689156331,TINF2,1
GO:0009247,glycolipid biosynthetic process,1/173,78/18888,0.512852096271141,0.650859609609752,0.607690689156331,B4GALT4,1
GO:0046323,glucose import,1/173,78/18888,0.512852096271141,0.650859609609752,0.607690689156331,SLC2A4,1
GO:2000514,"regulation of CD4-positive, alpha-beta T cell activation",1/173,78/18888,0.512852096271141,0.650859609609752,0.607690689156331,XCL1,1
GO:0017157,regulation of exocytosis,2/173,188/18888,0.515662349505653,0.653929628019416,0.610557085496718,CPLANE2/SEPTIN1,2
GO:0043087,regulation of GTPase activity,3/173,298/18888,0.515779058061139,0.653929628019416,0.610557085496718,MAP4K4/RGL4/XCL1,3
GO:0042246,tissue regeneration,1/173,79/18888,0.517332510271411,0.654609933144415,0.611192268697739,TMEM182,1
GO:0043299,leukocyte degranulation,1/173,79/18888,0.517332510271411,0.654609933144415,0.611192268697739,FCGR3A,1
GO:0055002,striated muscle cell development,1/173,79/18888,0.517332510271411,0.654609933144415,0.611192268697739,MYOM2,1
GO:0070227,lymphocyte apoptotic process,1/173,79/18888,0.517332510271411,0.654609933144415,0.611192268697739,PRKD2,1
GO:0006352,DNA-templated transcription initiation,2/173,189/18888,0.518500440155477,0.654800702991835,0.611370385542505,GTF3C1/RRN3,2
GO:0032640,tumor necrosis factor production,2/173,189/18888,0.518500440155477,0.654800702991835,0.611370385542505,FCGR3A/SPON2,2
GO:0032680,regulation of tumor necrosis factor production,2/173,189/18888,0.518500440155477,0.654800702991835,0.611370385542505,FCGR3A/SPON2,2
GO:0060759,regulation of response to cytokine stimulus,2/173,189/18888,0.518500440155477,0.654800702991835,0.611370385542505,GFI1/NR1H3,2
GO:2001242,regulation of intrinsic apoptotic signaling pathway,2/173,190/18888,0.521327534997512,0.657642084495678,0.614023309550589,RRN3/SERINC3,2
GO:0021536,diencephalon development,1/173,80/18888,0.521771952863949,0.657642084495678,0.614023309550589,SEMA5A,1
GO:0051966,"regulation of synaptic transmission, glutamatergic",1/173,80/18888,0.521771952863949,0.657642084495678,0.614023309550589,OXTR,1
GO:1903036,positive regulation of response to wounding,1/173,80/18888,0.521771952863949,0.657642084495678,0.614023309550589,SMOC2,1
GO:0000075,cell cycle checkpoint signaling,2/173,191/18888,0.52414359640642,0.659985213078988,0.616211027765931,CHFR/CUL4A,2
GO:0097696,receptor signaling pathway via STAT,2/173,191/18888,0.52414359640642,0.659985213078988,0.616211027765931,CLCF1/IL6R,2
GO:0140694,non-membrane-bounded organelle assembly,4/173,413/18888,0.525489091058619,0.660921854210215,0.617085545228873,EFL1/MYOM2/PSPC1/SEPTIN1,4
GO:0003151,outflow tract morphogenesis,1/173,81/18888,0.526170796555705,0.660921854210215,0.617085545228873,SEMA3C,1
GO:0008344,adult locomotory behavior,1/173,81/18888,0.526170796555705,0.660921854210215,0.617085545228873,SLITRK6,1
GO:0019233,sensory perception of pain,1/173,81/18888,0.526170796555705,0.660921854210215,0.617085545228873,MMP24,1
GO:0050810,regulation of steroid biosynthetic process,1/173,81/18888,0.526170796555705,0.660921854210215,0.617085545228873,GFI1,1
GO:0006006,glucose metabolic process,2/173,192/18888,0.526948588355405,0.661290428803895,0.617429673740663,GALM/PC,2
GO:0033674,positive regulation of kinase activity,3/173,303/18888,0.526977848507026,0.661290428803895,0.617429673740663,IL6R/MERTK/SLC11A1,3
GO:0003407,neural retina development,1/173,82/18888,0.530529410486468,0.663806235181076,0.619778616720931,RPGRIP1,1
GO:0036465,synaptic vesicle recycling,1/173,82/18888,0.530529410486468,0.663806235181076,0.619778616720931,SLC2A4,1
GO:0070897,transcription preinitiation complex assembly,1/173,82/18888,0.530529410486468,0.663806235181076,0.619778616720931,RRN3,1
GO:0140029,exocytic process,1/173,82/18888,0.530529410486468,0.663806235181076,0.619778616720931,SNAP25,1
GO:0140056,organelle localization by membrane tethering,1/173,82/18888,0.530529410486468,0.663806235181076,0.619778616720931,SNAP25,1
GO:2000142,regulation of DNA-templated transcription initiation,1/173,82/18888,0.530529410486468,0.663806235181076,0.619778616720931,RRN3,1
GO:0050777,negative regulation of immune response,2/173,194/18888,0.532525227604618,0.664367589571758,0.620302738715134,NR1H3/XCL1,2
GO:0071466,cellular response to xenobiotic stimulus,2/173,194/18888,0.532525227604618,0.664367589571758,0.620302738715134,ABCC2/SLC22A1,2
GO:0071706,tumor necrosis factor superfamily cytokine production,2/173,194/18888,0.532525227604618,0.664367589571758,0.620302738715134,FCGR3A/SPON2,2
GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,2/173,194/18888,0.532525227604618,0.664367589571758,0.620302738715134,FCGR3A/SPON2,2
GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,4/173,417/18888,0.533099012918998,0.664367589571758,0.620302738715134,LPXN/PRDM16/PXN/TNFAIP6,4
GO:0001570,vasculogenesis,1/173,83/18888,0.534848160459128,0.664367589571758,0.620302738715134,ZFP36L1,1
GO:0006289,nucleotide-excision repair,1/173,83/18888,0.534848160459128,0.664367589571758,0.620302738715134,CUL4A,1
GO:0010833,telomere maintenance via telomere lengthening,1/173,83/18888,0.534848160459128,0.664367589571758,0.620302738715134,TINF2,1
GO:0031424,keratinization,1/173,83/18888,0.534848160459128,0.664367589571758,0.620302738715134,KRT86,1
GO:0032371,regulation of sterol transport,1/173,83/18888,0.534848160459128,0.664367589571758,0.620302738715134,NR1H3,1
GO:0032374,regulation of cholesterol transport,1/173,83/18888,0.534848160459128,0.664367589571758,0.620302738715134,NR1H3,1
GO:0050871,positive regulation of B cell activation,1/173,83/18888,0.534848160459128,0.664367589571758,0.620302738715134,CLCF1,1
GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,1/173,83/18888,0.534848160459128,0.664367589571758,0.620302738715134,RRN3,1
GO:0150076,neuroinflammatory response,1/173,83/18888,0.534848160459128,0.664367589571758,0.620302738715134,CD200,1
GO:2000736,regulation of stem cell differentiation,1/173,83/18888,0.534848160459128,0.664367589571758,0.620302738715134,CDK6,1
GO:0002028,regulation of sodium ion transport,1/173,84/18888,0.539127408969661,0.669037627998495,0.624663032130225,SCN4B,1
GO:0002437,inflammatory response to antigenic stimulus,1/173,84/18888,0.539127408969661,0.669037627998495,0.624663032130225,FCGR3A,1
GO:0002520,immune system development,2/173,197/18888,0.540806353937709,0.670474897154358,0.626004972958836,CLCF1/SANBR,2
GO:0090276,regulation of peptide hormone secretion,2/173,197/18888,0.540806353937709,0.670474897154358,0.626004972958836,NNAT/SNAP25,2
GO:0051149,positive regulation of muscle cell differentiation,1/173,85/18888,0.543367515236851,0.671928212480767,0.627361895679539,SHOX2,1
GO:0051591,response to cAMP,1/173,85/18888,0.543367515236851,0.671928212480767,0.627361895679539,ZFP36L1,1
GO:0061053,somite development,1/173,85/18888,0.543367515236851,0.671928212480767,0.627361895679539,SEMA3C,1
GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,1/173,85/18888,0.543367515236851,0.671928212480767,0.627361895679539,GJC2,1
GO:0031396,regulation of protein ubiquitination,2/173,198/18888,0.543544258872791,0.671928212480767,0.627361895679539,CHFR/FBXO2,2
GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,2/173,198/18888,0.543544258872791,0.671928212480767,0.627361895679539,PRDM16/TNFAIP6,2
GO:0007059,chromosome segregation,4/173,423/18888,0.54440131328202,0.672261603554221,0.627673174253588,CDC16/CENPM/CHFR/SEPTIN1,4
GO:0046879,hormone secretion,3/173,311/18888,0.544597166995769,0.672261603554221,0.627673174253588,NNAT/SLC16A2/SNAP25,3
GO:0071375,cellular response to peptide hormone stimulus,3/173,311/18888,0.544597166995769,0.672261603554221,0.627673174253588,PXN/SLC2A4/ZFP36L1,3
GO:0099504,synaptic vesicle cycle,2/173,199/18888,0.54627088479332,0.673978244146803,0.629275956926438,SLC2A4/SNAP25,2
GO:0042886,amide transport,3/173,312/18888,0.546773029911717,0.673978244146803,0.629275956926438,NNAT/SLC16A2/SNAP25,3
GO:0051047,positive regulation of secretion,3/173,312/18888,0.546773029911717,0.673978244146803,0.629275956926438,NNAT/OXTR/SNAP25,3
GO:0006900,vesicle budding from membrane,1/173,86/18888,0.547568835231747,0.674313606275346,0.629589075823358,SLC2A4,1
GO:0034243,regulation of transcription elongation by RNA polymerase II,1/173,86/18888,0.547568835231747,0.674313606275346,0.629589075823358,ZMYND8,1
GO:0050727,regulation of inflammatory response,4/173,425/18888,0.548137903608041,0.674691731257508,0.629942121284475,CD200/NR1H3/TNFAIP6/XCL1,4
GO:0002791,regulation of peptide secretion,2/173,200/18888,0.548986207559338,0.674768250341429,0.630013565162933,NNAT/SNAP25,2
GO:0030073,insulin secretion,2/173,200/18888,0.548986207559338,0.674768250341429,0.630013565162933,NNAT/SNAP25,2
GO:0030705,cytoskeleton-dependent intracellular transport,2/173,200/18888,0.548986207559338,0.674768250341429,0.630013565162933,FLOT2/KIF13A,2
GO:0055013,cardiac muscle cell development,1/173,87/18888,0.551731721706851,0.677173109339915,0.632258919461366,SHOX2,1
GO:0071277,cellular response to calcium ion,1/173,87/18888,0.551731721706851,0.677173109339915,0.632258919461366,RYR3,1
GO:1901879,regulation of protein depolymerization,1/173,87/18888,0.551731721706851,0.677173109339915,0.632258919461366,SEMA5A,1
GO:0016032,viral process,4/173,428/18888,0.553713202895549,0.678677358880754,0.633663398133324,APOBEC3D/APOBEC3H/NECTIN2/PC,4
GO:0001935,endothelial cell proliferation,2/173,202/18888,0.554382853934963,0.678677358880754,0.633663398133324,PRKD2/SEMA5A,2
GO:0006399,tRNA metabolic process,2/173,202/18888,0.554382853934963,0.678677358880754,0.633663398133324,GTF3C1/METTL2A,2
GO:0051701,biological process involved in interaction with host,2/173,202/18888,0.554382853934963,0.678677358880754,0.633663398133324,NECTIN2/PC,2
GO:0090087,regulation of peptide transport,2/173,202/18888,0.554382853934963,0.678677358880754,0.633663398133324,NNAT/SNAP25,2
GO:0000281,mitotic cytokinesis,1/173,88/18888,0.555856524225053,0.678677358880754,0.633663398133324,RHOB,1
GO:0001892,embryonic placenta development,1/173,88/18888,0.555856524225053,0.678677358880754,0.633663398133324,ZFP36L1,1
GO:0033627,cell adhesion mediated by integrin,1/173,88/18888,0.555856524225053,0.678677358880754,0.633663398133324,LPXN,1
GO:0045824,negative regulation of innate immune response,1/173,88/18888,0.555856524225053,0.678677358880754,0.633663398133324,NR1H3,1
GO:0046889,positive regulation of lipid biosynthetic process,1/173,88/18888,0.555856524225053,0.678677358880754,0.633663398133324,NR1H3,1
GO:1901264,carbohydrate derivative transport,1/173,88/18888,0.555856524225053,0.678677358880754,0.633663398133324,SLC37A1,1
GO:0009749,response to glucose,2/173,203/18888,0.557064136063092,0.679792346483526,0.634704433058099,NME2/NPTX1,2
GO:0042060,wound healing,4/173,430/18888,0.557410073035294,0.679792346483526,0.634704433058099,MERTK/SLC11A1/SMOC2/TFPI2,4
GO:0098813,nuclear chromosome segregation,3/173,317/18888,0.557561722630372,0.679792346483526,0.634704433058099,CDC16/CHFR/SEPTIN1,3
GO:0001843,neural tube closure,1/173,89/18888,0.559943589188301,0.680441124190597,0.635310179929003,SEMA4C,1
GO:0006029,proteoglycan metabolic process,1/173,89/18888,0.559943589188301,0.680441124190597,0.635310179929003,COL2A1,1
GO:0006094,gluconeogenesis,1/173,89/18888,0.559943589188301,0.680441124190597,0.635310179929003,PC,1
GO:0042310,vasoconstriction,1/173,89/18888,0.559943589188301,0.680441124190597,0.635310179929003,OXTR,1
GO:0050672,negative regulation of lymphocyte proliferation,1/173,89/18888,0.559943589188301,0.680441124190597,0.635310179929003,XCL1,1
GO:0072384,organelle transport along microtubule,1/173,89/18888,0.559943589188301,0.680441124190597,0.635310179929003,KIF13A,1
GO:2000243,positive regulation of reproductive process,1/173,89/18888,0.559943589188301,0.680441124190597,0.635310179929003,OXTR,1
GO:0045732,positive regulation of protein catabolic process,2/173,205/18888,0.562392524355549,0.683094693497896,0.637787748574019,CHFR/CUL4A,2
GO:0030071,regulation of mitotic metaphase/anaphase transition,1/173,90/18888,0.563993259866019,0.683105665171684,0.63779799254047,CDC16,1
GO:0032945,negative regulation of mononuclear cell proliferation,1/173,90/18888,0.563993259866019,0.683105665171684,0.63779799254047,XCL1,1
GO:0034644,cellular response to UV,1/173,90/18888,0.563993259866019,0.683105665171684,0.63779799254047,CUL4A,1
GO:0048145,regulation of fibroblast proliferation,1/173,90/18888,0.563993259866019,0.683105665171684,0.63779799254047,CDK6,1
GO:0060606,tube closure,1/173,90/18888,0.563993259866019,0.683105665171684,0.63779799254047,SEMA4C,1
GO:1901606,alpha-amino acid catabolic process,1/173,90/18888,0.563993259866019,0.683105665171684,0.63779799254047,MAT1A,1
GO:0001763,morphogenesis of a branching structure,2/173,206/18888,0.565039596833207,0.683408624633869,0.63808085791058,SEMA3C/SHOX2,2
GO:0016051,carbohydrate biosynthetic process,2/173,206/18888,0.565039596833207,0.683408624633869,0.63808085791058,PC/PGD,2
GO:0032869,cellular response to insulin stimulus,2/173,206/18888,0.565039596833207,0.683408624633869,0.63808085791058,SLC2A4/ZFP36L1,2
GO:0006400,tRNA modification,1/173,91/18888,0.568005876423269,0.684975169220524,0.639543499846572,METTL2A,1
GO:0030901,midbrain development,1/173,91/18888,0.568005876423269,0.684975169220524,0.639543499846572,EN2,1
GO:0033273,response to vitamin,1/173,91/18888,0.568005876423269,0.684975169220524,0.639543499846572,LRAT,1
GO:0051453,regulation of intracellular pH,1/173,91/18888,0.568005876423269,0.684975169220524,0.639543499846572,SLC11A1,1
GO:0060021,roof of mouth development,1/173,91/18888,0.568005876423269,0.684975169220524,0.639543499846572,COL2A1,1
GO:0097006,regulation of plasma lipoprotein particle levels,1/173,91/18888,0.568005876423269,0.684975169220524,0.639543499846572,MSR1,1
GO:0009914,hormone transport,3/173,322/18888,0.568196878234967,0.684975169220524,0.639543499846572,NNAT/SLC16A2/SNAP25,3
GO:0009746,response to hexose,2/173,208/18888,0.570299423603079,0.68718812156197,0.641609675890665,NME2/NPTX1,2
GO:0019319,hexose biosynthetic process,1/173,92/18888,0.57198177594866,0.687927638051284,0.642300143202507,PC,1
GO:0022406,membrane docking,1/173,92/18888,0.57198177594866,0.687927638051284,0.642300143202507,SNAP25,1
GO:0032411,positive regulation of transporter activity,1/173,92/18888,0.57198177594866,0.687927638051284,0.642300143202507,NR1H3,1
GO:0045995,regulation of embryonic development,1/173,92/18888,0.57198177594866,0.687927638051284,0.642300143202507,TLE6,1
GO:0051216,cartilage development,2/173,209/18888,0.572912151614333,0.688724925493421,0.643044549750424,COL2A1/SHOX2,2
GO:0051223,regulation of protein transport,4/173,440/18888,0.575647895705539,0.690408439544311,0.64461640303289,CD200/NNAT/NR1H3/SNAP25,4
GO:0001656,metanephros development,1/173,93/18888,0.575921292482012,0.690408439544311,0.64461640303289,SLC22A1,1
GO:0032465,regulation of cytokinesis,1/173,93/18888,0.575921292482012,0.690408439544311,0.64461640303289,KIF13A,1
GO:0050886,endocrine process,1/173,93/18888,0.575921292482012,0.690408439544311,0.64461640303289,OXTR,1
GO:1903432,regulation of TORC1 signaling,1/173,93/18888,0.575921292482012,0.690408439544311,0.64461640303289,SRMS,1
GO:2001251,negative regulation of chromosome organization,1/173,93/18888,0.575921292482012,0.690408439544311,0.64461640303289,TINF2,1
GO:0006790,sulfur compound metabolic process,3/173,326/18888,0.576592352290105,0.69089125507074,0.645067195332272,ACSL5/B4GALT4/MAT1A,3
GO:0009152,purine ribonucleotide biosynthetic process,2/173,211/18888,0.578103180083732,0.691546433248055,0.645678918155773,ACSL5/NME2,2
GO:0001942,hair follicle development,1/173,94/18888,0.579824757041768,0.691546433248055,0.645678918155773,FOXQ1,1
GO:0007091,metaphase/anaphase transition of mitotic cell cycle,1/173,94/18888,0.579824757041768,0.691546433248055,0.645678918155773,CDC16,1
GO:0019646,aerobic electron transport chain,1/173,94/18888,0.579824757041768,0.691546433248055,0.645678918155773,MTCO2P12,1
GO:0021766,hippocampus development,1/173,94/18888,0.579824757041768,0.691546433248055,0.645678918155773,CDK6,1
GO:0045104,intermediate filament cytoskeleton organization,1/173,94/18888,0.579824757041768,0.691546433248055,0.645678918155773,KRT86,1
GO:0051492,regulation of stress fiber assembly,1/173,94/18888,0.579824757041768,0.691546433248055,0.645678918155773,PXN,1
GO:0051952,regulation of amine transport,1/173,94/18888,0.579824757041768,0.691546433248055,0.645678918155773,OXTR,1
GO:0055006,cardiac cell development,1/173,94/18888,0.579824757041768,0.691546433248055,0.645678918155773,SHOX2,1
GO:0097194,execution phase of apoptosis,1/173,94/18888,0.579824757041768,0.691546433248055,0.645678918155773,COLEC11,1
GO:0042098,T cell proliferation,2/173,213/18888,0.583248242868038,0.694550915644325,0.648484125224993,SLC11A1/XCL1,2
GO:0014020,primary neural tube formation,1/173,95/18888,0.583692497652163,0.694550915644325,0.648484125224993,SEMA4C,1
GO:0030641,regulation of cellular pH,1/173,95/18888,0.583692497652163,0.694550915644325,0.648484125224993,SLC11A1,1
GO:0033555,multicellular organismal response to stress,1/173,95/18888,0.583692497652163,0.694550915644325,0.648484125224993,VDAC3,1
GO:0045103,intermediate filament-based process,1/173,95/18888,0.583692497652163,0.694550915644325,0.648484125224993,KRT86,1
GO:0001960,negative regulation of cytokine-mediated signaling pathway,1/173,96/18888,0.587524839370153,0.697190174077282,0.65094833217885,NR1H3,1
GO:0006637,acyl-CoA metabolic process,1/173,96/18888,0.587524839370153,0.697190174077282,0.65094833217885,ACSL5,1
GO:0016079,synaptic vesicle exocytosis,1/173,96/18888,0.587524839370153,0.697190174077282,0.65094833217885,SNAP25,1
GO:0035383,thioester metabolic process,1/173,96/18888,0.587524839370153,0.697190174077282,0.65094833217885,ACSL5,1
GO:0042982,amyloid precursor protein metabolic process,1/173,96/18888,0.587524839370153,0.697190174077282,0.65094833217885,FLOT2,1
GO:0031032,actomyosin structure organization,2/173,215/18888,0.588347280881528,0.697190174077282,0.65094833217885,MYOM2/PXN,2
GO:0034284,response to monosaccharide,2/173,215/18888,0.588347280881528,0.697190174077282,0.65094833217885,NME2/NPTX1,2
GO:0060348,bone development,2/173,215/18888,0.588347280881528,0.697190174077282,0.65094833217885,COL2A1/SHOX2,2
GO:0070374,positive regulation of ERK1 and ERK2 cascade,2/173,215/18888,0.588347280881528,0.697190174077282,0.65094833217885,PRKD2/XCL1,2
GO:0045787,positive regulation of cell cycle,3/173,332/18888,0.588994487550598,0.69763606506108,0.651364648993156,CDC16/CUL4A/SMOC2,3
GO:0009612,response to mechanical stimulus,2/173,216/18888,0.590879526889995,0.698145079598186,0.651839902627391,KCNJ2/SLITRK6,2
GO:0048167,regulation of synaptic plasticity,2/173,216/18888,0.590879526889995,0.698145079598186,0.651839902627391,ARC/SNAP25,2
GO:1901605,alpha-amino acid metabolic process,2/173,216/18888,0.590879526889995,0.698145079598186,0.651839902627391,MAT1A/SERINC3,2
GO:1903828,negative regulation of protein localization,2/173,216/18888,0.590879526889995,0.698145079598186,0.651839902627391,CD200/NR1H3,2
GO:0022404,molting cycle process,1/173,97/18888,0.591322104312094,0.698145079598186,0.651839902627391,FOXQ1,1
GO:0022405,hair cycle process,1/173,97/18888,0.591322104312094,0.698145079598186,0.651839902627391,FOXQ1,1
GO:0051153,regulation of striated muscle cell differentiation,1/173,97/18888,0.591322104312094,0.698145079598186,0.651839902627391,SHOX2,1
GO:0048732,gland development,4/173,449/18888,0.59169866092391,0.698269501319463,0.651956071952438,MTCO2P12/NTN1/OXTR/SEMA3C,4
GO:1901654,response to ketone,2/173,217/18888,0.593400252367511,0.699956779590628,0.653531439789471,NR1H3/OXTR,2
GO:0070664,negative regulation of leukocyte proliferation,1/173,98/18888,0.595084611680196,0.701457526803427,0.65493264842883,XCL1,1
GO:0006417,regulation of translation,4/173,451/18888,0.595217357695335,0.701457526803427,0.65493264842883,RBM4B/UPF3A/ZCCHC4/ZFP36L1,4
GO:0009952,anterior/posterior pattern specification,2/173,219/18888,0.598407132293094,0.70440504582274,0.657684670274558,ARC/SEMA3C,2
GO:0006835,dicarboxylic acid transport,1/173,99/18888,0.598812677788729,0.70440504582274,0.657684670274558,ABCC2,1
GO:0019217,regulation of fatty acid metabolic process,1/173,99/18888,0.598812677788729,0.70440504582274,0.657684670274558,NR1H3,1
GO:0038202,TORC1 signaling,1/173,99/18888,0.598812677788729,0.70440504582274,0.657684670274558,SRMS,1
GO:0048545,response to steroid hormone,3/173,338/18888,0.601163629769179,0.706491136808627,0.659632399170528,NR1H3/OXTR/ZFP36L1,3
GO:0000041,transition metal ion transport,1/173,100/18888,0.602506616089998,0.706491136808627,0.659632399170528,SLC11A1,1
GO:0008593,regulation of Notch signaling pathway,1/173,100/18888,0.602506616089998,0.706491136808627,0.659632399170528,DLK2,1
GO:0048661,positive regulation of smooth muscle cell proliferation,1/173,100/18888,0.602506616089998,0.706491136808627,0.659632399170528,IL6R,1
GO:0051310,metaphase chromosome alignment,1/173,100/18888,0.602506616089998,0.706491136808627,0.659632399170528,SEPTIN1,1
GO:0072080,nephron tubule development,1/173,100/18888,0.602506616089998,0.706491136808627,0.659632399170528,SLC22A1,1
GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,1/173,100/18888,0.602506616089998,0.706491136808627,0.659632399170528,COL2A1,1
GO:0010810,regulation of cell-substrate adhesion,2/173,221/18888,0.603367911760026,0.707179049969079,0.660274685796372,CDK6/MAP4K4,2
GO:0032784,regulation of DNA-templated transcription elongation,1/173,101/18888,0.606166737200091,0.709168263648448,0.662131962870948,ZMYND8,1
GO:0033108,mitochondrial respiratory chain complex assembly,1/173,101/18888,0.606166737200091,0.709168263648448,0.662131962870948,TIMM21,1
GO:0042632,cholesterol homeostasis,1/173,101/18888,0.606166737200091,0.709168263648448,0.662131962870948,NR1H3,1
GO:0060761,negative regulation of response to cytokine stimulus,1/173,101/18888,0.606166737200091,0.709168263648448,0.662131962870948,NR1H3,1
GO:0001841,neural tube formation,1/173,102/18888,0.609793348924389,0.710184474663185,0.663080772664574,SEMA4C,1
GO:0006892,post-Golgi vesicle-mediated transport,1/173,102/18888,0.609793348924389,0.710184474663185,0.663080772664574,KIF13A,1
GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway,1/173,102/18888,0.609793348924389,0.710184474663185,0.663080772664574,PRKD2,1
GO:0008585,female gonad development,1/173,102/18888,0.609793348924389,0.710184474663185,0.663080772664574,TNFAIP6,1
GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,1/173,102/18888,0.609793348924389,0.710184474663185,0.663080772664574,BCL2L10,1
GO:0032677,regulation of interleukin-8 production,1/173,102/18888,0.609793348924389,0.710184474663185,0.663080772664574,PRKD2,1
GO:0042773,ATP synthesis coupled electron transport,1/173,102/18888,0.609793348924389,0.710184474663185,0.663080772664574,MTCO2P12,1
GO:0042775,mitochondrial ATP synthesis coupled electron transport,1/173,102/18888,0.609793348924389,0.710184474663185,0.663080772664574,MTCO2P12,1
GO:0055092,sterol homeostasis,1/173,102/18888,0.609793348924389,0.710184474663185,0.663080772664574,NR1H3,1
GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,1/173,102/18888,0.609793348924389,0.710184474663185,0.663080772664574,CHFR,1
GO:0006364,rRNA processing,2/173,224/18888,0.610722661293027,0.710623973262334,0.663491121075594,DDX49/ZCCHC4,2
GO:0031330,negative regulation of cellular catabolic process,2/173,224/18888,0.610722661293027,0.710623973262334,0.663491121075594,SLC11A1/UPF3A,2
GO:0045055,regulated exocytosis,2/173,225/18888,0.613151210972857,0.712114922194925,0.664883181315568,FCGR3A/SNAP25,2
GO:0050730,regulation of peptidyl-tyrosine phosphorylation,2/173,225/18888,0.613151210972857,0.712114922194925,0.664883181315568,CLCF1/IL6R,2
GO:0031123,RNA 3'-end processing,1/173,103/18888,0.613386756282852,0.712114922194925,0.664883181315568,ZFP36L1,1
GO:0032637,interleukin-8 production,1/173,103/18888,0.613386756282852,0.712114922194925,0.664883181315568,PRKD2,1
GO:0035282,segmentation,1/173,103/18888,0.613386756282852,0.712114922194925,0.664883181315568,SEMA3C,1
GO:0007596,blood coagulation,2/173,226/18888,0.615568251434138,0.713353928357802,0.66604000914429,MERTK/TFPI2,2
GO:0009260,ribonucleotide biosynthetic process,2/173,226/18888,0.615568251434138,0.713353928357802,0.66604000914429,ACSL5/NME2,2
GO:0009408,response to heat,1/173,104/18888,0.616947261535078,0.713353928357802,0.66604000914429,CRYAB,1
GO:0019218,regulation of steroid metabolic process,1/173,104/18888,0.616947261535078,0.713353928357802,0.66604000914429,GFI1,1
GO:0032642,regulation of chemokine production,1/173,104/18888,0.616947261535078,0.713353928357802,0.66604000914429,IL6R,1
GO:0042100,B cell proliferation,1/173,104/18888,0.616947261535078,0.713353928357802,0.66604000914429,CLCF1,1
GO:0042102,positive regulation of T cell proliferation,1/173,104/18888,0.616947261535078,0.713353928357802,0.66604000914429,XCL1,1
GO:0061326,renal tubule development,1/173,104/18888,0.616947261535078,0.713353928357802,0.66604000914429,SLC22A1,1
GO:1990830,cellular response to leukemia inhibitory factor,1/173,104/18888,0.616947261535078,0.713353928357802,0.66604000914429,LRAT,1
GO:0006885,regulation of pH,1/173,105/18888,0.620475164205139,0.715505395355232,0.66804877792186,SLC11A1,1
GO:0015837,amine transport,1/173,105/18888,0.620475164205139,0.715505395355232,0.66804877792186,OXTR,1
GO:0031507,heterochromatin formation,1/173,105/18888,0.620475164205139,0.715505395355232,0.66804877792186,LRIF1,1
GO:0032602,chemokine production,1/173,105/18888,0.620475164205139,0.715505395355232,0.66804877792186,IL6R,1
GO:0045639,positive regulation of myeloid cell differentiation,1/173,105/18888,0.620475164205139,0.715505395355232,0.66804877792186,ZFP36L1,1
GO:0110020,regulation of actomyosin structure organization,1/173,105/18888,0.620475164205139,0.715505395355232,0.66804877792186,PXN,1
GO:0006402,mRNA catabolic process,3/173,348/18888,0.6209184405905,0.715696053948315,0.668226790891345,SLC11A1/UPF3A/ZFP36L1,3
GO:0000819,sister chromatid segregation,2/173,229/18888,0.622750380102806,0.716328448438899,0.668817241179129,CDC16/CHFR,2
GO:0048705,skeletal system morphogenesis,2/173,229/18888,0.622750380102806,0.716328448438899,0.668817241179129,COL2A1/SHOX2,2
GO:0019395,fatty acid oxidation,1/173,106/18888,0.623970761106194,0.716328448438899,0.668817241179129,CYP4V2,1
GO:0032204,regulation of telomere maintenance,1/173,106/18888,0.623970761106194,0.716328448438899,0.668817241179129,TINF2,1
GO:0032526,response to retinoic acid,1/173,106/18888,0.623970761106194,0.716328448438899,0.668817241179129,LRAT,1
GO:0046425,regulation of receptor signaling pathway via JAK-STAT,1/173,106/18888,0.623970761106194,0.716328448438899,0.668817241179129,IL6R,1
GO:0046545,development of primary female sexual characteristics,1/173,106/18888,0.623970761106194,0.716328448438899,0.668817241179129,TNFAIP6,1
GO:0097306,cellular response to alcohol,1/173,106/18888,0.623970761106194,0.716328448438899,0.668817241179129,KCNMB1,1
GO:1990823,response to leukemia inhibitory factor,1/173,106/18888,0.623970761106194,0.716328448438899,0.668817241179129,LRAT,1
GO:0051091,positive regulation of DNA-binding transcription factor activity,2/173,230/18888,0.625121450494535,0.717329650188694,0.669752037212458,CD200/PRKD2,2
GO:0030316,osteoclast differentiation,1/173,107/18888,0.627434346364879,0.7184365058917,0.670785479593926,TNFAIP6,1
GO:0032231,regulation of actin filament bundle assembly,1/173,107/18888,0.627434346364879,0.7184365058917,0.670785479593926,PXN,1
GO:0032963,collagen metabolic process,1/173,107/18888,0.627434346364879,0.7184365058917,0.670785479593926,MMP24,1
GO:0060079,excitatory postsynaptic potential,1/173,107/18888,0.627434346364879,0.7184365058917,0.670785479593926,ZMYND8,1
GO:0050817,coagulation,2/173,231/18888,0.627481049223469,0.7184365058917,0.670785479593926,MERTK/TFPI2,2
GO:0019318,hexose metabolic process,2/173,232/18888,0.629829186238323,0.719752102114367,0.672013817569429,GALM/PC,2
GO:0001776,leukocyte homeostasis,1/173,108/18888,0.630866211445486,0.719752102114367,0.672013817569429,MERTK,1
GO:0003279,cardiac septum development,1/173,108/18888,0.630866211445486,0.719752102114367,0.672013817569429,SEMA3C,1
GO:0006641,triglyceride metabolic process,1/173,108/18888,0.630866211445486,0.719752102114367,0.672013817569429,NR1H3,1
GO:0006939,smooth muscle contraction,1/173,108/18888,0.630866211445486,0.719752102114367,0.672013817569429,OXTR,1
GO:0031398,positive regulation of protein ubiquitination,1/173,108/18888,0.630866211445486,0.719752102114367,0.672013817569429,CHFR,1
GO:0140888,interferon-mediated signaling pathway,1/173,108/18888,0.630866211445486,0.719752102114367,0.672013817569429,NR1H3,1
GO:1901796,regulation of signal transduction by p53 class mediator,1/173,108/18888,0.630866211445486,0.719752102114367,0.672013817569429,RRN3,1
GO:0007599,hemostasis,2/173,233/18888,0.632165872264601,0.720596335140039,0.672802055987675,MERTK/TFPI2,2
GO:0046390,ribose phosphate biosynthetic process,2/173,233/18888,0.632165872264601,0.720596335140039,0.672802055987675,ACSL5/NME2,2
GO:0001676,long-chain fatty acid metabolic process,1/173,109/18888,0.634266645173917,0.722032100496391,0.674142592757795,ACSL5,1
GO:1901800,positive regulation of proteasomal protein catabolic process,1/173,109/18888,0.634266645173917,0.722032100496391,0.674142592757795,CHFR,1
GO:1902476,chloride transmembrane transport,1/173,109/18888,0.634266645173917,0.722032100496391,0.674142592757795,APOL1,1
GO:0032611,interleukin-1 beta production,1/173,110/18888,0.63763593376143,0.724266664947368,0.676228947466444,PANX1,1
GO:0032651,regulation of interleukin-1 beta production,1/173,110/18888,0.63763593376143,0.724266664947368,0.676228947466444,PANX1,1
GO:0051100,negative regulation of binding,1/173,110/18888,0.63763593376143,0.724266664947368,0.676228947466444,TFIP11,1
GO:0071347,cellular response to interleukin-1,1/173,110/18888,0.63763593376143,0.724266664947368,0.676228947466444,XCL1,1
GO:2001252,positive regulation of chromosome organization,1/173,110/18888,0.63763593376143,0.724266664947368,0.676228947466444,TINF2,1
GO:0007218,neuropeptide signaling pathway,1/173,111/18888,0.640974360828172,0.72517969206175,0.677081417136039,QRFP,1
GO:0007229,integrin-mediated signaling pathway,1/173,111/18888,0.640974360828172,0.72517969206175,0.677081417136039,NME2,1
GO:0009063,amino acid catabolic process,1/173,111/18888,0.640974360828172,0.72517969206175,0.677081417136039,MAT1A,1
GO:0030038,contractile actin filament bundle assembly,1/173,111/18888,0.640974360828172,0.72517969206175,0.677081417136039,PXN,1
GO:0043149,stress fiber assembly,1/173,111/18888,0.640974360828172,0.72517969206175,0.677081417136039,PXN,1
GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,1/173,111/18888,0.640974360828172,0.72517969206175,0.677081417136039,BCL2L10,1
GO:0090263,positive regulation of canonical Wnt signaling pathway,1/173,111/18888,0.640974360828172,0.72517969206175,0.677081417136039,SEMA5A,1
GO:0090398,cellular senescence,1/173,111/18888,0.640974360828172,0.72517969206175,0.677081417136039,CDK6,1
GO:0120034,positive regulation of plasma membrane bounded cell projection assembly,1/173,111/18888,0.640974360828172,0.72517969206175,0.677081417136039,ZMYND8,1
GO:0009206,purine ribonucleoside triphosphate biosynthetic process,1/173,112/18888,0.644282207426496,0.727643282510187,0.679381607461734,NME2,1
GO:0045833,negative regulation of lipid metabolic process,1/173,112/18888,0.644282207426496,0.727643282510187,0.679381607461734,GFI1,1
GO:0048024,"regulation of mRNA splicing, via spliceosome",1/173,112/18888,0.644282207426496,0.727643282510187,0.679381607461734,UPF3A,1
GO:0051303,establishment of chromosome localization,1/173,112/18888,0.644282207426496,0.727643282510187,0.679381607461734,SEPTIN1,1
GO:0042176,regulation of protein catabolic process,3/173,362/18888,0.647448843775568,0.729425355015309,0.68104548220949,CHFR/CUL4A/FBXO2,3
GO:0006664,glycolipid metabolic process,1/173,113/18888,0.647559752064077,0.729425355015309,0.68104548220949,B4GALT4,1
GO:0009145,purine nucleoside triphosphate biosynthetic process,1/173,113/18888,0.647559752064077,0.729425355015309,0.68104548220949,NME2,1
GO:0034440,lipid oxidation,1/173,113/18888,0.647559752064077,0.729425355015309,0.68104548220949,CYP4V2,1
GO:0036503,ERAD pathway,1/173,113/18888,0.647559752064077,0.729425355015309,0.68104548220949,FBXO2,1
GO:0062014,negative regulation of small molecule metabolic process,1/173,113/18888,0.647559752064077,0.729425355015309,0.68104548220949,GFI1,1
GO:1903313,positive regulation of mRNA metabolic process,2/173,240/18888,0.648203104048405,0.729830779591011,0.681424016591055,UPF3A/ZFP36L1,2
GO:0008380,RNA splicing,4/173,484/18888,0.650627622803574,0.731802935424257,0.683265367198366,LSM8/RBM4B/TFIP11/UPF3A,4
GO:1903509,liposaccharide metabolic process,1/173,114/18888,0.650807270726815,0.731802935424257,0.683265367198366,B4GALT4,1
GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,1/173,114/18888,0.650807270726815,0.731802935424257,0.683265367198366,RRN3,1
GO:0046634,regulation of alpha-beta T cell activation,1/173,115/18888,0.654025036901539,0.734779437182139,0.686044449473277,XCL1,1
GO:0099565,"chemical synaptic transmission, postsynaptic",1/173,115/18888,0.654025036901539,0.734779437182139,0.686044449473277,ZMYND8,1
GO:0023061,signal release,4/173,487/18888,0.655409724725541,0.736013973470679,0.68719710389659,NNAT/OXTR/SLC16A2/SNAP25,4
GO:0009205,purine ribonucleoside triphosphate metabolic process,2/173,244/18888,0.657117454645473,0.737075044911208,0.688187798702994,EFL1/NME2,2
GO:2001234,negative regulation of apoptotic signaling pathway,2/173,244/18888,0.657117454645473,0.737075044911208,0.688187798702994,COL2A1/RRN3,2
GO:0006368,transcription elongation by RNA polymerase II,1/173,116/18888,0.657213321598499,0.737075044911208,0.688187798702994,ZMYND8,1
GO:0045333,cellular respiration,2/173,245/18888,0.659317828419894,0.739008654036155,0.689993159251335,MTCO2P12/PRDM16,2
GO:0001824,blastocyst development,1/173,117/18888,0.660372393373667,0.739008654036155,0.689993159251335,SLC25A34,1
GO:0007006,mitochondrial membrane organization,1/173,117/18888,0.660372393373667,0.739008654036155,0.689993159251335,TOMM40,1
GO:0019882,antigen processing and presentation,1/173,117/18888,0.660372393373667,0.739008654036155,0.689993159251335,SLC11A1,1
GO:0051261,protein depolymerization,1/173,117/18888,0.660372393373667,0.739008654036155,0.689993159251335,SEMA5A,1
GO:0006090,pyruvate metabolic process,1/173,118/18888,0.663502518350831,0.740901554533127,0.691760511212534,PC,1
GO:0009201,ribonucleoside triphosphate biosynthetic process,1/173,118/18888,0.663502518350831,0.740901554533127,0.691760511212534,NME2,1
GO:0042303,molting cycle,1/173,118/18888,0.663502518350831,0.740901554533127,0.691760511212534,FOXQ1,1
GO:0042633,hair cycle,1/173,118/18888,0.663502518350831,0.740901554533127,0.691760511212534,FOXQ1,1
GO:1904659,glucose transmembrane transport,1/173,118/18888,0.663502518350831,0.740901554533127,0.691760511212534,SLC2A4,1
GO:0048738,cardiac muscle tissue development,2/173,248/18888,0.665851546576962,0.743075843128572,0.693790587922599,MYLK2/SHOX2,2
GO:0002832,negative regulation of response to biotic stimulus,1/173,119/18888,0.666603960243496,0.743075843128572,0.693790587922599,NR1H3,1
GO:0031644,regulation of nervous system process,1/173,119/18888,0.666603960243496,0.743075843128572,0.693790587922599,ZMYND8,1
GO:1990748,cellular detoxification,1/173,119/18888,0.666603960243496,0.743075843128572,0.693790587922599,SLC11A1,1
GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,2/173,249/18888,0.668007053896021,0.74399574558056,0.694649476916096,ADM5/NME2,2
GO:1901617,organic hydroxy compound biosynthetic process,2/173,249/18888,0.668007053896021,0.74399574558056,0.694649476916096,GFI1/PMEL,2
GO:0050000,chromosome localization,1/173,120/18888,0.669676980376581,0.745094926245125,0.695675753313793,SEPTIN1,1
GO:0009144,purine nucleoside triphosphate metabolic process,2/173,250/18888,0.670151397741247,0.745094926245125,0.695675753313793,EFL1/NME2,2
GO:0016054,organic acid catabolic process,2/173,250/18888,0.670151397741247,0.745094926245125,0.695675753313793,MAT1A/PGD,2
GO:0046395,carboxylic acid catabolic process,2/173,250/18888,0.670151397741247,0.745094926245125,0.695675753313793,MAT1A/PGD,2
GO:0009199,ribonucleoside triphosphate metabolic process,2/173,251/18888,0.672284600462518,0.745698980670655,0.696239743219939,EFL1/NME2,2
GO:0051222,positive regulation of protein transport,2/173,251/18888,0.672284600462518,0.745698980670655,0.696239743219939,NNAT/SNAP25,2
GO:1901653,cellular response to peptide,3/173,376/18888,0.672648373453486,0.745698980670655,0.696239743219939,PXN/SLC2A4/ZFP36L1,3
GO:0002698,negative regulation of immune effector process,1/173,121/18888,0.672721837707935,0.745698980670655,0.696239743219939,XCL1,1
GO:0008645,hexose transmembrane transport,1/173,121/18888,0.672721837707935,0.745698980670655,0.696239743219939,SLC2A4,1
GO:0030510,regulation of BMP signaling pathway,1/173,121/18888,0.672721837707935,0.745698980670655,0.696239743219939,TNFAIP6,1
GO:0072009,nephron epithelium development,1/173,121/18888,0.672721837707935,0.745698980670655,0.696239743219939,SLC22A1,1
GO:0032984,protein-containing complex disassembly,2/173,252/18888,0.674406684936243,0.747244928446999,0.69768315444985,SEMA5A/TFIP11,2
GO:0007264,small GTPase-mediated signal transduction,4/173,500/18888,0.675627349844581,0.747434442133953,0.69786009845026,MAP4K4/NTN1/RGL4/RHOB,4
GO:0030326,embryonic limb morphogenesis,1/173,122/18888,0.675738788849648,0.747434442133953,0.69786009845026,SHOX2,1
GO:0035113,embryonic appendage morphogenesis,1/173,122/18888,0.675738788849648,0.747434442133953,0.69786009845026,SHOX2,1
GO:1904892,regulation of receptor signaling pathway via STAT,1/173,122/18888,0.675738788849648,0.747434442133953,0.69786009845026,IL6R,1
GO:0050870,positive regulation of T cell activation,2/173,253/18888,0.676517674553956,0.747974672381467,0.698364497381409,FLOT2/XCL1,2
GO:0046883,regulation of hormone secretion,2/173,254/18888,0.67861759321109,0.748490289862797,0.69884591601293,NNAT/SNAP25,2
GO:0001838,embryonic epithelial tube formation,1/173,123/18888,0.678728088089177,0.748490289862797,0.69884591601293,SEMA4C,1
GO:0015749,monosaccharide transmembrane transport,1/173,123/18888,0.678728088089177,0.748490289862797,0.69884591601293,SLC2A4,1
GO:0022904,respiratory electron transport chain,1/173,123/18888,0.678728088089177,0.748490289862797,0.69884591601293,MTCO2P12,1
GO:0045834,positive regulation of lipid metabolic process,1/173,123/18888,0.678728088089177,0.748490289862797,0.69884591601293,NR1H3,1
GO:0071482,cellular response to light stimulus,1/173,123/18888,0.678728088089177,0.748490289862797,0.69884591601293,CUL4A,1
GO:0006821,chloride transport,1/173,124/18888,0.681689987410284,0.750150306658753,0.700395830519608,APOL1,1
GO:0033865,nucleoside bisphosphate metabolic process,1/173,124/18888,0.681689987410284,0.750150306658753,0.700395830519608,ACSL5,1
GO:0033875,ribonucleoside bisphosphate metabolic process,1/173,124/18888,0.681689987410284,0.750150306658753,0.700395830519608,ACSL5,1
GO:0034032,purine nucleoside bisphosphate metabolic process,1/173,124/18888,0.681689987410284,0.750150306658753,0.700395830519608,ACSL5,1
GO:0043244,regulation of protein-containing complex disassembly,1/173,124/18888,0.681689987410284,0.750150306658753,0.700395830519608,SEMA5A,1
GO:0006164,purine nucleotide biosynthetic process,2/173,256/18888,0.682784315678509,0.751033580893704,0.701220520699527,ACSL5/NME2,2
GO:0000077,DNA damage checkpoint signaling,1/173,125/18888,0.684624736513782,0.751701518319737,0.701844156501698,CUL4A,1
GO:0002065,columnar/cuboidal epithelial cell differentiation,1/173,125/18888,0.684624736513782,0.751701518319737,0.701844156501698,CDK6,1
GO:0021761,limbic system development,1/173,125/18888,0.684624736513782,0.751701518319737,0.701844156501698,CDK6,1
GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,1/173,125/18888,0.684624736513782,0.751701518319737,0.701844156501698,CHFR,1
GO:0045860,positive regulation of protein kinase activity,2/173,257/18888,0.684851169700234,0.751701518319737,0.701844156501698,IL6R/SLC11A1,2
GO:0009142,nucleoside triphosphate biosynthetic process,1/173,126/18888,0.687532582838096,0.753680885827202,0.703692240461657,NME2,1
GO:0098659,inorganic cation import across plasma membrane,1/173,126/18888,0.687532582838096,0.753680885827202,0.703692240461657,KCNJ2,1
GO:0099587,inorganic ion import across plasma membrane,1/173,126/18888,0.687532582838096,0.753680885827202,0.703692240461657,KCNJ2,1
GO:0097305,response to alcohol,2/173,259/18888,0.688951992318388,0.754915480944616,0.704844949811958,KCNMB1/SLC2A4,2
GO:0009100,glycoprotein metabolic process,3/173,386/18888,0.689830009453138,0.755231716999828,0.705140211191664,B4GALT4/COL2A1/FBXO2,3
GO:0003231,cardiac ventricle development,1/173,127/18888,0.690413771579649,0.755231716999828,0.705140211191664,SEMA3C,1
GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway,1/173,127/18888,0.690413771579649,0.755231716999828,0.705140211191664,PRDM16,1
GO:2001056,positive regulation of cysteine-type endopeptidase activity,1/173,127/18888,0.690413771579649,0.755231716999828,0.705140211191664,BCL2L10,1
GO:0032409,regulation of transporter activity,2/173,260/18888,0.690986013858411,0.755536724282552,0.705424988558548,NR1H3/SCN4B,2
GO:0032612,interleukin-1 production,1/173,129/18888,0.696097146011111,0.759191084700809,0.708836969834092,PANX1,1
GO:0032652,regulation of interleukin-1 production,1/173,129/18888,0.696097146011111,0.759191084700809,0.708836969834092,PANX1,1
GO:0050868,negative regulation of T cell activation,1/173,129/18888,0.696097146011111,0.759191084700809,0.708836969834092,XCL1,1
GO:0051225,spindle assembly,1/173,129/18888,0.696097146011111,0.759191084700809,0.708836969834092,SEPTIN1,1
GO:0097237,cellular response to toxic substance,1/173,129/18888,0.696097146011111,0.759191084700809,0.708836969834092,SLC11A1,1
GO:0098773,skin epidermis development,1/173,129/18888,0.696097146011111,0.759191084700809,0.708836969834092,FOXQ1,1
GO:0090068,positive regulation of cell cycle process,2/173,263/18888,0.697022846087036,0.759878843638492,0.709479112466148,CDC16/CUL4A,2
GO:0043393,regulation of protein binding,1/173,130/18888,0.698899811064689,0.761082322094214,0.710602768998747,TFIP11,1
GO:0055007,cardiac muscle cell differentiation,1/173,130/18888,0.698899811064689,0.761082322094214,0.710602768998747,SHOX2,1
GO:0072522,purine-containing compound biosynthetic process,2/173,264/18888,0.699013472525365,0.761082322094214,0.710602768998747,ACSL5/NME2,2
GO:1902903,regulation of supramolecular fiber organization,3/173,392/18888,0.699812582995866,0.761630347089753,0.711114445683391,CRYAB/PXN/SEMA5A,3
GO:0072329,monocarboxylic acid catabolic process,1/173,131/18888,0.701676777302338,0.763014232074966,0.712406543100347,PGD,1
GO:1903052,positive regulation of proteolysis involved in protein catabolic process,1/173,131/18888,0.701676777302338,0.763014232074966,0.712406543100347,CHFR,1
GO:0009141,nucleoside triphosphate metabolic process,2/173,266/18888,0.702962420792525,0.764089587817962,0.713410574788442,EFL1/NME2,2
GO:0000209,protein polyubiquitination,2/173,267/18888,0.704920801237573,0.765571937236082,0.714794605885421,CDC16/CHFR,2
GO:0032386,regulation of intracellular transport,2/173,267/18888,0.704920801237573,0.765571937236082,0.714794605885421,CRYAB/MYLK2,2
GO:0060828,regulation of canonical Wnt signaling pathway,2/173,268/18888,0.706868492244811,0.767027363942449,0.716153499946675,SEMA5A/TLE6,2
GO:0002244,hematopoietic progenitor cell differentiation,1/173,133/18888,0.707154548349272,0.767027363942449,0.716153499946675,CDK6,1
GO:0048593,camera-type eye morphogenesis,1/173,133/18888,0.707154548349272,0.767027363942449,0.716153499946675,RPGRIP1,1
GO:0032868,response to insulin,2/173,269/18888,0.708805524024339,0.768494410257967,0.717523242934776,SLC2A4/ZFP36L1,2
GO:0008033,tRNA processing,1/173,134/18888,0.709855815378628,0.768662205466765,0.717679908957012,METTL2A,1
GO:0031570,DNA integrity checkpoint signaling,1/173,134/18888,0.709855815378628,0.768662205466765,0.717679908957012,CUL4A,1
GO:0051384,response to glucocorticoid,1/173,134/18888,0.709855815378628,0.768662205466765,0.717679908957012,ZFP36L1,1
GO:0006354,DNA-templated transcription elongation,1/173,135/18888,0.712532308070294,0.770264774677165,0.719176186147223,ZMYND8,1
GO:0031109,microtubule polymerization or depolymerization,1/173,135/18888,0.712532308070294,0.770264774677165,0.719176186147223,CRYAB,1
GO:0045814,"negative regulation of gene expression, epigenetic",1/173,135/18888,0.712532308070294,0.770264774677165,0.719176186147223,LRIF1,1
GO:0072175,epithelial tube formation,1/173,135/18888,0.712532308070294,0.770264774677165,0.719176186147223,SEMA4C,1
GO:0006631,fatty acid metabolic process,3/173,401/18888,0.714330033016183,0.771884110372082,0.720688117767945,ACSL5/CYP4V2/NR1H3,3
GO:0006639,acylglycerol metabolic process,1/173,136/18888,0.715184252330083,0.772159098427658,0.720944866963218,NR1H3,1
GO:0030168,platelet activation,1/173,136/18888,0.715184252330083,0.772159098427658,0.720944866963218,MERTK,1
GO:0043488,regulation of mRNA stability,2/173,273/18888,0.716447674947334,0.772875057808708,0.721613339615775,SLC11A1/ZFP36L1,2
GO:0110053,regulation of actin filament organization,2/173,273/18888,0.716447674947334,0.772875057808708,0.721613339615775,PXN/SEMA5A,2
GO:0006638,neutral lipid metabolic process,1/173,137/18888,0.717811872015818,0.773051263254175,0.721777858057245,NR1H3,1
GO:0007368,determination of left/right symmetry,1/173,137/18888,0.717811872015818,0.773051263254175,0.721777858057245,DNAH5,1
GO:0034219,carbohydrate transmembrane transport,1/173,137/18888,0.717811872015818,0.773051263254175,0.721777858057245,SLC2A4,1
GO:0090288,negative regulation of cellular response to growth factor stimulus,1/173,137/18888,0.717811872015818,0.773051263254175,0.721777858057245,TNFAIP6,1
GO:1903311,regulation of mRNA metabolic process,3/173,404/18888,0.719048178503448,0.774058971424072,0.722718728965797,SLC11A1/UPF3A/ZFP36L1,3
GO:0046328,regulation of JNK cascade,1/173,138/18888,0.720415388955782,0.774559343031791,0.72318591292166,MAP4K4,1
GO:0061041,regulation of wound healing,1/173,138/18888,0.720415388955782,0.774559343031791,0.72318591292166,SMOC2,1
GO:0070555,response to interleukin-1,1/173,138/18888,0.720415388955782,0.774559343031791,0.72318591292166,XCL1,1
GO:0007098,centrosome cycle,1/173,139/18888,0.722995022967017,0.777008424098526,0.725472556215037,ATF5,1
GO:0140014,mitotic nuclear division,2/173,277/18888,0.723921781024158,0.777355540507593,0.725796649777963,CDC16/FBXO43,2
GO:1903039,positive regulation of leukocyte cell-cell adhesion,2/173,277/18888,0.723921781024158,0.777355540507593,0.725796649777963,FLOT2/XCL1,2
GO:0007498,mesoderm development,1/173,140/18888,0.725550991873449,0.778131530226627,0.726521171195755,ZFP36L1,1
GO:0009581,detection of external stimulus,1/173,140/18888,0.725550991873449,0.778131530226627,0.726521171195755,MMP24,1
GO:0043467,regulation of generation of precursor metabolites and energy,1/173,140/18888,0.725550991873449,0.778131530226627,0.726521171195755,PRDM16,1
GO:0051092,positive regulation of NF-kappaB transcription factor activity,1/173,141/18888,0.72808351152386,0.780522498823455,0.728753556387438,PRKD2,1
GO:0046165,alcohol biosynthetic process,1/173,142/18888,0.730592795809685,0.78256091897252,0.730656776262948,GFI1,1
GO:0062013,positive regulation of small molecule metabolic process,1/173,142/18888,0.730592795809685,0.78256091897252,0.730656776262948,NR1H3,1
GO:0007093,mitotic cell cycle checkpoint signaling,1/173,143/18888,0.733079056682667,0.783919672324696,0.73192540892779,CHFR,1
GO:0009582,detection of abiotic stimulus,1/173,143/18888,0.733079056682667,0.783919672324696,0.73192540892779,MMP24,1
GO:0060972,left/right pattern formation,1/173,143/18888,0.733079056682667,0.783919672324696,0.73192540892779,DNAH5,1
GO:2001235,positive regulation of apoptotic signaling pathway,1/173,143/18888,0.733079056682667,0.783919672324696,0.73192540892779,SERINC3,1
GO:0007269,neurotransmitter secretion,1/173,144/18888,0.735542504172339,0.785575258500114,0.733471186679309,SNAP25,1
GO:0010565,regulation of cellular ketone metabolic process,1/173,144/18888,0.735542504172339,0.785575258500114,0.733471186679309,NR1H3,1
GO:0099643,signal release from synapse,1/173,144/18888,0.735542504172339,0.785575258500114,0.733471186679309,SNAP25,1
GO:0032006,regulation of TOR signaling,1/173,145/18888,0.737983346403356,0.787528850803416,0.735295205001534,SRMS,1
GO:0090090,negative regulation of canonical Wnt signaling pathway,1/173,145/18888,0.737983346403356,0.787528850803416,0.735295205001534,TLE6,1
GO:0030177,positive regulation of Wnt signaling pathway,1/173,146/18888,0.740401789612673,0.789455324328212,0.737093903225605,SEMA5A,1
GO:0098781,ncRNA transcription,1/173,146/18888,0.740401789612673,0.789455324328212,0.737093903225605,GTF3C1,1
GO:0009799,specification of symmetry,1/173,147/18888,0.742798038166563,0.791354964120355,0.738867547491422,DNAH5,1
GO:0009855,determination of bilateral symmetry,1/173,147/18888,0.742798038166563,0.791354964120355,0.738867547491422,DNAH5,1
GO:0007548,sex differentiation,2/173,288/18888,0.743626353887033,0.79190978546696,0.739385569752289,MERTK/TNFAIP6,2
GO:0006119,oxidative phosphorylation,1/173,148/18888,0.74517229457749,0.792769233456938,0.740188013986979,MTCO2P12,1
GO:1903038,negative regulation of leukocyte cell-cell adhesion,1/173,148/18888,0.74517229457749,0.792769233456938,0.740188013986979,XCL1,1
GO:0045165,cell fate commitment,2/173,289/18888,0.745357015223009,0.792769233456938,0.740188013986979,IL6R/LY9,2
GO:0035148,tube formation,1/173,149/18888,0.747524759520825,0.794418595033481,0.741727979992425,SEMA4C,1
GO:2000377,regulation of reactive oxygen species metabolic process,1/173,149/18888,0.747524759520825,0.794418595033481,0.741727979992425,CRYAB,1
GO:0001890,placenta development,1/173,150/18888,0.749855631851413,0.795910244030251,0.743120693864116,ZFP36L1,1
GO:0016331,morphogenesis of embryonic epithelium,1/173,150/18888,0.749855631851413,0.795910244030251,0.743120693864116,SEMA4C,1
GO:0018205,peptidyl-lysine modification,1/173,150/18888,0.749855631851413,0.795910244030251,0.743120693864116,NNAT,1
GO:0009165,nucleotide biosynthetic process,2/173,293/18888,0.752180443206144,0.798048883912576,0.745117486297935,ACSL5/NME2,2
GO:0048193,Golgi vesicle transport,2/173,294/18888,0.753861676967583,0.799503220012984,0.746475362088771,CEP19/KIF13A,2
GO:0072073,kidney epithelium development,1/173,152/18888,0.754453385089481,0.799801344835494,0.746753713481561,SLC22A1,1
GO:1901293,nucleoside phosphate biosynthetic process,2/173,295/18888,0.755533134467098,0.800616387346822,0.747514697475786,ACSL5/NME2,2
GO:0003002,regionalization,3/173,429/18888,0.756052308769149,0.800836978642763,0.747720657831404,ARC/DNAH5/SEMA3C,3
GO:0010950,positive regulation of endopeptidase activity,1/173,153/18888,0.75672065475107,0.801215331407896,0.748073915967557,BCL2L10,1
GO:0008064,regulation of actin polymerization or depolymerization,1/173,154/18888,0.758967109340238,0.802274345874841,0.749062690231226,SEMA5A,1
GO:0009411,response to UV,1/173,154/18888,0.758967109340238,0.802274345874841,0.749062690231226,CUL4A,1
GO:0015748,organophosphate ester transport,1/173,154/18888,0.758967109340238,0.802274345874841,0.749062690231226,SLC37A1,1
GO:0030010,establishment of cell polarity,1/173,154/18888,0.758967109340238,0.802274345874841,0.749062690231226,FLOT2,1
GO:0034470,ncRNA processing,3/173,433/18888,0.761596461419308,0.804723384552613,0.75134929394713,DDX49/METTL2A/ZCCHC4,3
GO:0031960,response to corticosteroid,1/173,156/18888,0.763398331559483,0.805635534330193,0.752200944470173,ZFP36L1,1
GO:0043535,regulation of blood vessel endothelial cell migration,1/173,156/18888,0.763398331559483,0.805635534330193,0.752200944470173,PRKD2,1
GO:0046718,symbiont entry into host cell,1/173,156/18888,0.763398331559483,0.805635534330193,0.752200944470173,NECTIN2,1
GO:0030832,regulation of actin filament length,1/173,157/18888,0.765583474023727,0.807610588124169,0.754045000828044,SEMA5A,1
GO:0006261,DNA-templated DNA replication,1/173,160/18888,0.772019240281386,0.81373292825402,0.75976127057013,ZNF365,1
GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,1/173,160/18888,0.772019240281386,0.81373292825402,0.75976127057013,BCL2L10,1
GO:0010976,positive regulation of neuron projection development,1/173,161/18888,0.774125213766613,0.815618832016787,0.761522089862582,NME2,1
GO:0048608,reproductive structure development,2/173,307/18888,0.774841607070614,0.816039729327947,0.761915070734811,MERTK/TNFAIP6,2
GO:0048592,eye morphogenesis,1/173,162/18888,0.776211844728239,0.817001482664617,0.762813034810827,RPGRIP1,1
GO:0070372,regulation of ERK1 and ERK2 cascade,2/173,308/18888,0.776389370128279,0.817001482664617,0.762813034810827,PRKD2/XCL1,2
GO:0044409,symbiont entry into host,1/173,163/18888,0.778279309796167,0.818655728237389,0.764357560876524,NECTIN2,1
GO:0009150,purine ribonucleotide metabolic process,3/173,446/18888,0.778917967657287,0.818992963134959,0.764672428329176,ACSL5/EFL1/NME2,3
GO:0007584,response to nutrient,1/173,164/18888,0.780327783996715,0.820140426037364,0.765743784596562,LRAT,1
GO:0061458,reproductive system development,2/173,311/18888,0.780977315472785,0.820488203730078,0.76606849558283,MERTK/TNFAIP6,2
GO:0031929,TOR signaling,1/173,165/18888,0.782357440767093,0.821268002435901,0.766796573352518,SRMS,1
GO:0051147,regulation of muscle cell differentiation,1/173,165/18888,0.782357440767093,0.821268002435901,0.766796573352518,SHOX2,1
GO:0043086,negative regulation of catalytic activity,3/173,449/18888,0.782766225254129,0.821362277925584,0.766884595925205,GFI1/TFIP11/TINF2,3
GO:0006633,fatty acid biosynthetic process,1/173,166/18888,0.784368451969748,0.822373275171865,0.767828537758831,NR1H3,1
GO:2000058,regulation of ubiquitin-dependent protein catabolic process,1/173,166/18888,0.784368451969748,0.822373275171865,0.767828537758831,CHFR,1
GO:0010952,positive regulation of peptidase activity,1/173,167/18888,0.786360987906572,0.824126798477584,0.769465756861646,BCL2L10,1
GO:0030509,BMP signaling pathway,1/173,168/18888,0.788335217333001,0.825859717100275,0.77108373790783,TNFAIP6,1
GO:0072594,establishment of protein localization to organelle,3/173,454/18888,0.789057991633422,0.826280735443701,0.771476831784737,MFF/TIMM21/TOMM40,3
GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,2/173,317/18888,0.789907628420169,0.826834204545502,0.771993591489801,PRDM16/TNFAIP6,2
GO:1902904,negative regulation of supramolecular fiber organization,1/173,169/18888,0.790291307471964,0.826899681731128,0.772054725835011,CRYAB,1
GO:0001822,kidney development,2/173,319/18888,0.792812771814553,0.829201010325944,0.77420341648828,IL6R/SLC22A1,2
GO:0007254,JNK cascade,1/173,171/18888,0.794149731199605,0.82992514522686,0.774879522411098,MAP4K4,1
GO:0051897,positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,1/173,171/18888,0.794149731199605,0.82992514522686,0.774879522411098,SEMA5A,1
GO:0060070,canonical Wnt signaling pathway,2/173,323/18888,0.798517485023142,0.834120571325688,0.778796682639907,SEMA5A/TLE6,2
GO:0051051,negative regulation of transport,3/173,462/18888,0.798812166558892,0.834120571325688,0.778796682639907,CD200/CRYAB/NR1H3,3
GO:0048660,regulation of smooth muscle cell proliferation,1/173,174/18888,0.799805416115241,0.834819191932203,0.779448966529648,IL6R,1
GO:0022409,positive regulation of cell-cell adhesion,2/173,325/18888,0.801317679342816,0.836058761875102,0.780606320745113,FLOT2/XCL1,2
GO:0022900,electron transport chain,1/173,175/18888,0.801656098118664,0.836073087345305,0.780619696064048,MTCO2P12,1
GO:0019216,regulation of lipid metabolic process,2/173,326/18888,0.802704872719685,0.836827954353518,0.781324495756131,GFI1/NR1H3,2
GO:0055088,lipid homeostasis,1/173,176/18888,0.803489769631808,0.837028378504992,0.781511626573491,NR1H3,1
GO:0009259,ribonucleotide metabolic process,3/173,466/18888,0.803547243364792,0.837028378504992,0.781511626573491,ACSL5/EFL1/NME2,3
GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,1/173,177/18888,0.805306586105392,0.837844225948034,0.782273362111521,PRDM16,1
GO:0030178,negative regulation of Wnt signaling pathway,1/173,177/18888,0.805306586105392,0.837844225948034,0.782273362111521,TLE6,1
GO:0072331,signal transduction by p53 class mediator,1/173,177/18888,0.805306586105392,0.837844225948034,0.782273362111521,RRN3,1
GO:0072001,renal system development,2/173,329/18888,0.80681530712229,0.839039061995467,0.783388949452283,IL6R/SLC22A1,2
GO:0048659,smooth muscle cell proliferation,1/173,178/18888,0.807106701577775,0.839039061995467,0.783388949452283,IL6R,1
GO:1903034,regulation of response to wounding,1/173,179/18888,0.808890268687719,0.840553850633929,0.784803268205578,SMOC2,1
GO:0062012,regulation of small molecule metabolic process,2/173,331/18888,0.809513366564344,0.840862008432104,0.785090987126796,GFI1/NR1H3,2
GO:0031214,biomineral tissue development,1/173,180/18888,0.810657438687025,0.84137158590048,0.785566766355318,TFIP11,1
GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,1/173,180/18888,0.810657438687025,0.84137158590048,0.785566766355318,PRDM16,1
GO:0042129,regulation of T cell proliferation,1/173,181/18888,0.812408361453069,0.842849126003889,0.786946307120238,XCL1,1
GO:0007389,pattern specification process,3/173,474/18888,0.81273892952208,0.842852494369454,0.786949452075558,ARC/DNAH5/SEMA3C,3
GO:0046394,carboxylic acid biosynthetic process,2/173,334/18888,0.81349789296818,0.8432999494336,0.787367229231004,NR1H3/SERINC3,2
GO:0043410,positive regulation of MAPK cascade,3/173,475/18888,0.813862129867884,0.843338021895292,0.787402776498251,PRKD2/SEMA4C/XCL1,3
GO:0043534,blood vessel endothelial cell migration,1/173,183/18888,0.815862057997112,0.844990331056922,0.78894549458723,PRKD2,1
GO:0045862,positive regulation of proteolysis,2/173,336/18888,0.816112991587792,0.844990331056922,0.78894549458723,BCL2L10/CHFR,2
GO:0016053,organic acid biosynthetic process,2/173,337/18888,0.81740828241521,0.845991289075227,0.789880063054806,NR1H3/SERINC3,2
GO:0015980,energy derivation by oxidation of organic compounds,2/173,338/18888,0.818695452966674,0.846983041940211,0.790806036910145,MTCO2P12/PRDM16,2
GO:0019693,ribose phosphate metabolic process,3/173,480/18888,0.819393525180565,0.847364790096367,0.791162465234585,ACSL5/EFL1/NME2,3
GO:0043484,regulation of RNA splicing,1/173,186/18888,0.820924417837626,0.84860713606258,0.792322411350816,UPF3A,1
GO:0030111,regulation of Wnt signaling pathway,2/173,342/18888,0.82376371201051,0.850650171533029,0.79422994043186,SEMA5A/TLE6,2
GO:0000070,mitotic sister chromatid segregation,1/173,188/18888,0.824222205038799,0.850650171533029,0.79422994043186,CDC16,1
GO:0042770,signal transduction in response to DNA damage,1/173,188/18888,0.824222205038799,0.850650171533029,0.79422994043186,CUL4A,1
GO:0048771,tissue remodeling,1/173,188/18888,0.824222205038799,0.850650171533029,0.79422994043186,SEMA3C,1
GO:0061136,regulation of proteasomal protein catabolic process,1/173,189/18888,0.825848384639242,0.851645811151801,0.79515954324812,CHFR,1
GO:0061138,morphogenesis of a branching epithelium,1/173,189/18888,0.825848384639242,0.851645811151801,0.79515954324812,SEMA3C,1
GO:0032956,regulation of actin cytoskeleton organization,2/173,344/18888,0.826250132439551,0.851719011622036,0.795227888623293,PXN/SEMA5A,2
GO:1902107,positive regulation of leukocyte differentiation,1/173,190/18888,0.827459606065917,0.851942617201015,0.795436663336584,ZFP36L1,1
GO:1903708,positive regulation of hemopoiesis,1/173,190/18888,0.827459606065917,0.851942617201015,0.795436663336584,ZFP36L1,1
GO:2000116,regulation of cysteine-type endopeptidase activity,1/173,190/18888,0.827459606065917,0.851942617201015,0.795436663336584,BCL2L10,1
GO:0006575,cellular modified amino acid metabolic process,1/173,191/18888,0.829056006116757,0.852904201258749,0.79633446936126,SLC16A2,1
GO:0021543,pallium development,1/173,191/18888,0.829056006116757,0.852904201258749,0.79633446936126,CDK6,1
GO:0030324,lung development,1/173,193/18888,0.832204883074809,0.855801746772218,0.799039832244351,HSD11B1,1
GO:0002040,sprouting angiogenesis,1/173,194/18888,0.83375762740367,0.856714242044872,0.799891805347159,SEMA5A,1
GO:0030258,lipid modification,1/173,194/18888,0.83375762740367,0.856714242044872,0.799891805347159,CYP4V2,1
GO:0008154,actin polymerization or depolymerization,1/173,196/18888,0.836820387220602,0.85907399879669,0.802095048850952,SEMA5A,1
GO:0009755,hormone-mediated signaling pathway,1/173,196/18888,0.836820387220602,0.85907399879669,0.802095048850952,NR1H3,1
GO:0009895,negative regulation of catabolic process,2/173,353/18888,0.837055014749862,0.85907399879669,0.802095048850952,SLC11A1/UPF3A,2
GO:0007051,spindle organization,1/173,197/18888,0.838330662900617,0.859697911974945,0.802677580358007,SEPTIN1,1
GO:0030323,respiratory tube development,1/173,197/18888,0.838330662900617,0.859697911974945,0.802677580358007,HSD11B1,1
GO:0061157,mRNA destabilization,1/173,198/18888,0.839827040586037,0.860889581810926,0.803790211489486,ZFP36L1,1
GO:0009060,aerobic respiration,1/173,199/18888,0.841309647433475,0.862066192654675,0.80488878243159,MTCO2P12,1
GO:0031099,regeneration,1/173,200/18888,0.842778609442893,0.863227891533592,0.805973430459979,TMEM182,1
GO:0050779,RNA destabilization,1/173,202/18888,0.845676097226934,0.86585127250869,0.808422813044394,ZFP36L1,1
GO:0022408,negative regulation of cell-cell adhesion,1/173,203/18888,0.847104869311904,0.866624965625011,0.809145190183965,XCL1,1
GO:0061014,positive regulation of mRNA catabolic process,1/173,203/18888,0.847104869311904,0.866624965625011,0.809145190183965,ZFP36L1,1
GO:0120032,regulation of plasma membrane bounded cell projection assembly,1/173,204/18888,0.848520489199998,0.867728458971404,0.810175493220516,ZMYND8,1
GO:0010639,negative regulation of organelle organization,2/173,365/18888,0.850521121810102,0.869429094347366,0.811763332238889,FBXO43/TINF2,2
GO:0060491,regulation of cell projection assembly,1/173,206/18888,0.851312752777252,0.869892991429137,0.812196460878548,ZMYND8,1
GO:0009566,fertilization,1/173,207/18888,0.852689633933956,0.870954306775064,0.81318738341308,NECTIN2,1
GO:0043123,positive regulation of canonical NF-kappaB signal transduction,1/173,208/18888,0.854053837848598,0.872001836820039,0.814165434970657,FLOT2,1
GO:0051348,negative regulation of transferase activity,1/173,213/18888,0.860688723764043,0.878079819212524,0.819840289047074,TINF2,1
GO:0071383,cellular response to steroid hormone stimulus,1/173,213/18888,0.860688723764043,0.878079819212524,0.819840289047074,ZFP36L1,1
GO:0045619,regulation of lymphocyte differentiation,1/173,215/18888,0.863257918765964,0.880352134979152,0.821961891177264,ZFP36L1,1
GO:0002064,epithelial cell development,1/173,216/18888,0.864524795007248,0.881295070128133,0.822842285200881,CDK6,1
GO:0050863,regulation of T cell activation,2/173,382/18888,0.867875935846626,0.884011287502003,0.825378346716229,FLOT2/XCL1,2
GO:1903037,regulation of leukocyte cell-cell adhesion,2/173,382/18888,0.867875935846626,0.884011287502003,0.825378346716229,FLOT2/XCL1,2
GO:0040029,epigenetic regulation of gene expression,1/173,220/18888,0.869476663671135,0.884941663617855,0.826247014697264,LRIF1,1
GO:0060541,respiratory system development,1/173,220/18888,0.869476663671135,0.884941663617855,0.826247014697264,HSD11B1,1
GO:0032412,regulation of monoatomic ion transmembrane transporter activity,1/173,221/18888,0.870686248907095,0.88582263569173,0.827069555409264,SCN4B,1
GO:0006457,protein folding,1/173,225/18888,0.87541415358261,0.889227394664781,0.830248490307352,CRYAB,1
GO:0006486,protein glycosylation,1/173,225/18888,0.87541415358261,0.889227394664781,0.830248490307352,B4GALT4,1
GO:0043413,macromolecule glycosylation,1/173,225/18888,0.87541415358261,0.889227394664781,0.830248490307352,B4GALT4,1
GO:0072330,monocarboxylic acid biosynthetic process,1/173,225/18888,0.87541415358261,0.889227394664781,0.830248490307352,NR1H3,1
GO:0007163,establishment or maintenance of cell polarity,1/173,226/18888,0.876569024258825,0.89004938385902,0.831015960238733,FLOT2,1
GO:0042180,cellular ketone metabolic process,1/173,227/18888,0.877713250965674,0.890859921654163,0.831772738296621,NR1H3,1
GO:1903050,regulation of proteolysis involved in protein catabolic process,1/173,228/18888,0.878846931239129,0.891659120544034,0.832518929513571,CHFR,1
GO:0022898,regulation of transmembrane transporter activity,1/173,229/18888,0.879970161726569,0.892447091944039,0.833254637915252,SCN4B,1
GO:0044242,cellular lipid catabolic process,1/173,230/18888,0.881083038194831,0.893223946201453,0.833979966530043,CEL,1
GO:0045861,negative regulation of proteolysis,1/173,231/18888,0.882185655538185,0.893989792605599,0.834695017398543,NR1H3,1
GO:0008406,gonad development,1/173,233/18888,0.884360488111761,0.895841171080953,0.836423601328113,TNFAIP6,1
GO:0045137,development of primary sexual characteristics,1/173,238/18888,0.889624512942657,0.900111245904653,0.840410459129781,TNFAIP6,1
GO:0051098,regulation of binding,1/173,238/18888,0.889624512942657,0.900111245904653,0.840410459129781,TFIP11,1
GO:0072593,reactive oxygen species metabolic process,1/173,238/18888,0.889624512942657,0.900111245904653,0.840410459129781,CRYAB,1
GO:0065004,protein-DNA complex assembly,1/173,240/18888,0.891662786692418,0.901819197067155,0.84200512870777,RRN3,1
GO:0070085,glycosylation,1/173,241/18888,0.892667845567483,0.902481233740192,0.842623255130342,B4GALT4,1
GO:0071826,protein-RNA complex organization,1/173,244/18888,0.895627737496064,0.905118298293707,0.845085413716025,TFIP11,1
GO:0016485,protein processing,1/173,245/18888,0.896596220729983,0.905741572530289,0.845667348659859,CPLANE2,1
GO:0022604,regulation of cell morphogenesis,1/173,246/18888,0.897555768754106,0.90635533511444,0.846240402821208,ARC,1
GO:0043254,regulation of protein-containing complex assembly,2/173,418/18888,0.898704185113556,0.907159261727718,0.846991008190539,CRYAB/TFIP11,2
GO:0007159,leukocyte cell-cell adhesion,2/173,419/18888,0.899457002642039,0.90756339412353,0.847368336097351,FLOT2/XCL1,2
GO:0033002,muscle cell proliferation,1/173,251/18888,0.902222323350898,0.909997055475348,0.849640582403963,IL6R,1
GO:0051896,regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,1/173,253/18888,0.904029210459084,0.911462496841089,0.851008826892201,SEMA5A,1
GO:0032886,regulation of microtubule-based process,1/173,258/18888,0.908402497737917,0.915513280499075,0.854790938236029,ATF5,1
GO:0001894,tissue homeostasis,1/173,259/18888,0.909253081092256,0.915653767623214,0.854922107409881,COL2A1,1
GO:0060249,anatomical structure homeostasis,1/173,259/18888,0.909253081092256,0.915653767623214,0.854922107409881,COL2A1,1
GO:0006260,DNA replication,1/173,278/18888,0.924001112830838,0.930141855175687,0.868449257934091,ZNF365,1
GO:0052548,regulation of endopeptidase activity,1/173,280/18888,0.92540756591447,0.931193623380133,0.869431266550934,BCL2L10,1
GO:0018105,peptidyl-serine phosphorylation,1/173,282/18888,0.926788138530193,0.932218537779394,0.870388202468323,PRKD2,1
GO:0043122,regulation of canonical NF-kappaB signal transduction,1/173,286/18888,0.929473527801695,0.934218780831313,0.872255777381183,FLOT2,1
GO:0016055,Wnt signaling pathway,2/173,466/18888,0.929502336500902,0.934218780831313,0.872255777381183,SEMA5A/TLE6,2
GO:0198738,cell-cell signaling by wnt,2/173,468/18888,0.930571922660777,0.934928872747367,0.872918771734282,SEMA5A/TLE6,2
GO:0016197,endosomal transport,1/173,289/18888,0.931423093059663,0.935258314214867,0.873226362663977,SNAP25,1
GO:0045859,regulation of protein kinase activity,2/173,470/18888,0.931626243091702,0.935258314214867,0.873226362663977,IL6R/SLC11A1,2
GO:0018209,peptidyl-serine modification,1/173,294/18888,0.934554006886104,0.937831865834652,0.875629220875358,PRKD2,1
GO:0051056,regulation of small GTPase mediated signal transduction,1/173,304/18888,0.940395788465623,0.942959172624213,0.880416453867635,MAP4K4,1
GO:0052547,regulation of peptidase activity,1/173,304/18888,0.940395788465623,0.942959172624213,0.880416453867635,BCL2L10,1
GO:0022407,regulation of cell-cell adhesion,2/173,496/18888,0.944030014505403,0.94601051615069,0.88326541395531,FLOT2/XCL1,2
GO:0007249,canonical NF-kappaB signal transduction,1/173,311/18888,0.944173602527097,0.94601051615069,0.88326541395531,FLOT2,1
GO:0009101,glycoprotein biosynthetic process,1/173,324/18888,0.950569065606841,0.952047975082698,0.888902432330662,B4GALT4,1
GO:0071496,cellular response to external stimulus,1/173,335/18888,0.955407857125115,0.956522251981793,0.893079948298995,KCNJ2,1
GO:0030522,intracellular receptor signaling pathway,1/173,369/18888,0.96758090306729,0.968333006373211,0.904107342486015,NR1H3,1
GO:0031331,positive regulation of cellular catabolic process,1/173,432/18888,0.982070380830306,0.982451915554794,0.917289800767358,ZFP36L1,1
GO:0031667,response to nutrient levels,1/173,490/18888,0.989625309610826,0.989625309610826,0.923987412223251,LRAT,1
